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Abstract
Extraction of outer membrane vesicles (OMVs) from Neisseria meningitidis for vaccine production 
relies exclusively on the use of detergent. Broader protection is induced from naturally formed 
vesicles but insufficient quantities are generated. Little is known about the mechanisms governing the 
release, morphology and composition of the OMVs. To identify factors involved in these processes 
two N. meningitidis proteins, GNA33 and RmpM, were examined. In addition the tol-pal genes from 
Escherichia coli, a complex which stabilises the outer membrane, were expressed in N. meningitidis. 
Increased vesicle release could be induced by deletion or mutation of RmpM, the structural protein 
binding the outer membrane to the peptidoglycan. Regulation of size and shape of vesicles was 
perturbed by the deletion of the GNA33 protein and by the expression of theTol-Pal proteins. 
Together these observations indicated a model of vesicle release controlled by selective 
disconnection of RmpM resulting in separation of the peptidoglycan from the outer membrane. 
Vesicle size is maintained by the even distribution of proteins that anchored the outer membrane to 
the peptidoglycan, including GNA33. A strain containing a mutated RmpM protein that lacked only 
the C-terminal peptidoglycan binding domain demonstrated the greatest increase in vesicle 
production. In addition, due to the presence of the RmpM N-terminal domain, this mutant 
maintained interaction with outer membrane proteins and produced vesicles enriched for the 
immunodominant protein PorA. This combination of PorA enrichment and increased vesicle release 
makes this strain an excellent candidate for vaccine production.
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Chapter 1- Introduction
It is a truth universally acknowledged that an infectious disease, that is serious and potentially life 
threatening, must be in want of a vaccine. The production of vaccines against disease caused by the 
pathogenic bacterium Neisseria meningitidis has been successful in eliciting protection against some 
forms of the disease, but neither individual vaccines against all forms nor a comprehensive vaccine 
have been achieved. With the failure of traditional methods of vaccine design to produce a global N. 
meningitidis vaccine, novel designs and delivery systems for vaccine antigens must be considered.
This in turn requires greater understanding of underlying processes that occur in the cell wall and 
outer membrane. It is one of these processes, the release of membrane vesicles, which is examined 
by this thesis.
1.1 Organism
N. meningitidis is a Gram negative diplococcal bacterium not known to have any environmental niche 
other than humans. The bacterium can cause clusters, endemic cases and epidemics of meningitis 
and septicaemia (135). N. meningitidis was first described in 1887 by Weischelbaum, who found Gram 
negative diplococcal bacteria in samples from six acute cases of cerebrospinal meningitis (28,33). The 
role of N, meningitidis as the causative agent of acute meningitis was described in a report of the 
Massachusetts medical board in 1898, commensal carriage of the organism was also described in this 
document (28). The organism colonises the nasal pharynx and is a commensal bacterium in 8-25% of 
the population (48). Among carriers, length of infection can vary from extended periods in about 25% 
of individuals, be intermittent in around 35% and transient in 40% (136).
N. meningitidis has been classified into twelve separate serogroups based on the capsular 
polysaccharide (CPS). Of these serogroups, six have been identified as the main causative agents of 
disease; serogroups A, B, C, W-135, X and Y. These serogroups are responsible for 90% of cases of 
meningococcal meningitis and septicaemia (48). The bacteria can also be classified by using
monoclonal antibodies against the variable antigens of the porin proteins PorA (variable regions 1 and 
2) and PorB and the outer membrane protein (OMP) FetA (41,171). Classification was further refined 
by the use of multi-locus sequence typing (MLST) which used regions of seven housekeeping genes to 
divide the bacteria into sequence types (ST) (86). Bacteria are now classed by the serogroup, PorA 
variable regions, FetA variable region (and PorB variable region if required) ST and clonal complex of 
the organism (66).
1.2 Disease
Disease prevalence of the different serogroups varies across the world; serogroups B and C are 
responsible for up to 90% of infections in developed countries, whereas in Africa disease is 
predominantly caused by serogroup A (48,100). In an area of sub-Saharan Africa known as the 
Meningitis belt meningococcal disease reoccurs as epidemics every 5-10 years (137). Infection is less 
common in developed countries. However, in the UK acute infection by N. meningitidis can result in 
fatality rates of up to 11% (50). Survivors of meningococcal disease can also suffer amputations and 
develop conditions such as epilepsy or deafness as a result of damage caused by the infection.
Among asymptomatic carriers of N. meningitidis progression to acute infection is rare; this may be 
due to immunity developed in these individuals. Invasion by the bacteria of the epithelial and 
endothelial cells and crossing over into the circulation can lead to clinical disease. A component of 
the Gram negative cell wall, Lipooligosaccharide (LOS) is important for the recognition of N. 
meningitidis by the innate immune system. Toll-like receptors 2 and 4 have been implicated as acting v 
as receptors for LOS (77). The adaptive immune response is also important in the immune response 
to N. meningitidis by activation of the complement system of bactericidal killing. The importance of 
complement in meningococcal infections is highlighted by individuals deficient in components of the 
complement pathway, who have an increased risk of meningococcal infection (77). It has been 
hypothesised that N. meningitidis is an 'accidental' pathogen. The bacteria are adapted to live 
. )
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commensally in humans and symptomatic infection is detrimental to the organism's survival (105).
The rapid onset and high fatality rate in untreated meningococcal infections indicate that it is not 
favourable to the bacteria to cause disease, as it prevents transmission of the organism.
Although it is possible to treat meningococcal infection with antibiotics, the rapid progression of 
disease means vaccination provides the best approach for controlling meningococcal infection. 
Vaccines to N. meningitidis can be produced using the CPS of the organism. CPS will provoke an 
immune response, however in order to produce a T-cell dependent response it is necessary to 
conjugate the CPS to protein carrier molecules such as diphtheria or tetanus toxoid. This approach 
has been successful in producing vaccines to serogroups A, C, W-135 and Y, but vaccines for 
serogroup B produced in this way do not elicit an effective immune response. This is thought to be 
due to the similarity of the serogroup B CPS to a human cell surface molecule, involved in neural cell 
adhesion. An immune response to the CPS is not induced in order to prevent autoimmunity (96). 
Alternative approaches have been used for the development of a vaccine to serogroup B 
meningococcus. Reverse vaccinology was used to identify new components of potential vaccines, and 
identified 29 proteins that induced bactericidal antibodies. This included the proteins Neisserial 
adhesin A (NadA), Factor H binding protein (fHbp) (GNA1870) and Neisserial heparin binding antigen 
(NHBA) (GNA2132), all of which have been considered as potential vaccine antigens (27,29,108,127).
1.3 The cell wall
N. meningitidis strains can be either encapsulated or unencapsulated, but all invasive (disease 
causing) strains express capsule (135). The N. meningitidis cell wall shares the typical structure of 
Gram negative bacteria; the outer membrane (OM) lies above a layer of peptidoglycan and below this 
lies the inner (cytoplasmic) membrane .(IM). The areas between the OM and peptidoglycan and the 
IM and peptidoglycan are called the periplasmic space (or periplasm). The capsule resides outside the 
outer membrane. N. meningitidis is capable of exchanging the genes responsible for capsule
3
production with other meningococci, leading to a process of capsule switching and resulting change in 
the serogroup of the organism (117). The outer membrane, peptidoglycan and inner membrane form 
a semi-permeable barrier around the cell, controlling the influx and efflux of molecules as well as the 
shape and size of the bacteria.
1.3.1 Peptidoglycan
Peptidoglycan is a network of glycan strands, containing chains of N-acetylglucosamine (NAG) and N- 
acetylmuramic acid (NAM) acid molecules linked by l,4-(3-glycosidic bonds. The chains are cross- 
linked by short peptides (usually pentapeptides) attached to the NAM residues (160). Modelling has 
demonstrated that the peptidoglycan forms a honeycomb like structure (94). The structure forms a 
rigid wall around the cell required to withstand the osmotic pressures of the cell and maintain cell 
shape. In E. coli the peptidoglycan is 2.5-7nm thick and has elastic properties due to movement 
allowed by the peptide bonds linking the glycan strands (160). The structure of peptidoglycan varies 
somewhat between Gram negative bacterial species. The peptidoglycan of N. meningitidis contains 
NAG-NAM chains crosslinked predominantly by tetrapeptides (4). Several antibiotics target 
peptidoglycan synthesis, as inhibition causes eventual lysis of the bacterial cells.
1.3.1.1 Peptidoglycan synthesis
i
Peptidoglycan synthesis (fig.l) begins in the cytoplasm. A NAM molecule linked to uridine 
diphosphate (UDP) is linked to amino acids by a series of enzymes called the Mur ligases. This forms 
short peptide chains (16). These peptides contain both L-amino acids and D-amino acids and include 
meso-diaminopimelate (m-DAP). Bacteria use racemase enzymes to convert L-amino acids to the D- 
amino acid form. D-alanine, which is important for the formation of the bond that links glycan 
strands, is produced using the enzyme D-alanine (D-ala) racemase. Once formed the D-ala residues 
are linked by the enzyme D-ala D-ala ligase. The racemase and ligase enzymes are both inhibited by 
the antibiotic D-cycloserine (point 1 fig. 1) (78,165).
Once completed the NAM-peptide molecule must be transported to the penicillin binding protein, 
which is positioned on the outer face of the inner membrane. The molecules are linked to a carrier 
lipid undecaprenyl phosphate which cycles between the inner and outer faces of the membrane. The 
pyrophosphate form (with two phosphates) of the lipid is dephosphorylated and linked to the NAM- 
peptide molecule in a reaction that requires UDP and releases uridine monophosphate (UMP). The 
NAG molecule is then added to the lipid-NAM-peptide. The carrier protein is 'flipped' to the outside 
face of the membrane and the NAG-NAM-peptide molecule is passed to the penicillin binding protein 
through a mechanism that has yet to be elucidated. The undecaprenyl pyrophosphate is recycled 
back to the inner face of the membrane (16,78).
The penicillin binding proteins (PBP) are multifunctional enzymes that catalyse the polymerization of 
the growing glycan chain through a transglycosylase activity, and the crosslinking of adjacent glycan 
strands through a transpeptidase activity. There are several different forms of PBP protein; the high 
molecular mass (HMM) proteins are those responsible for the incorporation of new glycan strands 
into the cell wall (124). N. meningitidis contains the PBP proteins PBP1 and PBP2 transcribed from 
the genes ponA and penA respectively (4,115). Penicillin resistance in N. meningitidis is linked to 
recombination of the penA gene with orthologues from commensal species (18). The transglycosylase 
function of the penicillin binding protein is blocked by glycopeptides including vancomycin (point 2 
fig. 1). Glycopeptides bind to the NAM-NAG-peptide precursor.at the D-alanyl-D-alanine portion and 
the bulky glycopeptide molecules prevent the transglycosylase having access to the precursor. 
Vancomycin is thought to act at the outer face of the inner membrane, but other glycopeptides cross 
this membrane and act at the point of transfer of the precursor to the penicillin binding protein (78).
After transglycosylation glycan strands are passed to the transpeptidase site of the penicillin binding 
protein. Here the strands are crosslinked by forming a peptide bond between the D-ala residue of one 
glycan chain and the m-DAP residue of an adjacent one. The energy required for this reaction is 
released by the cleavage of the peptide bond linking the terminal D-ala residue to the peptide (78).
The cross-linking reaction is inhibited by the penicillin fam ily of antibiotics (point 3 fig. 1). The
penicillins bind to  the transpeptidase site and are cleaved by the enzyme. However the product of 
this cleavage remains bound to the transpeptidase and the complex has a half life of the order o f 10 
minutes. This prevents the transpeptidase from catalyzing any further cross-linking reactions 
(78,172).
UDP—NAM
UDP—NAG
Periplasm
Transpeptidase
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membrane
D-kla
Transglycosylase
site
NAG—
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Protein  
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m-DAP
D-Ala
D-kla
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D-alanine racemase 
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Figure 1. Synthesis of peptidoglycan and action of antibiotics that inhibit peptidoglycan synthesis. The
synthesis of peptidoglycan from the cytoplasm to assembly in the periplasm. The inhibitory action of the 
antibiotics D-cycloserine, glycopeptides and penicillins are indicated at points 1, 2, and 3 respectively.
UDP—NAM < ------------------------- -----------UDP—NAM <
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1.3.1.2 Maintenance and degradation of the peptidoglycan
The peptidoglycan is maintained by the PBP proteins driving peptidoglycan synthesis and murein
hydrolases which cleave peptidoglycan fo r degradation, cell division and remodelling of the cell wall.
There are a large number of peptidoglycan cleavage enzymes, which are divided into three main
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groups. The /V-Acetylmuramyl-L-alanine amidases cleave the bond between the NAM molecule and L- 
alanine. Carboxypeptidases and endopeptidases cleave the peptide bonds in the amino acid linkages; 
carboxypeptidases remove the C-terminal amino acid whereas endopeptidases cleave within the 
amino acid chain. The peptidases are further categorised as LD (cleaving between an L amino acid and 
a D amino acid) or DD (cleaving between two D amino acids). Glycan strand cleaving enzymes are 
divided into three further groups; lysozymes, lytic transglycosylases and A/-acetylglucosamidases. N- 
acetylglucosamidases hydrolyse glycosidic bonds in a variety of substrates including peptidoglycan, N- 
glycans and chitins. The lysozyme and lytic transglycosylase enzymes cleave the same 3-1,4-glycosidic 
bond between NAG and NAM, however lytic transglycosylase enzymes also catalyse a 
transglycosylase reaction that forms a 1,6-anhydromuramic acid at the NAM residue. This reaction 
may conserve the energy from the cleavage of the (3-1,4-glycosidic bond, making it available for 
further rearrangement reactions (63,161). Gram negative bacteria usually contain multiple 
peptidoglycan hydrolases (161). In N. meningitidis only the lytic transglycosylase GNA33 has been 
positively identified (65). The hydrolases of Neisseria gonorrhoeae are better studied and in this 
species a family of lytic transglycosylases similar to those of E. coli have been discovered. N. 
gonorrhoeae produces cytotoxic peptidoglycan monomers using some of these enzymes. Although 
these enzymes (with the exception of GNA33) have not been positively identified, homologues to the 
genes encoding lytic transglycosylases are present in the N. meningitidis genome (26). In addition to 
the lytic transglycosylases, N. gonorrhoeae also contains other peptidoglycan hydrolases including the 
carboxypeptidase and endopeptidase enzymes PBP3 and PBP4 (134) as well as the amidase enzyme 
AmiC (44).
Enlargement and remodelling of the peptidoglycan requires the action of several peptidoglycan 
hydrolases. Work in E. coli has shown that lytic transglycosylases facilitate the breaking of bonds to 
allow the insertion of new peptidoglycan strands, whilst excess pentapeptides are trimmed from new 
peptidoglycan by DD-carboxypeptidases. Both these processes regulate cell wall growth (161). In cell
division, amidases, lytic transglycosylases and endopeptidases have all been implicated in the 
separation of the daughter cells in E coli by deletion analysis (161). The amidase AmiC is not required 
for cell separation in N. gonorrhoeae (44). Remodelling of the peptidoglycan is also required to allow 
large transmembrane complexes such as pili and flagella to pass through the cell wall (161). In N. 
gonorrhoeae the assembly of a type IV secretion system involved in the secretion of deoxyribonucleic 
acid (DNA) requires the presence of two lytic transglycosylase enzymes, AtIA and LtgX. The genes for 
both of these proteins are contained in the gene cluster of the type IV secretion system. It is thought 
that both enzymes produce breaks in the peptidoglycan allowing different proteins of the type IV 
system to interact with each other (72).
There is strong evidence that the proteins involved in murein synthesis and degradation in E. coli may 
form a multienzyme complex that controls peptidoglycan turnover and the shape of the organism. 
This complex would contain penicillin binding proteins, endopeptidases and lytic transglycosylases 
(61,62). Although the control of bacterial shape is different in £  coli and N. meningitidis (rod shaped 
bacteria and cocci respectively) the formation of complexes of the GNA33 protein with penicillin 
binding proteins implies a similar mechanism may be present in N. meningitidis (65).
1.3.2 The outer membrane
The outer membrane is considered to be the outermost layer of the cell envelope and as such must 
provide a selectively permeable barrier between the cell and the external environment. This 
membrane is a complex structure, composed of integral membrane proteins, lipoproteins, 
phospholipids and LOS (10). In order to be permeable to certain compounds, the OM contains protein 
channels to allow the influx and efflux of solutes that would normally be unable to cross the lipid 
bilayer; these are formed by integral OMPs containing (3-barrel structures. The correct folding and 
insertion of p-barrel OMPs in N. meningitidis requires the Omp85 protein complex (162,163). There is 
no energizing proton gradient across the outer membrane (unlike the inner membrane) and there is
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also no access to adenosine triphosphate (ATP) in the periplasm. Therefore transport processes are 
either passive, or rely on energy transduction from proteins in the inner membrane using the proton 
motive force that can be generated there (14).
1.3.2.1 Transport through the outer membrane
Passive transport occurs via non-specific protein channels, formed by the porin proteins (102). In N. 
meningitidis the porin proteins PorA and PorB are the most abundant proteins in the Neisserial OM. 
Although PorA shows a strong antigenic response, the response to PorB is much lower. PorA 
therefore, has been recognised as an important antigenic target for vaccine development (98). The 
porin proteins form complexes, with each other and with other OMPs including reduction modified 
protein M (RmpM). Although complex formation has been observed with several OMPs, recent 
evidence demonstrates that PorA, PorB and RmpM are the main proteins involved in porin complex 
formation in the outer membrane (89,119,121). In N. meningitidis and other Gram negative species, 
the TonB system provides active transport across the outer membrane. Transport is energized by a 
proton motive force generated in the inner membrane by the proteins ExbB and ExbD (57). This 
energy is transduced across the outer membrane by the TonB protein which binds to transporters in 
the outer membrane through an N-terminal motif on the transporter proteins called the Ton-box 
(19). The TonB system has been linked to the transport of iron and other molecules in N. meningitidis 
and proteins shown to bind to TonB include the iron acquisition proteins HmbR and TbpA (107), In E. 
coli and other Gram negative bacteria a second transport system with a high level of similarity in the 
inner membrane proteins to the TonB system has been identified (57,111). This complex, the Tol-Pal 
complex, is not present in N. meningitidis.
1.3.2.2 Lipooligosaccharide
LOS forms the major part of the outer surface of the outer membrane and N. meningitidis expresses 
12 immunologically distinct LOS types (69). LOS consists of a lipid molecule, lipid A, linked to an
oligosaccharide core region. In some Gram negative bacteria the core region is linked to 
polysaccharide, producing lipopolysaccharide (LPS), but this is not the case in N. meningitidis (14). LOS 
is an important virulence factor for N. meningitidis. Mutation of genes involved in the assembly of 
LOS affects the adhesion of bacteria to epithelial cells and their invasion as well as the survival of the 
bacteria in the blood (110). LOS is an endotoxin and in the host exposure leads to the up-regulation of 
pro-inflammatory cytokines through pathways including those linked to Toll like receptor 4. The 
response of Toll like receptor 4 differs between N. meningitidis strains, probably due to variation in 
Lipid A (113). Inflammation caused by LOS is a major factor in the pathogenesis of meningococcal 
disease. LOS is also bound by the complement factor C4b and O-acetylation in the core 
oligosaccharide is thought to disrupt this binding in some LOS types (69). LOS is a good antigen and 
has been considered as a vaccine candidate, using a peptide antigen that mimics a bactericidal LOS 
antigen (142). However, the inflammatory properties of LOS make it an undesirable component of 
vaccine preparations; strains that produce no detectable LOS can be produced in N. meningitidis by 
mutation of the IpxA gene, part of the pathway of LOS synthesis (133). This is despite IpxA being an 
essential gene in E. coli (42). However, the undetectable levels of LOS in these strains were shown to 
be caused by the insertion of a second truncated copy of the IpxA gene. Deletion of the IpxA gene in 
N. meningitidis could not be achieved and the gene may also be essential in N. meningitidis, despite 
the ability to produce mutants with no detectable LOS (174). Reduction of the number of acyloxyacyl 
linked fatty acids linked to the lipid A molecule, through mutation of the genes IpxLl or lpxL2, also 
reduces the endotoxin activity of LOS. However, only LOS produced from the IpxLl mutated strains 
maintained adjuvant activity (154). The mutation of Ipxl singly, and in combination wtih mutations to 
the genes synX and IgtA which prevent the expression of carbohydrate structures similar to. those 
found on human cells as part of the LOS, is being tested as a method of detoxifying LOS for vaccine 
production (150,176).
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1.3.2.3 Organisation of proteins in the outer membrane
Organisation of proteins in the outer membrane is a complex process, involving insertion and 
assembly of the proteins into the outer membrane. A complex of proteins, named the Omp85 
complex, has been identified in E. coli and N. meningitidis involved in the organization of p-barrel 
proteins in the outer membrane. The first protein identified in this complex was Omp85 (BamA in E. 
coli) (14). BamA associates with the proteins BamB, BamC, BamD and BamE, although only BamD and 
BamA are essential. Homologues of the genes for BamC, BamD (previously named ComL) and BamE 
were found in the N. meningitidis MC58 genome. The BamD protein is also essential in N. 
meningitidis; BamC and BamE were both non-essential proteins. In N. meningitidis RmpM also
associates with the Omp85 complex, stabilizing the protein interactions (162). The importance of the
< >
Omp85 protein in correct assembly of OMPs was demonstrated by the aggregation of unfolded OMPs
in N. meningitidis bacteria depleted for Omp85. The same aggregation of proteins did not occur in E.
coli (15). This is presumably because the unfolded proteins activate the aE stress response pathway
which prevents further translation of OMPs and upregulates the transcription of chaperones and
protease (1,15). N. meningitidis lacks several of the genes active in this pathway (see table 1. pg. 16)
(15).
1.3.2.4 Disruption of the outer membrane
v
Disruption of the outer membrane can be caused by a variety of agents, including cationic detergents, 
chelating agents such as ethylenediaminetetraacetic acid (EDTA), large and small polycationic 
peptides and proteins and calcium and magnesium ions. Most of these agents act by interaction with 
the LPS or LOS. In the case of the chelating agents, chelation of stabilising divalent cations from the 
LPS leads to its destabilisation and release. By contrast it is hypothesised that calcium and magnesium 
ions bind to the LPS and alter the fluidity of the LPS layer. LPS is also disrupted by the binding of 
cationic peptides and detergents (148). The antibiotic polymyxin B is an example of a detergent like.
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molecule that functions by disruption of both the outer membrane and inner membrane. Polymyxin B 
binds first to the LPS in the outer membrane and disrupts the structure, leading to permeabilisation 
of the outer membrane. The antibiotic is then able to penetrate to the inner membrane, where the 
disruption of the structure leads to the leakage of the cell contents. This is the lethal action of the 
antibiotic (78,148). N. meningitidis is not susceptible to polymyxin B; this is thought to be due to 
modifications of the lipid A molecule and is also related to the Mtr efflux pump. The presence of the 
PorB protein also effects the sensitivity of N. meningitidis strains to polymyxin B (146).
1.4. Outer membrane vesicles
A unique feature of Gram negative bacteria is the blebbing of the outer membrane into structures 
called outer membrane vesicles (OMVs). These structures are 10-300nm in diameter and consist of 
outer membrane: OMPs; LOS and phospholipids as well as containing constituents of the periplasm 
(10,35). Although OMVs have been observed from many bacterial species, including E. coli, generally 
only very low amounts are released. In contrast, certain Gram negative bacterial species including N. 
meningitidis, and bacteria in the genera of Porphyromonas and Treponema produce larger amounts 
of OMVs during normal growth (58).
In a typical Ercoli or Pseudomonas aeruginosa culture, OMVs constitute about 1% of the total OM 
material present. In contrast, about 8-12% of the protein and endotoxin content of a typical N. 
meningitidis culture is comprised of OMVs (35). This far greater abundance of OMVs produced by N. 
meningitidis could indicate that different mechanisms are responsible for the release and 
composition of vesicles in different species. Transmission electron microscopy images of native OMVs 
(produced without the use of detergent to extract vesicles from the organism) from N. meningitidis 
and other Gram negative species are similar in shape and appearance, although some variation in size 
and differences in electron density within the vesicles can be observed (6,37,68,92,101). However, 
without a comprehensive study to compare OMVs from different species using a single methodology
for preparation and examination of the samples, it is difficult to say how much of this difference may 
be due to differences in preparation methods. The proteomic profiles of natively derived vesicles 
from high vesicle producing mutants of N. meningitidis and E. coli have been examined in two studies 
by Scorza et al. and Ferrari et al. (6,37). Comparison of the two profiles showed that both E. coli and 
N. meningitidis vesicles were constituted mainly and possibly exclusively by outer membrane and 
periplasmic proteins. The similar OMV proteomic profiles of the two species indicated that a common 
mechanism may be responsible for the release of vesicles in both species (6).
1.4.1 Functions of outer membrane vesicles
The function of OMVs continues to be debated and several different hypotheses have been proposed.
Outer membrane vesicles are involved in the transfer of DNA and in its uptake (90), the transfer of
proteins and in the delivery of antimicrobial agents. In P. aeruginosa, under conditions of restricted
nutrition, OMVs can deliver an autolysin (a peptidoglycan hydrolase) to other bacteria of the same
species or those with similar peptidoglycan chemotypes and cause lysis (90). Outer membrane
vesicles can also modulate virulence in several species, including Neisseria. Vesicles may provide a
mechanism for the release of virulence factors by several bacteria, which protects such factors from
dilution by diffusion and inactivation by host factors (10). In addition P. aeruginosa uses OMVs to
deliver virulence factors directly to the cytoplasm of host cells. These factors include phospholipase C,
proteases and haemolysins and aid invasion of the bacteria (13). In N. meningitidis the ADP-ribosyl
transferase enzyme NarE (a potential toxin), is present in a subgroup of hypervirulent group B strains.
The mechanism for delivery of the toxin to eukaryotic cells has been putatively linked to OMVs
(35,91). It is also thought that the OMVs may increase the inflammatory response in meningococcal
sepsis, probably due to endotoxin (a virulence factor) contained within the OMV (95). Neisserial
OMVs may also modulate the immune response by binding bactericidal factors in serum, preventing
them binding to the organism (74). Also meningococcal OMVs may have an immunosuppressive
function, inhibiting the proliferation of CD4+ T-cells due to binding of neisserial Opa proteins to the
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human coinhibitory receptor carcinoembryonic antigen-related cellular adhesion molecule 1 (79). 
OMVs are also used as a method of both intra-and inter-species communication and communication 
between prokaryotes and eukaryotes, such as in the symbiotic relationship between Rhizobium 
species and leguminous plants (90). OMV production in E. coli is affected by the disruption of genes in 
the envelope stress response pathways aE and Cpx. Impairing either of these pathways leads to an 
increase in vesicle production; however vesiculation is not directly controlled by either pathway. 
There is a relationship between the production of vesicles and the amount of misfolded protein 
present in the periplasm and it has been hypothesised that vesiculation may be a method of 
removing this material directly (93). Vesicle release can be activated by agents that produce envelope 
stress, such as ethanol, and low vesiculation mutants show decreased survival when exposed to these 
agents. However, the mechanism for activating this response is not clear (93).
1.4.2 Release of outer membrane vesicles
Several mechanisms have been hypothesised for the release of outer membrane vesicles in Gram 
negative bacteria. In E. coli the formation of OMVs is predominantly the result of the mutation of 
genes involved in the structure of the OM and peptidoglycan or links between them. This indicates 
that the release of OMVs may be a function of disruption of the connections between the outer 
membrane and the peptidoglycan. However, OMV release is independent of overall membrane 
instability (92). Models of vesicle release in Gram negative organisms have indicated that the release 
of outer membrane vesicles is due to turgor pressure in the periplasmic space leading to bulging and 
eventual blebbing of the outer membrane. Turgor pressure may be due to muramyl peptides 
produced from peptidoglycan turnover (175) or from membrane stress caused by misfolded protein 
present in the outer membrane (93). An alternative explanation for the blebbing of the outer 
membrane is that the membrane is disconnected from the peptidoglycan due to changes in the 
density of proteins linking the outer membrane to the peptidoglycan and inner membrane (31).
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Several genes affect the release of membrane vesicles in E. coli and other Gram negative bacteria, 
these genes and their potential homologues in the N. meningitidis genome are shown in table 1.
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The genes which affect the release of membrane vesicles in Gram negative bacteria are involved in a 
variety of pathways. Several are involved in envelope stress responses; others are involved in 
peptidoglycan synthesis and turnover, synthesis of LPS and outer membrane stability. In addition 
genes encoding lipoproteins have also been implicated in changes to vesicle release. The diverse 
nature of the gene products involved does not support any one theory of the causes of vesicle 
release.
1.4.3 Outer membrane vesicle vaccines
Due to the inherent problems of producing a capsular vaccine for serogroup B N. meningitidis, other
approaches have been sought. One of the most promising of these approaches is using OMVs to
produce vaccine based on the antigens displayed on the bacterial outer membrane. Outer membrane
vaccines for serogroup B N. meningitidis are effective as a method of immunisation against meningitis
epidemics. Serogroup B OMV vaccines have been used for control of epidemic strains in New Zealand,
Cuba and Norway and the vaccines have been shown to be both safe and immunogenic against these
strains (11,17,59,167). The New Zealand vaccine is 80% effective in reducing the risk of infection
among children under five years (43)(97). Outer membrane vesicle vaccines are most effective when
dealing with clonal outbreaks of disease. In a situation where disease is caused by several different
meningococcal strains or where the vaccine strain is not homologous to the epidemic strain, the
levels of protection are reduced. This is due to antigenic variation, leading to poor cross reactivity of
the antibodies produced. In addition, variation in expression of antigenic proteins, particularly PorA,
also affects cross reactivity. Vaccines of this type, therefore, are often referred to as 'tailor made'
OMV vaccines. (59,141). Proteomic analysis of the New Zealand vaccine identified forty proteins,
including seven proteins thought to be key proteins in the antigenic response: Omp85, FetA, PorA,
PorB, RmpM, OpcA and NspA (159). The specificity of OMV vaccines has been attributed to PorA
which is the immunodominant antigen both in vitro and in animal models (123) and is the major
target for the bactericidal immune response elicited by the New Zealand OMV vaccine (87). The
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degree of cross reactive immunity induced by OMV vaccines is predominantly due to the variation of 
PorA antigens (141). PorA is known to have hyper-variable regions present in the surface exposed 
parts of the protein. The two variable surface exposed loops, designated VR1 and VR2, can elicit 
bactericidal antibodies. Evolutionary pressure to escape the immune response has resulted in distinct 
families of VR1 and VR2 sequences, which need to be represented in any broad spectrum vaccine 
based on PorA (118). As PorA is the immunodominant target for bactericidal antibodies, attempts 
have been made to engineer a broader-spectrum OMV vaccine by the inclusion of several different 
PorA subtypes in a single OMV formulation (153). Vaccines of this kind produce broader protection 
(106); however the level of bactericidal response varies between different subtypes of the PorA 
antigen. This difference is probably the result of differing immunogenicity among PorA subtypes. 
Evidence suggests that the immunogenicity of these PorAs can be improved by using a heterologous 
prime boost strategy for immunisation (83). Also, although these vaccines induce broader protection, 
the protection is still limited primarily to the PorA subtypes contained within the vaccine (155).
More recent strategies for design of an OMV vaccine for group B N. meningitidis have included three 
approaches: the combination of multiple PorA subtypes into vesicles, the use of OMVs from the 
commensal species Neisseria lactamica, or the combination of OMVs with purified proteins in a 
vaccine formulation. The combination of multiple PorA subtypes has been produced in the vaccines 
HexaMen and NonaMen (six and nine PorA variants, respectively). NonaMen has been predicted to 
cover 75% of the strains circulating globally. However up to four doses of the vaccine may be required 
in the primary immunisation to cover some of the least immunogenic PorA subtypes (60). In addition 
the ability of N. meningitidis to rapidly change the subtype or expression levels of PorA is likely to lead 
to the need to periodically reformulate the vaccine (51). The vesicles of the commensal species N. 
lactamica provided a potentially attractive alternative to N. meningitidis vesicles, as N. lactamica has 
been implicated in the development of immunity to N. meningitidis in young children. Immunisation, 
with N. lactamica vesicles also protected mice against lethal challenge with several N. meningitidis
Istrains (52). A phase I clinical trial of an N. lactamica OMV vaccine showed that the vaccine was 
immunogenic and produced similar antibody levels and bactericidal activity as the Norwegian N. 
meningitidis OMV vaccine against heterologous strains. Results indicated that N. lactamica vesicles 
could be used as an adjuvant or in a combination vaccine with purified proteins, although it was 
unlikely a successful vaccine candidate could be produced using them alone (51).
Combination vaccines, using both OMV and recombinant purified proteins have also shown success in 
clinical trials. The Novartis vaccine rMenB has been produced in two formulations, one without OMV 
(rMenB) and one containing OMVs from the NZ98/254 strain (rMenB-OMV). Both vaccines contain 
recombinant proteins: fHbp sub-variant 1.1 fused to the lipoprotein GNA2091, NHBA sub-variant 2 
fused to GNA1Q30 and NadA variant 3. The functions of the GNA2091 and GNA1030 proteins are not 
known, but the fusion proteins increase the stability and immunogenicity of the fHbp and NHBA 
proteins (38). The OMVs from the NZ98/254 strain included in rMenB-OMV contain PorA subtype 
P I.7-2,4 (82). Clinical trials have shown that the OMV component increases the immunogenicity of 
the vaccine; this is thought to be due to an adjuvant effect of the LPS contained in the OMVs or the 
effects of the presence of other protein antigens in the OMV. In addition the presence of PorA 
produces a strong immune response to homologous strains (38,130). The rMenB-OMV vaccine shows 
better potential to produce cross-protection than monovalent OMV vaccines and can also induce 
immunological memory (38). Although this vaccine needs to be tested against a wider strain panel to 
fully establish the levels of cross-protection to strains heterologous for the vaccine antigens 
produced, the combination of purified protein and OMV offers the best option currently for a cross- 
protective N. meningitidis group B vaccine.
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1.4.4 Production of outer membrane vesicles
The specificity of the immune response to an OMV vaccine is not solely dependent on the protein 
composition in the OMV, and can also be affected by the methods used to produce the vaccine. 
Although N. meningitidis produces a greater number of vesicles than most other Gram negative 
species, producing sufficient OMVs for vaccine production is usually accomplished by detergent 
extraction using deoxycholate. Deoxycholate extraction also removes much of the endotoxic LOS 
component of OMVs. The lack of cross reactivity in OMV vaccines may be due in part to this process, 
as OMVs could become contaminated by proteins from other sub-cellular fractions not found in 
naturally released 'native' vesicles. Proteomic analysis of detergent extracted compared to natively 
produced OMVs showed that detergent extracted OMVs contain a number of proteins which localise 
to the inner membrane and cytoplasm. In contrast native OMVs were composed almost exclusively of 
OMPs and contained more OMPs. Immunisation with native OMVs also produced a broader range of 
bactericidal antibodies than immunisation by detergent extracted OMVs from the same strain 
(37,150). The use of detergent also removes some lipoproteins, including the important protein 
antigens fHbp and NHBA, and can promote vesicle aggregation (150). To improve the quality of OMV 
vaccines it is desirable eliminate detergent extraction, in order to minimise the contamination with 
cytoplasmic proteins, prevent the loss of lipoproteins and improve the consistency of OMV 
composition between batches of, vaccine.
OMV release is likely to be controlled by proteins and structures related to the structure of the cell 
wall and outer membrane. Three proteins that are involved in vesicle release in E. coli and N. 
meningitidis are examined in more detail, the N. meningitidis lytic transglycosylase GNA33, the OMP 
RmpM and the £. coli protein complex Tol-Pal.
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1.5. GNA33
In the search for suitable vaccine antigens that could be exploited in a vesicle vaccine several 
candidate proteins were identified (109). Genome derived Neisserial antigen 33 (gna33) was derived 
from the Neisserial genome and found to be a potential mimetic antigen, which could elicit an
antibody response by mimicking loop 4 of the PorA protein in serotype P1.2 strains. (53). The GNA33
/
protein shares 41.3% amino acid sequence homology with the lytic transglycosylase MltA in E. coli. 
Despite significant, sequence homology with the E. coli MltA protein, GNA33 only shares 21.5% 
structure identity by x-ray crystallography. However the protein also shares significant sequence 
homology with the LtgC protein of N. gonorrhoeae (95% amino acid identity). GNA33 is a lipoprotein 
of 44.5kDa which attaches to the outer membrane and peptidoglycan and produces degradation 
products from the murein cleavage reaction which indicate that it is acting as a lytic transglycosylase 
(65). The structure of the N. gonorrhoeae LtgC protein has been mapped by X-ray crystallography and 
has been shown, like MltA, to contain several domains. The N-terminal domain (domain 1) comprises 
a (3-barrel and domain 2 forms part of the active site of the enzyme, producing a groove between 
domain 1 and domain 2. Both these domains are equivalent between ItgC (and potentially GNA33) 
and MltA; however MltA lacks domain 3 which in LtgC is formed by a 66 amino acid insertion into 
domain 2 forming a small (3-barrel. The presence of domain 3 causes the relative positions of domains 
1 and 2 to vary between LtgC and MltA, the effect of which is to make the groove between the two 
domains wider in ItgC than in MltA. The amino acids forming this loop are also present in GNA33. The 
loop may be of importance as conserved residues and homology between MltA and other lytic 
transglycosylases indicate that part of the active site of the enzyme is positioned in this groove, 
thought to be important in binding the glycan strand. However, the two enzymes share conserved 
residues in the active site and probably share a common reaction mechanism (112).
\
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1.5.1 Deletion of gna33
Characterisation of a Agna33 mutant in several strains (MC58, BZ232 and NMB) showed that the 
bacteria exhibited changes in viability; they produced fewer colonies than the equivalent wildtype 
strain and growth appeared to be retarded (2). Morphology of the cells was also different. Rather 
than the normal diplococci, cells grew in clusters where the inner membranes and peptidoglycan 
were separated, but the outer membrane was continuous. The mutant also released OMPs into the 
medium and showed decreased virulence, possibly due to increased susceptibility to complement 
mediated lysis (2). The release of OMPs is due to an abnormally high level of OMV production from
Agna33 (37). The predicted function of GNA33 Is to anchor to both the outer membrane and the
\
peptidoglycan and the loss of this link may cause the vesicle releasing phenotype.
Compared to the phenotype of MltA mutants Of E. coli, which show no change in growth or release of
OMPs (81), the phenotype of the Agna33 mutant is surprisingly severe. The lack of phenotype in the
AmltA mutant has been hypothesized to be due to functional redundancy. E. coli contains seven
recognized lytic transglycosylases, the membrane bound enzymes MltA, B, C, D, F and EmtA and the
soluble lytic transglycosylase Slt70 (81). N. meningitidis contains homologues for all these proteins
(65), but apparently does not demonstrate the same level of functional redundancy. The other lytic
transglycosylase proteins have not been cloned and assayed, so it is not known if these proteins are
functional. In N. gonorrhoeae, several lytic transglycosylase genes have also been identified and the
mutation of one (ItgC, which shares homology with mltA) produces a phenotype very similar to that
of the Agna33 mutant (25). Other lytic transglycosylases ItgA (slt70) a(nd ItgD (mltB) have been
identified as being involved in the release of peptidoglycan monomers from N. gonorrhoeae and lytic
transglycosylases of unknown function ItgB (mltC) and ItgE (m ltD ) have also been identified (26). The
two Neisserial species therefore appear to have a similar functional arrangement in their lytic
transglycosylases, a single lytic transglycosylase (GNA33 or LtgC) that is primarily responsible for
peptidoglycan processing and turnover and several other lytic transglycosylases that perform other
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/functions in N. gonorrhoeae and for which functions have not been elucidated in N. meningitidis. In E. 
coli the family of murein hydrolases, including the lytic transglycosylases are important in diverse 
functions including murein turnover, autolysis, spore formation, cell elongation and cell division (63). 
The other lytic transglycosylases in the N. meningitidis genome may therefore be found to perform a 
variety of functions.
1.6. Tol-Pal
Tol-Pal is a complex of proteins spanning the inner and outer membranes and is found in many Gram 
negative bacteria. Tol-Pal has a variety of functions, including transport of molecules across the cell 
wall, a structural role and a function in the final separation of the outer membrane during cell division 
(45,49). Deletion of the tol-pal gene cluster in E. coli will produce a phenotype which is detergent 
sensitive, tolerant of filamentous bacteriophages and molecules such as colicin A which use the Tol- 
Pal complex to cross the membrane, fails to separate during cell division and releases larger numbers
- I
of vesicles into the medium (7,45,156). The Tol-Pal complex forms a link between the inner 
membrane, peptidoglycan and outer membrane and is wide spread among Gram negative bacteria. 
However, it is lacking in species including: N. meningitidis; N. gonorrhoeae; Borrelia burgdorferi; 
Treponema pallidum  and Porphyromonas gingivalis. In a phylogenetic tree based on ribosomal 
ribonucleic acid (rRNA) these bacteria do not have close relationships to each other and are more 
closely related to bacteria containing the Tol-Pal complex, indicating that the loss of the tol-pal cluster 
was not a single evolutionary event in a cluster of Gram negative bacteria (139). Bacteria that lack 
the tol-pal cluster all produce OMVs at a higher rate than other Gram negative bacteria 
(12,34,129,175).
1.6.1 Structure of the tol-pal operon
The Tol-Pal complex consists of five proteins: TolQ, ToIR, TolA, TolB and Pal. The operon which 
encodes these also contains another two genes; ybgF and ybgC whose functions do not appear to be
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related to the Tol-Pal complex. ybgF is a periplasmic protein of unknown function and ybgC is a 
cytoplasmic protein w ith thioesterase activity (49,55). The genes are arranged in an operon w ith two 
promoters, the first prom oter (Pi) reading from ybgC to ybgF and the second (PB) from tolB to  ybgF 
(Fig.2). Although the first prom oter is capable of reading through the entire operon to produce one 
long polycistronic messenger ribonucleic acid (mRNA) the majority of transcription of tolB, pal and 
ybgF is controlled by the PB promoter (156). Both promoters have Rho-dependent term inators. The 
translation of toIR is dependent on tolQ translation; this is due to the toIR ribosome binding site being 
non-functional. In order to  translate toIR therefore, it is necessary to use the ribosome from tolQ 
translation. (156).
P I PB
Figure 2: The tol-pal operon. The genes of the tol-pal complex are arranged in a single 6kb operon along with the 
two genes of unknown function, ybgCand ybgF.
1.6.2 Structure of the Tol-Pal complex
The proteins of the Tol-Pal complex are distributed in the inner membrane, the periplasm and the 
outer membrane. TolQ and ToIR are both inner membrane proteins, TolQ contains three 
transmembrane (TM) domains, whereas ToIR contains one TM and two periplasmic domains. ToIR 
shows the capacity to dimerise and the 3rd transmembrane domain of TolQ appears to be able to 
interact w ith both ToIR and the ToIR dimer. The tw o proteins interact w ith each other and w ith TolA, 
which also contains a TM domain. TolA contains three domains, TolA I is the inner membrane domain 
interacting with TolQ and ToIR whereas Tol A II and III are periplasmic. The TolA III domain appears to 
regulate interaction w ith the periplasmic TolB protein and both TolA and TolB have also been shown 
to  interact w ith Pal and w ith  porins (164). The interaction between TolA and Pal shows that TolA must 
cross both the periplasm and the peptidoglycan layer (22). Pal interacts at the N-terminal glyceride 
moiety with the outer membrane and at the C-terminal end w ith peptidoglycan. Pal dimerises both in
tolA
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vitro and in vivo and interacts with several other OMPs including major lipoprotein (Lpp) and outer
i
membrane protein A (OmpA). Interactions with Lpp and OmpA are independent of the presence of 
/ '' 
the Tol proteins, however TolB interacts with Lpp and OmpA in a Pal dependent manner (21). The
interaction between Pal and TolA appears to form two complexes, a major TolA/Pal heterodimer and
a minor TolA/Pal multimer. Interaction also appears to be driven by a proton motive force (PMF),
i
treatment with carbonyl cyanide m-chlorophenylhydrazone (CCCP) which blocks the production of 
membrane potentials, inhibits the TolA/Pal interaction. Homology with, the TonB system in E. coli 
suggests that TolQ and ToIR may be responsible for the production of the PMF and complexes of 
TolA/TolQ and TolA/ToIR are observed with or without CCCP treatment (22). Overproduction of TolQ 
and ToIR drives the co-precipitation of Pal with overproduced TolA. It is therefore hypothesised that 
TolQTM helices II and III and the ToIR TM helix form an ion pore which produces the proton motive 
force to drive the TolA/Pal interaction. As the ratio of TolQ to ToIR has been estimated to be 3:1 the 
construction of the pore.is likely to be more than a simple heterodimer (23). A diagram of the Tol-Pal 
complex is shown in figure 3.
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Outer Membrane
Inner Membrane
Figure 3: The arrangement of the Tol-Pal complex in the E. coli cell wall. The IM proteins TolQ and ToIR provide 
a proton motive force allowing TolA to interact with Pal. TolB interacts with both proteins. Pal also interacts 
with other proteins in the OM including Lpp and OmpA. TolB interacts with these proteins in a Pal dependent 
manner.
1.6.3 Functions of the Tol-Pal complex
Peptidoglycan
The mutation of several genes of the to l-po l complex affects both the membrane integrity and 
production of vesicles from  E. co li cells. Deletion of tolA, tolQR, tolBPal, tolB  and pol produce a 
vesicle releasing phenotype; however tolQR  and to lA  mutants release a greater amount of vesicles 
than tolB  and pol mutant strains. Mutants of to l-pa l express low levels o f the OMPs, OmpF and LamB 
(7) and demonstrate other indicators of outer membrane defects, including susceptibility to 
vancomycin and detergents and the release of RNase I. It is possible to  restore the TolA phenotype by 
plasmid complementation of the Afo/A mutant. A plasmid carrying to lA  will also reduce susceptibility 
to sodium dodecyl sulphate (SDS) and vancomycin and reduce the level of OMV release in A lpp  
mutants; however this effect is not be seen if pal is also mutated. Similarly, overproducing Pal in an 
A/pp mutant complements the mutation, but not if there is also a Ato/A mutation. Lpp is not capable 
of complementing a Apo/ m utant (21,22). The interaction between TolA and Pal is vital fo r the
maintenance of membrane integrity by the Tol-Pal complex. The interaction between TolA and Pal is 
abolished if the TolA III domain is deleted; this is also the domain that governs the interaction 
between TolA and TolB. The TolA/TolB interaction is also important for maintaining membrane 
integrity and both TolA and TolB interact with porins. The Tol-Pal complex may affect porin 
biogenesis or help to regulate porin activity (164).
The importance of tol-pal operon is highlighted as it is highly conserved among Gram negative 
bacteria, even though the complex also allows the entry of some bacteriophages and bacteriocins 
into the ceil. Tol-Pal certainly appears to perform an important structural role in anchoring the 
peptidoglycan to the outer membrane as is evidenced by the membrane instability seen in Tol-Pal 
mutants. The role of the Tol-Pal complex is nbt purely structural. Experiments have indicated that 
the Tol-Pal complex may be involved in the transport of macromolecules through the outer 
membrane. In E. coli, Pseudomonas putida and P. aeruginosa mutation of genes in the tol-pal 
complex resulted in bacteria defective in the utilisation of several carbon sources due to a failure to 
uptake these carbon sources at the cytoplasmic membrane (80). Mutants of tolA and pal have 
defects in the polymerisation of the 016 antigen in E. coli, possibly due to an extra-cytoplasmic stress 
response which is activated in these mutants (158) or indicating that Tol-Pal has a role in the 
transport of subunits through the outer membrane (49). There is evidence that apart from its 
structural and transport roles, the Tol-Pal system may also be important in the division of bacterial 
cells. Tol-Pal proteins localise to the site of cell constriction during cell division in and are involved in 
the proper invagination of the outer membrane by attaching the outer membrane to the inward 
moving peptidoglycan and inner membrane. In addition A tol-pal mutants also have a 'chaining' 
phenotype consistent with a failure of proper separation of the OM during cell division and the 
production of rpembrane blebs from mutant E. coli appears to be localised to the poles of constricting 
cells. The interaction between TolA and Pal in such a system would involve TolA engaging Pal before 
retracting back, pulling Pal and the OM inwards, this could possibly explain the requirement of a PMF
for JolA-Pal interaction (45). The Tol-Pal complex appears to have several possible physiological roles 
in Gram negative bacteria related to the structure and function of the bacterial cell wall, therefore its 
absence from N. meningitidis could be important in understanding the membrane dynamics and 
vesicle release of the organism.
1.7. RmpM
RmpM is one of the five major OMPs from N. meningitidis (144) and binds to both the peptidoglycan
and outer membrane. Additionally, RmpM has a role in stabilising protein complexes. The RmpM
protein shares 94.2% amino acid homology with the gonococcal Class III OMP (RmpG) (70) and shares
35% homology at the C-terminal end with the E. coli protein OmpA, known to be involved in the
binding of peptidoglycan (54). RmpM has unusual electrophoretic mobility in the presence of SDS,
appearing 6kDa larger than the predicted size of the protein calculated from the amino acid
sequence. Similar behaviour has also been seen in gonococcal class III OMP (70). The OmpA like
domain of RmpM contains a hydrophilic groove hypothesised to contain the conserved residues
essential for peptidoglycan binding. The binding of RmpM to peptidoglycan has been shown both by
Western blot and through computer docking analysis of a glycan strand with the putative structure of
the OmpA like domain. It has been proposed that RmpM may act as a dimer to bind two glycan
strands simultaneously and weak dimer/monomer equilibrium for the protein has been
demonstrated, although dimer formation for RmpM has not been observed directly. Although the C-
terminal end of RmpM contains as conserved motif for peptidoglycan binding, the N-terminal domain
does not contain a recognized motif for binding with the outer membrane (54). RmpM interacts with
several other OMPs, the iron regulated OMPs lactoferrin receptor LbpA, transferrin receptor TbpA
and siderophore receptor FetA. LbpA, TbpA and FetA oligomers are decreased in an ArmpM mutant
strain, indicating that RmpM has a stabilizing effect on these protein complexes. However, RmpM
does not appear to be involved in iron acquisition (114). Similarly, RmpM interacts with the porins,
PorA and PorB, and is important in stabilising porin complexes (88). These interactions are likely to
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be responsible for anchoring RmpM to the outer membrane allowing it to act as a bridge between the 
peptidoglycan and outer membrane (64). RmpM is involved in heteroligomeric complexes of PorA,
i
PorB and RmpM and also of PorA, PorB, FetA and RmpM (88,89,119). By forming linkages between 
the peptidoglycan and the outer membrane RmpM may be involved in maintaining the structural 
stability of the membrane. As well as complexes with the porins RmpM is important in the 
Stabilisation of the Omp85 protein complex, which organises (3-barrel proteins in the outer membrane 
(162).
1.7.1 RmpM in virulence
Analysis of neisserial strains by Southern blotting demonstrated that the rm pM  gene was present in 
N. meningitidis but not in commensal species including Neisseria lactamica, Neisseria mucosa and 
Neisseria sicca. It was therefore hypothesised that RmpM could be used as a marker of virulence 
(169). However, later analysis by of chromosomal DNA and detection of RmpM protein in OMVs 
showed that RmpM was present in strains of N. lactamica and N. sicca (143). It was also 
hypothesised that antibodies to RmpM protein may be blocking the bactericidal response to OMV 
vaccines, analogous to the effect of gonococcal protein III (70). Subsequent work showed that anti- 
RmpM antibodies were immunogenic although not bactericidal and that inclusion of RmpM in an 
OMV vaccine made no difference to the bactericidal response (116).
1.7.2 Deletion of rmpM
The apparent importance of RmpM as a structural protein means that a knockout mutant would be 
expected to exhibit phenotypic changes similar to those seen in mutants of other proteins linking the 
outer membrane to the peptidoglycan. However the tsrmpM mutant strain is similar to the parent 
strain in terms of growth curves, colony morphology and the overall profile of OMPs (70). The 
decrease of protein complexes which usually contain RmpM in a mutant strain indicates that deletion 
of rm pM  does destabilise these complexes. However in OMV preparations that have been freeze-
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dried the presence of RmpM does not increase the stability of PorA trimers and may in fact 
destabilise them (5). There has been little research into the effect of rm pM  deletion on the structure 
and release of OMVs. There is no difference in the quantity of OMVs produced when extracted by 
detergent, but Arm pM  mutants release more vesicles naturally than the wild-type strain (5,150). The 
lack of obvious phenotypic features (other than OMV release) like those observed in Agna33 and 
Atol-pal mutants may indicate functional redundancy of the structural role of RmpM with other OMPs 
such as GNA33 fulfilling its role. The importance of RmpM in a variety of outer membrane 
interactions, between both proteins and peptidoglycan and in the formation of oligomeric complexes 
means that the protein may be very important in the structure and antigenicity of OMV vaccines. The 
interaction of RmpM with PorA and porin complexes is likely to be particularly important for vaccine 
production as the presentation of PorA on the cell surface may be affected.
1.8. Aims of thesis
The release of membrane vesicles from N. meningitidis is an important part of the biology of the 
organism; however the factors governing the release of vesicles are poorly understood. The process 
of vesiculation has been studied in other Gram negative bacteria such as E. coli and several 
hypotheses have been proposed for the mechanisms of membrane vesicle release, but the relevance 
of these hypotheses to vesiculation in N. meningitidis has not been examined. The aim of this thesis is 
to investigate the factors affecting vesicle release in N. meningitidis, by elucidating the role of 
proteins that have been previously shown to affect vesicle production. The N. meningitidis lytic 
transglycosylase GNA33 and the OMP RmpM will be studied, as well as investigating the effect of 
expression of the E. coli protein complex Tol-Pal. Examination of the effects of these proteins on both 
the phenotype of the organism and the vesicles produced by the bacteria will provide insights into 
both the mechanisms of vesiculation in N. meningitidis and the best methods for the adaption of the 
bacteria to produce native OMVs for vaccine production.
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Chapter 2- Materials and Methods 
2.1 Materials
All chemicals were obtained from either Sigma-Aldrich Chemicals (St Louis, MO, USA) or BDH AnaIR
r
grade'(Surrey, UK) unless otherwise stated. All restriction enzymes and restriction enzyme buffers 
were obtained from New England Biolabs (Ipswich, MA, USA) unless otherwise stated. EDTA used 
was the disodium salt. All water was purified using a Milli-Q purification system (Millepore, Billerica, 
MA, USA).
2.1.1 Solutions
Common buffers and broth used in the study and their formulations are given in table 1 below:
Table 1. Formulations of commonly used solutions.
Name Formulation
Phosphate buffered saline (PBS) 137mM sodium chloride 
2.7mM potassium chloride 
lOmM Disodium hydrogen phosphate 
1.8mM potassium dihydrogen phosphate 
pH 7.4 adjusted with Hydrochloric acid
Tris(hydroxymethyl)aminomethane (Tris) buffered 
saline (TBS)
137mM sodium chloride 
Tris24.8mM
pH 7.4 adjusted with Hydrochloric acid
Tris-acetate EDTA buffer (TAE) 40mMTris
ImMEDTA
0.1% (v/v) Glacial acetic acid
Tris-EDTA buffer (TE) lOmMTris 
Im M  EDTA
pH 7.5 adjusted with Hydrochloric acid
Saline-sodium citrate buffer (SSC) 20X 3M sodium chloride
0.3M sodium citrate
pH 7 adjusted with Hydrochloric acid
Luria Lysogeny Broth (LB) Broth/Agar (8) 10g/LTryptone (Oxoid, Cambridge, UK)
8g/L sodium Chloride
5g/L Yeast Extract (Oxoid)
pH 7.5 adjusted with sodium Hydroxide
For agar: 15g/L Agar Flakes (Sigma-Aldrich)
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2.1.2 N. meningitidis strains
The strains of N. meningitidis used in this work are listed in table 2 below. The sources of the strains 
- were Health Protection Agency Manchester Laboratory Services (HPA-MLS), Oxford University (OU) 
and the Norwegian Institute of Public Health (NIPH).
Table 2. N. meningitidis strains.
Strain
name
Serogroup PorA variable 
regions
FetA variable 
region
PorB type ST Clonal
complex
Source
H44/76 B P I.7,16 F3-3 15 ST-32 cc32 H PA-MLS
MC58 B P I.7,16-2 . Fl-5 15 ST-74 cc32 OU
Name Background strain Mutation Source
gna33
Downstream 
single crossover
H44/76 Insertion of linearised plasmid downstream 
of gna33
c
This study
gna33 Upstream 
single crossover
H44/76 Insertion of linearised plasmid upstream of 
gna33
This study
Agna33 H44/76 &gria33 This study
kgna33 MC58 kgna33 This study
H44/76v.tolFT H44/76 Strain containing the pMIDGTolFl plasmid This study
gna33 single 
crossover ::tol-pal
gna33 downstream 
single crossover
Strain containing the pMIDGTol-Pal 
plasmid
This study
gna33 single 
crossover: :tolFl
gna33 downstream 
single crossover
Strain containing the pMIDGTolFl plasmid This study
LsiaD MC58 As/oD C. Tang (36)
ArmpM H44/76 Ar/np/VJ NIPH (70)
RmpM C-term H44/76 Deletion of the final 207 bases of the 
rmpM gene
This study
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2.1.3 E. coli strains
i '
The strains of E. coli used in this study are listed in table 3. 
Table 3. E. coli strains.
Strain Genotype Source
OneshotToplO F- mcrA A{mrr-hsdRMS-mcrBC) 
4>80/ocZAM15 A/ocX74 recAl 
oroD139 A(oro/eu)7697 go/U 
galK rpsl (StrR) endAl nupG
Invitrogen, Carlsbard, 
CA, USA
5-alpha F' lq F' proA+B+ laqlq A(LacZ)M15 
zzfr.tTnlO {Tet*)/fhuA2A(argF- 
lacZ)U169 phoA glnV44 
08OA(lacZ)M15 gyrA96 recAl 
relA l endAl thi-1 hsdR17
New England Biolabs
TB28TolQ-Pal (Atol-pal) rph l ilvG rfb-50 laclZYA 
<>frttolQ-pal<>
Gerding et al. (45)
2.1.4 Plasmids
Plasmids used in this study are listed in table 4. 
Table 4. Plasmids used in this study.
Plasmid Name Description Source
pCR2.1 Topo Topo cloning vector. Contained complementary 5'-thymidine 
overhangs bound to topoisomerase enzyme, lacZa gene and 
ampR and kanR antibiotic resistance genes.
Invitrogen
pUC19 Cloning vector. Contained lacZa gene and ampR resistance 
gene.
Invitrogen
pBSUDGNA33ERM For deletion of gna33 gene by homologous recombination. 
Contained ermC antibiotic resistance gene flanked by 
sequences homologous to the flanking sequences of the gna33 
gene. Also contained ampR resistance gene.
Adu-Bobie 
et al. (2)
pMIDG201 Shuttle vector for E. coli and N. meningitidis. Contained 
constitutive meningococcal promoter ner, kanR resistance gene 
and the RepA origin of replication.
J.S. Kroll 
(103,104)
TopoTFl pCR2.1Topo cloning vector. Contained the E. coli genes ybgC, 
tolQ, toIR and partial tolA and promoter Px.
This study
TopoTF2 pCR2.1 Topo cloning vector. Contained the E. coli genes partial 
tolA, tolB and pal and promoter PB.
This study
TopoTF3 pCR2.1 Topo cloning vector. Contained the E. coli genes tolQ, 
toIR and to!A.
This study
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TopoTF4 pCR2.1 Topo cloning vector. Contained the E. coli genes tolB 
and pal.
This study
pMIDGTolFl pMIDG201 vector. Contained E.coli genes ybgC, tolQ, toIR and 
partial tolA and promoter Plt
This study
pMIDGTolF3 pMIDG201 vector. Contained E.coli genes tolQ, toIR and tolA 
under control of the ner promoter.
This study
pMIDGTol-Pal pMIDG201 vector. Contained E.coli genes ybgC, tolQ, toIR, tolA, 
.tolB and pal under control of the Px and PB promoters.
This study
pMIDGTol-Palner pMIDG201 vector. Contained E.coli genes tolQ, toIR, tolA, tolB 
and pal under control of the ner promoter.
This study
pMIDGTol-Pal
recovered
pMIDG201 vector. pMIDGTol-Pal after recombination byN. 
meningitidis, contained kanR gene and RepA origin of 
replication.
This study
pMIDGTol-Palner
recovered
pMIDG201 vector. pMIDGTol-Palner after recombination by N. 
meningitidis, contained kanR gene and RepA origin of 
replication.
This study
pMIDGTol-PalPmB pMIDG201 vector. pMIDGTol-Pal after recombination by N. 
meningitidis strain gna33 downstream single crossover. 
Addition of PmB origin of replication to pMIDGTol-Pal.
This study
TopoRmpM pCR2.1Topo cloning vector. Contained the N. meningitidis gene 
rmpM.
This study
TopoKan2 pCR2.1 Topo cloning vector. Contained a second copy of the 
kanR gene.
This study
pUCRmpM pUC19 cloning vector. Contained the N. meningitidis gene 
rmpM.
This study
pRmpMC-term pUC19 cloning vector. Contained the N. meningitidis gene 
rm pM  truncated at 523bp. Contained kanR resistance gene.
This study
2.2 Microbiological methods
Microbiological techniques were carried out in a Class II microbiological safety cabinet unless 
otherwise stated. 1
2.2.1 Propagation and maintenance of N. meningitidis strains
N. meningitidis strains were maintained as frozen stocks at -70°C on Protect Beads (Technical Services 
consultants, Lancashire, England). To produce frozen stocks, single colonies were selected and ' 
inoculated onto Mueller Hinton (97) agar plates (Oxoid). A loop of the resulting culture was 
resuspended into the protect beads cryo-protectant media following the manufacturer's instructions. 
The media was then drained and the beads stored at -70°C.
For revival of frozen stocks a single bead was extracted from the vial and used to inoculate an agar 
plate of blood agar base No.2 (Oxoid) containing 7% v/v of defibrinated horse blood (Oxoid). After 
inoculation plates were incubated at 37°C in an atmosphere containing 5% carbon dioxide for 
approximately 15 hours (overnight).
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Routine culture of N. meningitidis strains was carried out on Mueller Hinton agar containing the 
selection antibiotics kanamycin (at 75pg/ml) and erythromycin (at 7pg/ml) where appropriate. For 
liquid culture Mueller Hinton broth (Oxoid) was used with appropriate selection antibiotics used at 
the same levels as in the agar plates.
2.2.2 Propagation and maintenance of E. coli strains
E. coli strains were frozen on protect beads by the same methods used for the N. meningitidis strains. 
E. coli were revived on LB agar plates, plates were incubated at 37°C for approximately 15 hours 
(overnight). .
Routine culture of E. coli strains was carried out on LB agar plates containing appropriate selection 
antibiotics ampicillin (at 50|ig/ml), erythromycin (at 150pg/ml) and kanamycin (at 50|ig/ml) as 
appropriate. Liquid cultures were carried out in LB broth with selection antibiotics at the same levels 
used in the plate culture. For the TB28TolQ-Pal strain 1% sodium chloride was added to the LB broth 
and LB agar used in the culture of this strain.
2.2.3 Transformation of E. coli OneShot ToplO and NEB 5-alphaF'lq
Transformation of E. coli was carried out according to manufacturer's protocols where commercial 
cells were used. E. coli OneShot ToplO cells (Invitrogen) were thawed on ice. Once thawed DNA was 
added to the cells and the E. coli incubated on ice for 30 minutes. Cells were then heat shocked at 
42°C for 30 seconds and placed back on ice. 250pl of Super Optimal broth with Catabolite repression 
(SOC) (Invitrogen) Was added to the cells and tubes were incubated for 1 hour at 37°C with shaking.
After incubation bacteria were centrifuged at 17,000xg for one minute and the resulting pellet 
resuspended in lOOpI of the SOC media. This suspension was inoculated onto pre-warmed LB plates 
containing selection antibiotics. Blue/White selection was used to identify colonies containing 
plasmids carrying DNA inserts. Blue/White selection used the lacZa gene which was present in the 
pCR2.1 Topo plasmid and the pUC19 plasmid. The a fragment encoded by the lacZa gene 
complements the deleted portion of the host strain's LacZ protein to allow synthesis of functional 3- 
galactosidase. This cleaves the substrate X-gal to a blue coloured product. Cloning of an insert into 
the multiple cloning site of the plasmid disrupted the LacZa gene; when the gene was disrupted 
functional enzyme was no longer produced, therefore colonies that contained vector and insert were 
capable of growing on antibiotic containing media but appeared white rather than blue when the 
media also contained X-gal. For blue/white selection plates were spread with 40pl of 40mg/ml 
bromo-chloro-indolyl-galactopyranoside (X-Gal) in dimethylformamide (USB Corporation, Cleveland, 
OH, USA) and allowed to dry for one hour. Plates were incubated overnight at 37°C.
The method for 5-alpha F' lq cells (New England Biolabs) was similar to the method for the 
OneShotToplO cells, with the following amendments: Cells were incubated for five minutes on ice 
after heat shock and were recovered in 950pl SOC media (New England Biolabs). For blue/white
i
selection in 5-alpha F' lq cells plates were spread with 40pl 40mg/ml X-Gal and contained 0.3mM  
isopropyl 3-D-l-thiogalactopyranoside (IPTG).
2.2.4 Production of competent E. coli from strain TB28TolQ-Pal
A single colony was inoculated into 5ml LB broth and grown overnight. 1ml of the suspension was 
then used to inoculate 100ml of LB broth and the culture was grown for 1-2 hours until it had reached 
optical density at 600nm (OD600) of 0.25. Optical density was measured in a WPA biowave C08000 cell 
density meter (WPA, Cambridge, UK), using polystyrene semi-micro cuvettes (VWR International,
West Chester, PA, USA). After growth the culture was placed on ice for ten minutes and the bacteria
were then.centrifuged at 15000xg for 10 minutes at 4°C. The cell pellet was gently resuspended in 
10ml ice cold 0.1M calcium chloride and incubated on ice for 20 minutes. The suspension was then 
centrifuged for 5 minutes at 6000xg 4°C. The pellet was resuspended in 5ml 0.1M calcium chloride 
with 15% glycerol. Cells were dispensed into lOOpI aliquots and frozen at -70°C.
2.2.5 Transformation of competent TB28TolQ-Pal
i
For competent cells produced in the lab, DNA was added to thawed cells and cells were incubated on 
ice for 30 minutes. Cells were then heat shocked for 2 minutes at 42°C and then placed back on ice. 
Bacteria were recovered in 900pl LB broth for 1 hour at 37°C with shaking. Cells were then spun down 
and resuspended in lOOpI before being spread onto selective LB plates.
pv
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2.2.6 Growth curves
N. meningitidis were grown overnight in 3ml Mueller Hinton broth in 7ml bijou tubes (Thermo Fisher 
Scientific, Waltham, MA, USA) with appropriate selection antibiotics to adapt the bacteria to growth 
in the media. Bacteria were then resuspended from the overnight culture into 13mls of fresh Mueller 
Hinton broth to an OD600 of 0.05 in 30ml Universal tubes (Thermo Fisher Scientific) and grown at 37°C 
with shaking for eight hours. The OD60o value of the culture was tested every hour. Results were the 
mean of three experiments.
2.2.7 Antibiotic sensitivity assays (solid media)
The method for antibiotic sensitivity assays on solid media was adapted from the work of Jorgensen 
et al (67). Bacteria were grown overnight in selection antibiotics. After growth bacteria were 
resuspended to an OD600 of 0.15 in sterile 145mM sodium chloride solution. Antibiotic containing . 
discs were produced using sterile filter paper discs (Sigma-Aldrich). Discs were soaked in antibiotic 
solutions of appropriate concentrations for three minutes and then air-dried for 30 minutes before 
use. Antibiotics used were D-cycloserine 6mg/ml, vancomycin 25mg/ml, polymyxin B 12.5mg/ml and
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ampicillin 5pg/ml. Mueller Hinton plates containing 5% Defibrinated horse blood were prepared and 
inoculated with bacteria from the saline solution using a sterile swab. After inoculation disks were 
placed on the surface of the plates. Plates were incubated overnight. Zones of inhibition were 
measured using an Allied Vision firewire camera (Allied Vision Technologies, Stadtroda, Germany) on 
a Kaiser RS3 XA stand with RB 218 Light set (Kaiser Fototechnik, Buchen, Germany). Images were 
analysed using the ProtoCOL software (Synbiosis, Cambridge, UK). Calibration was set using the 
diameter of the plate and zones measured using the manual measure feature. Results were the mean 
of three experiments.
2.2.8 Antibiotic sensitivity assays (liquid media)
Bacteria were grown overnight in Mueller Hinton broth with selection antibiotics to adapt the 
bacteria to growth in the media. Bacteria were resuspended in broth with selection antibiotics and 
grown to an OD600=1.2. Cells were split into 2ml samples and centrifuged for 1 minute at 9600xg to 
pellet the cells. The growth media was removed and replaced with fresh media containing lOpg/ml 
polymyxin B, 3pg/ml ampicillin or control media without antibiotics. Bacteria were incubated in the 
media for two hours and then serially diluted to a 10'6 dilution. 50pl of this dilution was plated out 
onto Mueller Hinton agar with and without selection antibiotics. Plates were grown for 24 hours and 
colonies were counted. Results were taken as the mean of three experiments.
2.2.9 Temperature sensitivity studies
Bacteria were grown overnight in Mueller Hinton broth to adapt them for growth in the media. 
Bacteria were resuspended into fresh Mueller Hinton broth at an OD600= 0.05 and were grown with 
shaking for 7 hours at 35°C, 37°C and 39°C. After 7 hours OD600 readings were taken from the 
cultures. Results were a mean of three experiments.
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2.2.10 Native OMV production
The method for native OMV production was adapted from that of Ferrari et al. (37). Bacteria were 
grown from frozen stocks overnight and then subcultured onto blood plates and grown for seven 
hours. Plates were then scraped and the bacteria resuspended into 4mls of Mueller Hinton broth 
which was then used to inoculate 50-150ml broth to an OD600=0.15. Broth cultures were grown 
overnight and the bacteria were then centrifuged at 7400xg 4°C for 1 hour. After centrifugation the 
supernatant was removed and passed through a 0.2pm stericup filter (Mijjepore) by vacuum 
filtration. The filtrate was placed into ultracentrifuge bottles and centrifuged for 2 hours at 200000xg 
4°C. The supernatant was poured off and 10ml PBS was added to each bottle to wash the pellet. The 
sample was centrifuged for 30 minutes at 200000xg 4°C, then the supernatant was removed and the 
PBS wash step repeated. Pellets were resuspended in 500pl PBS buffer containing 3% sucrose. After 
resuspension OMV samples were purified by fast protein liquid chromatography (FPLC) using an 
instrument consisting of a Pharmacia gradient programmer GP-250 Plus and a liquid chromatography 
controller LCC-500 Plus, driving high precision pumps P-500 (Pharmacia Biotech, St Albans, UK). 
Samples were first centrifuged at 8,600xg 4°C for 15 minutes to remove insoluble debris. Supernatant 
was diluted to 600pl with water and separation was carried out on a Superdex 200 column 
(Amersham biosciences, Sweden). The column was equilibrated with PBS pH7.4 and calibrated with 
protein standards. Flow rate was 500pl per minute for a total time of 60 minutes. Protein content was 
monitored by Refractive Index (Rl) and Ultraviolet (UV) spectroscopy using a Lambda 600 
spectrophotometer (PerkinElmer, Waltham, MA, USA). Flow through fraction containing the OMV 
was collected and pooled. For electron microscopy, 1500pl of flow through fraction was 
ultracentrifuged for 2 hours at 200000xg 4°C and OMVs resuspended in 50pl PBS.
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2.2.11 Phenotype testing of the TB28TolQ-Pal strain
This method was used for testing the phenotype of the TB28TolQ-Pal strain when transformed with 
the pMIDGTol-Pal plasmids. The method was adapted from Gerding et al. (45). Bacterial growth on 
SDS and Deoxycholate (DOC) media was initially tested and it was found that 0.5% DOC gave the 
clearest differentiation between the wildtype and Ato/-po/ phenotype. LB agar plates were made 
containing DOC. Bacteria were grown overnight in broth culture, after growth overnight suspensions 
were diluted to an OD60o=0.02 and serially diluted to 10'4. 5pl of each suspension was spotted onto 
the plate and the plates incubated for 24 hours at 30°C. Plates were photographed using Allied vision 
firewire camera and stand. Photographs were taken with the ProtoCOL software. After the first 
incubation, plates were incubated for a further 72 hours at room temperature and then 
photographed again.
2.3 Molecular biology techniques for DNA
2.3.1 Preparation of Genomic DNA
Genomic DNA extractions were carried out using the Wizard Total genomic DNA extraction kit 
(Promega, Fitchburg, Wl, USA) according to the manufacturer's instructions. Bacteria were 
resuspended from plate culture in 600pl nuclei lysis buffer and incubated for 5 minutes at 80°C. After 
incubation the cells were cooled to room temperature and 3pl of RNase A (4mg/ml) was added. The 
suspension was incubated at 37°C for 15-60 minutes. After incubation 200pl protein precipitation 
solution was added and the suspension was vortexed for 20 seconds before being incubated on ice 
for 5 minutes. After incubation the suspension was centrifuged for 3 minutes at 17000xg and the 
supernatant mixed with 600pl of 2-propanol. After 2 minutes centrifugation at 17000xg the 2- 
propanol was decanted and the DNA pellet washed with 1ml of 70% (v/v) ethanol. The pellet was 
centrifuged for another 2 minutes at 17000xg and the ethanol was then aspirated off and the pellet
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allowed to air dry for 15 minutes. The pellet was then resuspended in lOOpI DNA resuspension buffer 
by incubating at 65°C for 1 hour.
2.3.2 Preparation of plasmid DNA
2.3.2.1 Small scale preparation of plasmid DNA from £. coli
Plasmid was extracted from E. coli using the GenElute miniprep kit (Sigma). Broths inoculated with a 
single colony were grown overnight at 37°C with shaking in 3-5ml of LB broth. 1.5-3ml of broth 
cultures were centrifuged at 17000xg for 2 minutes. Culture medium was discarded and the cell pellet 
was resuspended in 200pl resuspension buffer. 200pl Lysis buffer was added and the solution allowed 
to clear. 350pl neutralisation buffer was added and the preparations were centrifuged at 17000xg for 
10 minutes. GenElute columns were prepared by eluting 500pl of column preparation solution 
through the column. After centrifugation, the supernatant was removed from the plasmid 
preparations and added to the column and centrifuged for 1 minute at 17000xg. Columns were then 
washed with 750pl wash solution and dried by centrifugation for 1 minute at 17000xg. Plasmid DNA 
was eluted from the column using 50pl elution buffer.
2.3.2.2 Large scale preparation of plasmid DNA from £. coli
For large scale plasmid production the Qiagen tips plasmid extraction kit was used (Qiagen, Venlo,
The Netherlands). Two sizes of Qiagen tips, P100 and P500, were used and the volumes for both tip
sizes are listed. Broths of 50ml or 200mLculture were inoculated from starter cultures and grown
overnight. Cells were pelleted for 10 minutes at 6000xg, 4°C. Supernatant was removed and cell
pellets resuspended in 4ml or 10ml Resuspension buffer P I containing RNase. 4ml or 10ml Lysis
buffer P2 was then added and the solution allowed to clear. After clearing 4ml or 10ml of chilled
Neutralisation buffer P3 was added and the culture was incubated for 15-20mins on ice before being
centrifuged for 30minutes at 13000xg, 4°C. Elution columns P100 and P500 were prepared by adding
4ml or 10ml equilibration buffer QTB respectively. After centrifugation supernatant was loaded on to
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the tips and allowed to pass through the resin by gravity flow. Tips were washed twice with 10ml or 
30ml wash buffer QC. Elution buffer QF was used to elute DNA from the columns. Eluted DNA was 
mixed with 0.7 volumes of 99% 2-Propanol and centrifuged for 30 minutes at 12000xg 4°C. 
Supernatant was decanted and the pellets washed with 1ml or 5ml 70% (v/v) ethanol. Pellets were 
then centrifuged for 10 minutes at 12000xg; 4°C. Ethanol was decanted and pellets allowed to air dry 
for 10-15 minutes before resuspension in 500pl of TE buffer.
2.3.2.3 Plasmid preparation from N. meningitidis
)
Plasmid was extracted from N. meningitidis using Qiagen tip P20 plasmid extraction kit (Qiagen). 
Method was the same as for Qiagen tips used above, with 0.3ml of the buffers PI, P2 and P3 used, 
lm l QBT was used to equilibrate the columns and 2x2ml used to wash the columns. 0.8ml QF was 
used to elute the plasmid and lm l of 70% (v/v) ethanol was used to wash the pellet. All centrifugation 
steps were carried out at 17,000xg. DNA was resuspended in 50pl TE buffer.
2.3.4 Oligonucleotide Primers
The names and sequences of desalted oligonucleotide primers (Invitrogen) used in this work are given 
in table 5. The lengths of the primers are given in bases.
Table 5. Oligonucleotides used in this study.
Primer Length (bases) Sequence
GNAUpstreamF 27 GAATTCCGAACACAATGAACAATGTCC
GNA33UpstreamR 25 GGATCCATGCTCTTGCTTTGGCAGG
GNA33DownstreamF 23 GGATCCCACGGGATATGTGTGGC
G N A33Downstrea m R 24 AAGCTTTTTAGTAGGGACAACCGG
M13 Forward 16 GTAAAACGACGGCCAG
M13 Reverse 17 CAGGAAACAGCTATGAC
GNA33 UpstreamDNAF 33 ATGCCGTCTGAACGAACACAATGAACAATGTCC
T7 Forward 20 TAATACGACTCACTATAGGG
GNA33SF1 18 CT G CACAG AAT CCT G AAG
GNA33FlankRev 19 CG AACG AACAAG G AT G ATG
GNA332F 18 GAG G G ATT CGT CAT GTT G
GNA333R 18 G G AACAT CTGTG GTATG G
T3 Reverse 20 AATTA ACCCT CACTA AAG G G
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GNA33TestFor 18 GG AAAG AGCT GT AT GT CG
GNA33TestRev 18 CGTCTATACCGTTGTACC
GNA33RNAF 23 GGTAG G AG CTG CCAG ACATAT CC
GNA33RNAR 23 G CCA AAG CAAG AG CAT CCAAACC
PorARNAF 24 CAAG CCATT GAT CCTT G G G ACAG C
PorARNAR 25 GTCGAAACCATGGGCATAGCTGATG
gdhRNAF 23 CGAACGTTTCGCATATCTCAAAG
gdhRNAR 23 CGTTAATCACATCCAGCAGCAGG'
Tol-PalFl 25 CTCGAGCTGTGCTGGTGTGATTCAC
Tol-PalRl 18 CTTACCAGAGCTTAGCTC
Tol-PalF2 19 GCAGCTGATAAG AAAG C AG
Tol-PalR2 25 CCCGGGAACCAGTAACGACAGACTC
Tol-PalnerFl 24 GGATCCTCGTGCGCTTCCCAAGTC
Tol-PalnerRl 31 CCCG GGGGTACCTCG CG ATT ACG GTTT G AAG
Tol-PalnerF2 24 GGTACCGCCATCGGTCCAGATAAG
T1F1 18 GTTAGCGAGAGCAACAAG
T1R1 19 CTGTT CAT CAG A ACG CTT C
T1F2 19 CTGCAGCTGATAAGAAAGC
T2F1 18 GTTCTATGACGCATCGTC
T2F2 19 CTACGTT GTT CAG ACCAAC
T2R2 18 GAATGAAGCCACCTGACG
T2R1 18 GACCTGTCCATCAGTTGC
T2F3 19 CTGGACAAGTACGATATCC
T2R3 19 G AGTT CTG AG CAAGTACAG
SF1 18 GTAAAGGTCCAATTCTCG
SF5 18 CTGATCTGGAGTTCGTTC
SR6 18 CGCTTTCTf ICIIGCTTC
pMIDG SeqR 22 GGCTTTACACI 1 lAl'GCTTCCG
pMIDG SeqF 19 G CAGT CTCTCG AG CT CAAG
KanF 18 GTT CCACAT CAT AG GTG G
KanR 19 G ACAAGT GGTAT G ACATT G
KanF2 18 CCTTAGCAGGAGACATTC
KanR2 19 G AAG AACAGTAT GT CG AG C
SF7 18 CGGATGGTTCTTACAATG
SF8 19 GTAATGGTCAGCTCCAATG
SF9 18 CAGGGAGATGTTGTATTC
RmpM F 26 G AATT CG ATGGT CAGGTT G AC 111 CG
RmpM R 26 AAGCTTGCTCAATCGCTGCAACTGAC
RmpM DNA F 31 ATGCCGTCTGAAGTTGCTTCTGTATCTGCTG
RmpM partial R 25 TCTAGAAACAGGTACGCCGTTGCTG
RmpM partial F 25 TCTAGAATTTCTGCTGTCGGCTTGG
RmpM X2 25 CCCGGGCGTTGAGTATTGACAGTCC
RmpM X3 25 CCCG GGGTTGCTTCTGTATCTG CTG
RmpM Kan R 28 TCTAGATAAGTGTGATGGATATCTGCAG
RmpM Kan F 26 ATGCATCTTGGTACCACTCCAGCATG
RmpM long F 26 CGTTGCATTGCTCGCTTCCGGCACTG
RmpM long R 24' GT CAG GTT CG ATACAT G CAAT CAG
RmpM short R 24 GCTGACCAGGTTGTTTGCCACTAC
' ■ \
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2.3.5 Polymerase chain reaction
Polymerase chain reaction (PCR) was used for the amplification of DNA regions using the primers 
Ijsted in table 3. For PCR the Amplitaq DNA polymerase kit (Applied Biosystems, Foster City, CA, USA) 
was used. Deoxynucleoside triphosphates (dNTPs): deoxyadenosine triphosphate (dATP), 
deoxyguanosine triphosphate (dGTP), deoxythymidine triphosphate (dTTP) and deoxycytidine 
triphosphate (dCTP) (Invitrogen) were used. PCR reactions were incubated in either a DNA Engine (MJ 
Research, Waltham, MA, USA), DNA Engine Dyad (Bio-Rad Laboratories, Hercules, CA, USA), or the 
Veriti 96 well thermal cycler (Applied Biosystems). Reactions were carried out in 0.2ml thin walled
i
P PCR tubes (Thermo Fisher Scientific). For multiple PCR reactions a master mix of all the components 
excluding the template DNA was set up and the mixture aliquoted into reaction tubes. After 
amplification results were examined by agarose gel electrophoresis. The reaction mixture used for 
PCR is detailed in table 6.
Table 6. Reaction mixture used for PCR.
Reagent Concentration
10X Amplitaq PCR buffer 1 r IX
dNTPs 10mM of each dNTP
Forward Primer lpM ol/pl
Reverse Primer IpM ol/pl
Template DNA ~20ng
Amplitaq DNA Polymerase 0.05U/pl
Magnesium Chloride (MgCI2) Solution 25mM Determined by experiment
Water To required total volume
For colony PCR the template DNA was not included and instead colonies were inoculated directly into 
the PCR mixture. Reactions were incubated in the thermal cycler following the programme listed in
r-
table 7:
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Table 7. Thermocycler reaction conditions used for PCR.
X 30 cycles
The annealing temperatures, extension times and concentration of MgCI2 used in each PCR reaction 
were determined empirically. The conditions used for the each PCR reaction are shown in table 8.
Table 8. Reaction conditions for primer pairs used in this study.
Forward primer Reverse primer Annealing
temperature
Extension
time
MgCI2
concentration
GNA33UpstreamF GNA33UpstreamR 57°C 2 minutes 2.5mM
GNA33DownstreamF GNA33DownstreamR 57°C 2 minutes 2.5mM
GNA33TestFor GNA33TestRev 50°C 2 minutes 1.5mM
GNA33TestFor GNA332F 50°C 2 minutes 1.5mM
GNA333R GNA33SF1 50°C 2 minutes 1.5mM
T3 Reverse GNA33TestRev 50°C 2 minutes 1.5mM
GNA33RNAF GNA33RNAR 58°C 2 minutes 1.5mM
Tol-PalnerFl Tol-PalnerRl 63°C 3 minutes 1.5mM
Tol-PalnerF2 Tol-PalR2 63°C 3 minutes 1.5mM
Tol-PalFl Tol-PalRl 58°C 3 minutes 1.5mM
Tol-PalF2 Tol-PalR2 58°C 3 minutes 1.5mM
Tol-PalFl Tol-PalR2 58°C 5 minutes 2.5mM
T2F2 pMIDG SeqR 50°C 3 minutes 1.5m M
SF1 T1R1 50°C 3 minutes 1.5mM
SF1 SR6 50°C 3 minutes 1.5mM
SF5 T2R2 50°C 3 minutes 1.5mM
RmpM F RmpM R 54°C 2 minutes 1.5mM
RmpM partial F RmpM R 50°C 2 minutes 1.5mM
RmpM F RmpM partial R 50°C 2 minutes 1.5mM
RmpM X2 RmpM partial R 50°C 2 minutes 1.5mM
RmpM X3 RmpM partial R 50°C 2 minutes 1.5mM
RmpM X3 RmpM R 54°C 2 minutes 1.5mM
RmpM Kan F RmpM Kan R 58°C 2 minutes 1.5mM
RmpM X3 RmpM Kan R 54°C 2 minutes 1.5mM
RmpM DNA F RmpM R 58°C 2 minutes 1.5mM
Temperature Time Function
95°C 3 minutes Denaturation of the template DNA in 
colony PCR also the lysis of the 
bacteria
95°C 30 seconds Denaturation
Annealing temperature 30 seconds Annealing of primers to template 
sequence
72°C Extension time Extension byTaq polymerase
72°C 10 minutes Final extension and addition of poly­
adenosine to the ends of PCR products
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2.3.6 Restriction digestion
For restriction digestions of plasmid DNA the mixture shown in table 9 was used. 
Table 9. Reaction mixture used for restriction digestions of plasmids
Component Volume
Restriction enzyme 3U-20U (dependant on enzyme)
10X Bovine Serum Albumin (BSA) (New England biolabs) IX
10X Restriction Enzyme buffer IX
Plasmid DNA ~200-500ng
Water To a total volume of lOpI
Reactions were incubated at 37°C for one hour. Results were examined by agarose gel 
electrophoresis. 1
To prepare DNA from plasmids for ligation a different reaction mixture was used, shown in table 10. 
Table 10. Reaction mixture used for restriction digestions of plasmids for ligation.
Component 1 Volume
Restriction enzyme 3U-20U (dependant on enzyme)
10X BSA IX
Restriction Enzyme buffer IX
Plasmid DNA ~l-2pg
Water To a total volume of 50pl
Reactions were incubated at 37°C for 2 hours. The restriction enzyme Xmal required incubation at 
37°C for 16 hours. Results were examined by agarose gel electrophoresis.
Restriction digests for Southern blotting were carried out using the mixture detailed in table 11:
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liable 11. Reaction mixture used for'restriction digestion of genomic DNA for Southern blotting.
Component Volume
Restriction enzyme 1 3U-20U (dependant on enzyme)
Restriction enzyme 2 (where used) 3U-20U (dependant on enzyme)
. 10X BSA IX
Restriction Enzyme buffer IX
Genomic DNA ~5pg
Water To a total volume of lOOpI
Digests were incubated for 16 hours (overnight) at 37°C.
2.3.7 Agarose gel electrophoresis
1% (w/v) Agarose (Invitrogen) gels were prepared by heating agarose in TAE buffer to dissolve the 
powder. The mixture was allowed to cool and Safeview (NBS Biologicals, Cambridgeshire, UK) was 
added (6pl/100ml). Gels were then poured into casting trays and allowed to set for thirty minutes. Set 
gels were submerged in TAE buffer in a horizontal electrophoresis tank (Bethesda research, 
Gaithersburg, MD, USA). DNA samples were mixed with 6X blue/orange loading dye (Promega) and 
the samples loaded into the wells along with a lkilo base pair (bp) marker ladder (Invitrogen) or a 
X/Hindlll marker ladder (Invitrogen). Electrophoresis was performed at 100V-160V for 1-1.5 hours. 
Gels were visualised using a UV transilluminator and photographed in a Kodak GL1500 gel 
documentation system (Kodak, Rochester, NY, USA) using a 590nm band pass filter. Band sizes were 
estimated using the Kodak Ml image analysis software (Kodak).
2.3.8 Sequencing
Sequencing reactions were prepared using the ABI prism™ BigDye™ Terminator v3.1 Cycle Sequencing 
kit (Applied Biosystems) using the mixture detailed in table 12:
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Table 12. Reaction mixture used for DNA sequencing
Component Concentration
Terminator Ready Reaction Mix IX
Sequencing primer lp M o l/p l
Sequencing template ~20ng
Sequencing buffer 0.5X
Water To lOpI
Reaction components were combined in 0.2ml thin walled PCR tubes. After mixing reactions were 
placed in the thermal cycler and incubated under the conditions in table 13:
Table 13. Thermocycler reaction conditions used for DNA sequencing
X 25 cycles
After the incubation was complete 5pl of 125mM EDTA was added to the sequencing reactions along 
with lOpI of water and 80pl of 96% (v/v) ethanol. The reactions were incubated for a minimum of 15 
minutes at room temperature to stop the reaction and precipitate the DNA. After incubation the 
reactions Were centrifuged at 3000xg to pellet the samples. Pellets were washed with 200pl 70% (v/v) 
ethanol and incubated for five minutes at room temperature. Samples were then centrifuged at 
2000xg for 15 minutes. The ethanol was discarded and pellets were dried by centrifugation of the 
upside down tubes for 2 minutes at 900xg. Pellets were resuspended in lOpI of Hi-Dye formamide 
(Applied Biosystems) and stored at -20°C prior to loading onto the sequencer. Sequencing was 
performed using an ABI 3130x1 genetic analyser (Applied Biosystems). Sequence data was analysed 
using the Vector NTI version 10.1 software (Invitrogen).
Temperature Duration
96°C 30 seconds
50°C 15 seconds
60°C 4 minutes
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2.3.9 Ligation of PCR products into pCR2.1 Topo vectors using the Topo cloning system
Topo cloning anneals PCR fragments to the Topo vector using overhanging 3'-poly-adenine tail added 
by Taq polymerase during the PCR reaction. The linearised topo vector contains complementary 5'- 
thymidine-overhangs and is bound to a topoisomerase-l enzyme. The complimentary overhangs allow 
the fragment to anneal to the vector and the topoisomerase enzyme ligates the fragment and vector 
sequences together, in the process being released from the DNA.Topo clones were produced using a 
pCR2.1 Topo cloning kit (Invitrogen) following the manufacturer's instructions. After PCR and agarose 
gel electrophoresis, 2pl of PCR product was mixed with lpl pCR2.1 Topo plasmid, lp l salt solution and 
water to 6pl. Reactions were incubated at room temperature for 5 minutes and then placed on ice.
3pl of the reaction was added to competent E. coli and the cells were transformed following standard 
protocols.
2.3.10 Ligation of DNA fragments
Ligations were carried out using T4 DNA ligase (New England biolabs) in 20pl reactions containing a 
6:1 ratio of insert:vector DNA (unless otherwise stated), IX  T4 DNA ligase buffer (New England 
biolabs) 20U/pl T4 DNA Ligase and the required volume of water. Reactions were incubated at room 
temperature for two hours or at 16°C overnight before transformation. Ligation reactions were added 
directly to cells and E. coli were transformed using standard protocols.
2.3.11 Southern blot
Restriction digests were carried out as detailed in section 2.3.6. After digestion, 5pl of the digest was 
run on a 100ml 0.6% agarose gel containing 6pl Safeview for 8 hours at 20mV. After running, gels 
were imaged under UV. The gel was then placed in denaturation buffer -  0.4M sodium hydroxide, 
0.6M sodium chloride for 30 minutes and then into neutralisation buffer -  0.5M Tris, 1.5M sodium 
chloride pH 7.5 for 30 minutes. Gels were blotted by capillary action overnight onto Hybond N+ 
nitrocellulose membrane (GE healthcare, Buckinghamshire, UK) with 20X SSC buffer. After blotting
i/
was completed the blot was washed for 15 minutes in 2X SSC with gentle shaking. The blot was 
crosslinked by UV for five minutes in a Kodak GL1500 gel documentation system. The blot was then 
washed briefly in distilled water and placed between two pieces of hybridisation mesh. The blot was 
placed in a hybridisation bottle (Stuart Scientific, Staffordshire, UK) and incubated for two hours at 
65°C with prehybridisation buffer -  5X SSC, 0.1% sodium N-lauryl sarcosine, 0.5g DIG luminescent 
detection kit blocking reagent (Roche, Basel, Switzerland), 0.02% SDS, 2% Salmon testes DNA (Sigma), 
50% formamide and water to 25ml. Incubation was carried out in a SI30H hybridisation oven (Stuart 
Scientific).
The DNA probe for detection of specific DNA sequences on the Southern blot was produced using the 
Digoxygenin (DIG) PCR probe synthesis kit (Roche) following the manufacturer's instructions. PCR was
performed with appropriate primers using a nucleotide mix containing dATP, dGTP, dCTP, dTTP and
\
deoxyuridine triphosphate (dUTP) linked to DIG molecules (DIG-dUTP). A control reaction was also 
prepared containing only unlabelled dTTP. The reaction mixture is detailed in table 14:
Table 14. Reaction mixture for the production of DIG-labelled DNA probes for Southern blotting.
Reagent Concentration in Probe synthesis 
reaction
Concentration in control reaction
10X PCR buffer IX IX
PCR DIG probe 
synthesis mix
200pM dATP, dCTP, dGTP, 130pM 
dTTP, 70pM DIG-dUTP
None
dNTP stock 
solution
None 200pM dATP, dCTP, dGTP, dTTP
Forward Primer lpM ol/pl lpM ol/|il
Reverse Primer lpM ol/pl lpM ol/pl
Enzyme Mix 0.05U/pl 0.05U/pJ
Template DNA 50ng 50ng
Water To 50pl To 50|il
PCR conditions for the probe synthesis are shown in table 15:
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Table 15. Thermocycler reaction conditions for the production of DIG-labelled DNA probes.
X 30 cycles
The products of the PCR reaction were examined by agarose gel electrophoresis, the labelled reaction 
product was retarded in the gel due to the DIG molecules and labelling could therefore be confirmed 
by comparison to the unlabelled control reaction.
After incubation DNA probe was added to prehybridisation buffer at a concentration of 0.5pl/ml. Pre­
hybridisation buffer was decanted from the hybridisation bottle and hybridisation buffer was added 
to the blot. 3.5ml of hybridisation buffer was used per 100cm2 blot area. Hybridisation temperature 
(Thyt>) was calculated using the following formulae:
Tm =16.6log(molNa+)+0.41(%GC)+81.5 
T hyb = (Tm-25)-36
Tm is the theoretical melting temperature of the Probe:DNA duplex. molNa+ refers to the molar 
concentration of sodium ions in the hybridisation buffer. %GC refers to the percentage guanosine- 
cytosine (GC) content of the probe sequence. -36 is the effect of adding 50% formamide to the 
hybridisation buffer. Hybridisation temperatures were optimised experimentally. The blot was 
hybridised overnight.
After hybridisation blot was washed with 2X SSC buffer containing 0.1% SDS twice for five minutes 
with shaking at room temperature in the hybridisation bottle. The blot was then washed twice for
f
fifteen minutes at 68°C in 0.1X SSC 0.1% SDS buffer in the hybridisation oven.
Temperature Time
95°C 2 minutes
95°C 30 seconds
62°C 30 seconds
72°C 40 seconds
72°C 7 minutes
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After washing the blot was detected using the DIG luminescent detection kit (Roche) following the 
manufacturer's instructions. The blot was washed for five minutes with shaking in washing buffer -  
0.1M maleic acid, 0.15M sodium chloride and 0.3% polyoxyethylene (20) sorbitan monolaurate 
(Tween20) pH 7.5. After washing the blot was then incubated with shaking in IX  blocking buffer 
(Roche) for 30 minutes. The blot was then incubated for 30 minutes in a 1:10000 dilution of Anti- 
digoxigenin alkaline phosphatase antibody (Roche) in blocking buffer. Once incubation was 
completed the blot was washed twice for 15 minutes with shaking in washing buffer. The blot was 
then equilibrated in 20ml detection buffer- 0.1M Tris-HCI, 0.1M sodium hydroxide pH9.5 for five 
minutes with shaking. After equilibration 2ml of chloro-5-substituted adamantyl-l,2-dioxetane 
phosphate (CSPD) (Roche) was diluted 1:100 in detection buffer. The blot was Incubated for five 
minutes in the detection solution and then excess liquid was removed and blot incubated for 15 
minutes at 37°C. Chemiluminescence was detected using a Kodak GL1500 gel documentation system, 
images were captured with 3 exposures of 15 minutes each and inverted final accumulation images 
were exported. Images were inverted.
2.4 Molecular biology techniques for Ribonucleic acid (RNA)
2.4.1 RNA extraction
Total RNA was extracted from N. meningitidis bacteria using the SV total RNA extraction kit (Promega) 
according to the manufacturer's instructions. Cells were either resuspended from plates or broth 
culture into lOOpI TE buffer containing 0.4mg/ml Lysozyme (Sigma-Aldrich). 75pl of RNA lysis buffer 
was added to the resuspension and then 350pl RNA dilution buffer. 200pl of 96% ethanol was added 
and mixed by pipetting. The mixture was then transferred to a spin column and centrifuged at 
17000xg for 1 minute. After centrifugation the spin column was washed with 600pl wash solution and 
centrifuged again under the same conditions. A mixture containing 40pl yellow core buffer, 5pl 
0.0009M manganese chloride and 5pl DNase I was added to spin column and incubated for 15
minutes at room temperature. After the incubation 200^1 of stop solution was added and the column 
centrifuged for 1 minute at 17000xg. 600pl of wash solution was added to the column and 
centrifuged as previously. 250^1 wash solution was added and centrifuged and the RNA was eluted 
with lOOpI nuclease free water.
2.4.2 Reverse Transcriptiori-PCR
Reverse Transcriptase (RT) PCR was carried out using the Access RT-PCR system (Promega) according 
to the manufacturer's instructions. 50ng total RNA was mixed with IX  AMV/7// 5X reaction buffer, 
0.2mM dNTP mix, 50pmol of both oligonucleotide primers, Im M  25mM MgS04,.l|il AMV Reverse 
transcriptase and lp l Tfl DNA polymerase. Reactions were incubated in the thermocycler using the 
conditions shown in table 16.
Table 16. Thermocycler reaction conditions for RT-PCR.
X 40 cycles
After incubation samples were examined by agarose gel electrophoresis.
2.5 Molecular biology techniques for proteins
2.5.1 OM preparation
Outer membranes were prepared from N. meningitidis by spheroplast lysis. Bacteria were grown
overnight on blood agar plates and resuspended in 200pl of 200mM Tris-HCI, Im M  EDTA. 200pl of
200mM Tris-HCI, Im M  EDTA, 1M sucrose and the suspension mixed by inversion. 24pil of Lysozyme
was added and then 400|il of sterile distilled water. The suspension was shaken on a rotary shaker for
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Temperature Duration
45°C 45 minutes
94°C 2 minutes
94°C 30 seconds
60°C 1 minute
68°C 2 minutes
68°C 7 minutes
30 minutes. Membranes were sedimented by centrifugation at 43000xg for 20 minutes. The pellet 
was resuspended in 800pl ice cold distilled water using a needle and syringe to homogenise the 
sample. The suspension was then centrifuged again under the same conditions and resuspended with 
a needle and syringe in 250pl ice cold distilled water.
2.5.2 Bicinchoninic assay
Bicinchoninic acid (BCA) assay was used to quantify the amount of protein in samples and was carried 
out using the BCA protein assay kit (Pierce, Rockford, IL, USA) following the manufacturer's 
instructions. Standards were produced by mixing BSA standard (Pierce) with the same buffer as was 
used for the samples to be tested in concentrations according to the manufacturer's instructions. 
lOpI of samples and standards as well as sample buffer were added to a 96-well microtitre plate 
(Nunc, Rochester, NY, USA). Protein assay reagent was made up by mixing reagent A (BCA detection 
reagent) with reagent B (4% copper sulphate solution) in a ratio of 50:1. 200pl of protein assay 
reagent was added to each of the samples and standards. The plate was shaken and then incubated a 
37°C for 30 minutes. After incubation the plate was read in a Labsystems Multiskan MS 
spectrophotometer (Labsystems, Helsinki, Finland) at 577nm. A standard curve was plotted and the 
protein concentrations calculated from the curve.
2.5.3 SDS polyacrylamide gel electrophoresis
SDS polyacrylamide gel electrophoresis (SDS PAGE) gels were cast in two formats. For mini-gels the 
Bio-Rad mini-protean 3 system (Bio-rad, Hercules, CA, USA) was used. 12% resolving gels were cast 
using the recipe detailed in table 17.
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Table 17. Recipe for the casting of mini-gels
' I
Reagent Quantity
3M Tris-HCI pH 8.8 0.65ml
30% acrylamide-bis solution (Bio-rad) 2ml
10% SDS solution 50pl
10% ammonium persulphate (APS) (Amresco, 
Solon, OH, USA)
50pl
N,N,N',N'-tetra-methyl-ethylenediamine (TEMED) 
(Bio-rad)
2 |il
Water 2.25ml
Once the casting stand was assembled the gel was poured and covered in water saturated 2-butanol 
before being allowed to set. Once set the top of the gel was rinsed with distilled water and dried with 
filter paper (Millepore). The stacking gel was poured using the recipe in table 18.
Table 18. Recipe for the casting of stacking gel for mini-gels
Reagent Quantity
0.5M Tris-HCI pH 6.8 0.65ml
30% acrylamide-bis solution 0.325ml
10% SDS solution 25pl
10% APS 25|il
TEMED lpl
Water 1.3pl
After the gel had set the comb was removed and the wells washed with distilled water. The amount 
of protein in each sample was tested with the BCA assay and the samples equalised for protein 
content. Samples were suspended in a 2X sample buffer containing 10%w/v sucrose, 5%v/v 2- 
mercaptoethanol, 4ml 10% SDS, 200pl 10% APS, 15ml 1M Tris-HCI pH7.2 and O.Olg bromophenol 
blue (Amersham biosciences) at IX  sample buffer concentration. Samples were then boiled in sample 
buffer at 95°C for five minutes before loading. Gels were run in running buffer containing 0.4M  
glycine, 0.1M Tris and 7mM SDS at 200V for 40-60 minutes, until the dye front reached the bottom of 
the gel.
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Large gels were cast on the Bio-rad Protean II xi system (Bio-rad). Large gels were poured using the 
recipe shown in table 19:
Table 19. Recipe for the casting of large gels
Reagent Quantity
3M Tris-HCI pH 8.8 6.25ml
30% acrylamide-bis solution 20ml
10% SDS solution 0.5ml
10% APS 0.5ml
TEMED 20pl
Water 23.25ml
Gels were poured by the'same method as mini-gels. The stacking gel was made up using the recipe in 
table 20:
Table 20. Recipe for the casting of stacking gel for the large gels.
Reagent Quantity
0.5M Tris-HCI pH 6.8 7.5ml
30% acrylamide-bis solution 2.6ml
10% SDS solution 200pl
10% APS 200pl
TEMED 8|il
Water 7ml
Large gels were loaded and run using the same buffers as small gels. Gels were run at 10mA overnight 
or until the dye front reached the bottom of the gel.
After electrophoresis all gels were removed from the casting plates and placed into Coomassie blue, 
solution. Gels were stained with Coomassie for 4-24 hours (mini gels) or 24-48 hours (large gels) 
incubation with gentle shaking. Once stained, the gels were destained with destain solution 
containing 45% v/v methanol and 10% v/v acetic acid in water. Gels were destained until bands 
became sufficiently clear. Gels were photographed on the Kodak 1500 gel documentation system 
under white light.
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2.5.4 Formaldehyde crosslinking and SDS PAGE
The formaldehyde crosslinking method was adapted from Sanchez et al (119). The amount of protein 
in the samples was tested with the BCA assay and the protein amounts in each sample were 
equalised. Preparations of outer membrane were resuspended in PBS containing 1% v/v 
formaldehyde. Samples were incubated at room temperature for 10 minutes, lm l of PBS was then 
added to preparations and the samples were centrifuged for 20 minutes at 17000xg. Supernatant was 
removed and the samples resuspended in PBS without formaldehyde. Control preparations were 
treated in the same way but formaldehyde was not included in the incubation step. For SDS PAGE 
samples were suspended in 2X sample buffer that did not contain 2-mercaptoethanol and were 
incubated for 20 minutes at 37°C before loading. Samples were loaded onto a large 8% SDS-PAGE gel 
and run at 10mA for 24 hours. Gels were stained with Coomassie blue and imaged following the same 
protocol as other SDS PAGE gels. Band identification was carried out using the Kodak Ml software 
(Kodak) using the automated band finder tool. The conditions for the identification of bands were the 
same for all gel lanes.
2.6 Immunological techniques
2.6.1 Western blotting
For western blotting, SDS PAGE gels were created and electrophoresed as previously described. When 
electrophoresis was complete, gels were assembled into the transblotting apparatus, Bio-rad trans­
blot cell (Bio-rad), with Hybond P polyvinylidine fluoride (PVDF) membrane (GE Healthcare). The 
trans-blot cell was filled with transblotting buffer- 25mM Tris, 0.2M glycine, 20% methanol and the 
blot was run at 10mA overnight. After blotting the gel was discarded and the membrane incubated in 
blocking buffer-TBS with 5% (w/v) Marvel milk powder (Premier International foods, Lincolnshire,
UK) for one hour with gentle shaking. After incubation the membrane was incubated with primary 
monoclonal antibody against the P3.15 epitope of the PorB protein- National Institute of Biological
Standards and Control (NIBSC) Number 02/310 (NIBSC, Hertfordshire, UK). Antibody was diluted 
1:1000 in blocking buffer and incubation was carried out for 2 hours at room temperature with gentle 
shaking. After incubation the membrane was washed three times for ten minutes duration each in 
TBS. Secondary antibody was then applied, Anti-mouse horseradish peroxidise (HRP) conjugated 
antibody (Sigma-Aldrich) was diluted 1:2000 in blocking buffer and incubated with the membrane for 
one hour at room temperature with shaking. The wash step was then repeated. 3,3 diaminobenzene 
(DAB) tablets were used for detection of the bands according to the manufacturer's instructions. The 
DAB solution was added to the membrane and allowed to incubate for 5-10 minutes until sufficient 
colour had appeared. The membrane was then rinsed with water to stop the reaction. The membrane 
was photographed under white light using the Kodak gel logic 1500 gel documentation system.
2.6.2 Slot blotting and immunoassay '
Native OMVs were prepared and used for slot blotting and immunoassay for the proteins PorA 
(epitopes P I.7 and P1.16) and PorB. For slot blotting samples were diluted in TBS buffer. Purified 
PorA and PorB proteins were used as standards and diluted in the same buffer. Slot blotting was 
performed on the Minifold II slot blotting system (Schleider and Shuell, Dassel, Germany). 400pl of 
sample was blotted and the wells washed with 400pl TBS. After blotting the apparatus was 
disassembled and the membrane was incubated for one hour in blocking buffer- 5% Marvel milk 
powder in TBS. Primary antibody for PorA P1.7 (NIBSC number 01/514) (NIBSC), P1.16 (NIBSC number 
01/538) (NIBSC) and PorB was diluted in blocking buffer to a concentration of 1:250. Blots were 
incubated with primary antibody for l  hour and then washed for 5 minutes in TBS. The wash step was 
repeated three times. Anti-mouse HRP conjugated secondary antibody was diluted in blocking 
solution to 1:2000 and was added to the blots. After a one hour incubation with secondary antibody 
the blots were washed with TBS for 10 minutes and the wash step repeated three times. Blots were 
detected with SuperSignal west PICO chemiluminescent substrate (Pierce) according to the 
manufacturer's instructions. Luminol/Enhaiicer solution was mixed in equal parts with stable
peroxide solution. The blot was incubated with the solution for 5 minutes before being imaged in the 
KODAK gel logic 1500 gel documentation system. Three 5 minute exposures were taken and the final 
accumulation was exported. Blots were analysed using the KODAK Ml analysis software (KODAK) for 
calculation of protein amounts. Region of interest (ROI) analysis was used to estimate brightness of 
standards and samples. Protein mass in the bands was calculated using mass curve analysis in the 
software.
2.7 Microscopy
2.7.1 Preparation of bacteria by Gram staining
Bacteria were Gram stained using a Gram stain for films kit (Sigma-Aldrich). Bacteria were grown in
broth overnight under the required conditions and a 5pl drop of the resultant culture was smeared
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onto glass slides (BDH) using a loop. The smears were allowed to dry and the slide was then flooded 
with 100% methanol for two minutes to fix the bacteria. Methanol was then poured from the slide 
and the slide allowed to dry. Fixed films were flooded with crystal violet solution for 1 minute and 
then rinsed with water. Gram's iodine solution was added to the slides for 1 minute and the slide was 
again rinsed. Decolouriser solution was run across the slide until it ran clear and the slide was rinsed 
again. Carbol fuschin counterstain was then applied for 1 minute and the slide was rinsed before 
being air dried.
2.7.2 Light microscopy
Slides were examined with an Olympus CX41 microscope (Olympus, Tokyo, Japan) under a 100X oil 
immersion objective using immersion oil (Olympus). Images were captured on an Olympus U-CMAD 3 
camera using the analySIS soft imaging system version 5 software (Olympus). Four images were 
taken on each slide at different locations. Experiments were repeated to ensure consistency.
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2.7.3 Vitreous Thin Film preparation
For vitreous thin film (VTF) microscopy bacteria were prepared by two methods. In the first method 
bacteria were scraped from overnight plate growth and resuspended in PBS to an OD600=13.2. 3-4pl of 
this suspension was spotted onto the grid before freezing. In the second method bacteria were 
scraped from overnight plate growth and resuspended in Mueller Hinton broth. 5pl drops of bacterial 
suspension were placed on parafilm (SPI supplies, West Chester, PA, USA). Grids were floated on 
these drops and incubated at 37°C for ~ 5 minutes. After incubation the grids were taken from the 
drops and placed into the freezing apparatus. For both methods grids were frozen on a Leica EM CPC 
(Leica, Vienna, Austria) plunge freezing apparatus. Grids were blotted for 3-6 seconds and frozen in 
liquid ethane (BOC gases, Guilford, UK).
2.7.4 Cryo-transmission electron microscopy (Cryo-TEM)
After freezing grids were kept under liquid nitrogen and transferred to a Gatan 914 cryo specimen 
holder (Gatan, Pleasanton, CA, USA). Grids were.examined in a Jeol JEM 2100 transmission electron 
microscope (JEOL, Tokyo, Japan) at 200kV. Images were taken with a Gatan 4K/4K CCD camera 
(Gatan) using the digital micrograph software (Gatan). Several sites were examined on each grid and 
experiments were repeated to ensure consistency.
2.7.5 Measurement of vesicles
Vesicle areas and perimeters were measured using the ImageJ software (http://rsb.info.nih.gov/ii.
National Institutes of Health, Bethesda, MD, USA). Images were divided into grids using the grid
/
feature of the software. Grid squares were chosen using an atmospheric noise random number 
generator (http://www.random.org/ Dublin, Ireland). Forty-five vesicles were selected by this method 
from vesicles imbedded in ice holes only. Vesicles were measured with the manual measuring tool, 
calibrated using the scale bar.
2.8 Statistics
2.8.1 Student's T-test
Pair wise comparison was carried out using a two tailed independent Student's t-test (T-test) (173) 
performed using Microsoft Excel software (Microsoft, Redmond, WA, USA). Groups contained at 
least three repetitions of the same experiment. Significance level was set at P<0.05. Normal 
distribution of the data for the wildtype samples and the measurements of OMVs was tested using 
the Shapiro-Wilk test with an alpha level of P=0.05 (128). Where unequal variance of the samples was 
shown by F-test a Welch's T-test was used.
2.8.2 F-test for equality of two standard deviations
Comparison of variance was carried out using the F-test for equality of two standard deviations (F- 
test) (131) contained in the Microsoft Excel software. The test was two tailed and the level of 
significance for the F-statistic was set at 0.05.
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Chapter 3- Investigation into phenotype and vesicle production of an H44/76 bang33 strain
3.1 Introduction
The genome derived neisserial antigen 33 (gna33) gene was first discovered in a genome wide search 
for candidate antigens for group B N. meningitidis vaccine, and the gene was found to be highly 
conserved amongst N. meningitidis strains (109). The gna33 gene is 1326bp long and lies at position 
32236-30911 in the N. meningitidis MC58 genome. Little is known about expression of gna33 and it 
has not been shown to be part of any operon. The gene encodes a 441 amino acid 47kDa protein, 
containing an N-terminal 20 amino acid consensus lipopolypeptide signal sequence (65). The signal 
sequence has also been shown to be involved in gene expression by exerting a negative effect at the 
transcriptional/post transcriptional level through the formation of secondary structure in the mRNA 
(126). The gna33 gene was shown to encode a lipoprotein that showed 41.3% amino acid homology 
to the £  coli membrane bound lytic transglycosylase enzyme MltA. Recombinantly expressed GNA33 
protein has been demonstrated to have lytic transglycosylase activity (65). In addition to MltA E. coli 
contains several membrane bound lytic transglycosylases, the proteins MltB, MltC, MltD, EmtA and 
MltF (26,73,125). These enzymes show partial functional redundancy and £  coli mltA deletion 
mutants show no obvious phenotype (81). Sequence homologues of mltB, mltC and mltD have been 
found in the N. meningitidis genome (65).
A Agna33 strain was created by Adu Bobie et al. in three N. meningitidis backgrounds, MC58, NMB 
and BZ232. The knockout mutant showed phenotypic changes including an attenuation of virulence in 
the infant rat model, decrease in growth rate and failure of the outer membrane of daughter cells to
separate in cell division (2). A release of outer membrane proteins into the media was also noted, this
(
was later shown to be caused by an increase in the release of outer membrane vesicles (37). The 
phenotypic changes in the Agna33 strain suggest that the lytic transglycosylases of N. meningitidis do 
not show the same functional redundancy as those of £  coli.
'62
The aim of this study was to investigate the phenotype of a Agna33 mutant in the N. meningitidis 
H44/76 strain and compare it to the phenotypes previously reported in Agna33 mutants in other 
strain backgrounds. H44/76 is an N. meningitidis group B strain, it has been used to manufacture an 
OMV vaccine and the strain and its vesicles have been extensively studied. H44/76 is also relatively 
easy to transform with plasmid DNA compared to other strains, justifying its use in this study. The 
strain was used to study the vesicle releasing phenotype of the Agna33 mutant in more detail, 
comparing the levels of vesiculation and the size and shape of the vesicles released by the wildtype 
and Agna33 mutant.
3.2 Construction of a recombination cassette to knock out gna33
The cloning strategy used for deleting the gna33 gene in the H44/76 strain was adapted from the 
approach used to construct Agna33 mutant in the MC58 strain by Adu-Bobie et al (2). Homologous 
recombination at two sites flanking the gna33 gene was used to replace gna33 in the genome with an 
antibiotic resistance gene. Exchange of regions of identical sequence is catalysed in Gram negative^ 
bacteria by enzymes of the RecABCD pathway and the E. coli genes that encode these enzymes have 
homologues in the N. meningitidis genome (30,76). In the strategy used, the amplified flanking 
sequences were the same as those used in the construction of the MC58 Agna33 mutant by Adu- 
Bobie et al, but the cloning strategy differed in the following ways: A kanamycin antibiotic resistance 
gene was used in place of the erythromycin resistance gene and a pUC19 vector was used instead of a 
pBluescript vector. The restriction enzymes EcoRl, BamHI and Hindlll were used in place of the 
enzymes Xbal, Smal and Xhol.
Amplification and topo cloning of the sequences flanking the gna33 gene were successful. Subcloning 
of the downstream sequence into the pUC19 vector backbone was also achieved. However, repeated 
subcloning of the upstream fragment only produced plasmids containing the insert in the reverse
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orientation. As a contingency the plasmid pBSUDGNA33ERM used for the construction of the MC58 
Agna33 strain by Adu-Bobie et al was obtained and used to transform H44/76.
3.3 Transformation of the gna33 knockout cassette
The plasmid pBSUDGNA33ERM contains the erythromycin resistance gen'e ermC, flanked by 
sequences homologous to the sequences upstream and downstream of the gna33 gene. A DNA 
uptake sequence for N. meningitidis was included in the downstream flanking sequence (fig. 1) (2). 
For the production of the MC58 Agna33 mutant the whole plasmid was transformed into N. 
meningitidis; this method was also used for the H44/76 strain. Transformation of whole plasmid 
provided several possible options for homologous recombination. A double crossover at both the 
upstream and downstream regions of homology would replace gna33 with the cassette containing 
the ermC gene (fig.lb). However homologous recombination involving only one of the two regions of 
homology (single crossover) would result in the complete plasmid being inserted into the genome. 
This would be either upstream or downstream (relative to the direction of transcription) of gna33 
(fig.4 pg. 68).
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A. Plasmid used for crossover
pBSUDGNA33ERM
D ow nstream
U pstream  
flanking sequence
ermC
flanking sequence
B. Double crossover
GNA33 test for (TF) GNA333R (3R)GNA33 2F (2FX3NA33 flank rev (FRJGNA33SF1 (SF1)
* " l  ---------------
ermC Upstream G e n o m eG en o m e Down­
stream
PCR reaction Length (bp)
PCR 1 (TF-TR) No product
PCR 2 (TF-2F) 1384bp
PCR 3 (3R-SF1) 1762bp
PCR 4 (T3-TR) No product
Figure 1. Plasmid pBSUDGNA33ERM and map of double crossover recombination in N. m eningitid is. (A) Map
of the pBSUDGNA33ERM plasmid used for the transformation. (B) Double crossover produces a complete knock 
out o f the gna33 gene and replacement with the Erythromycin resistance (ermC) cassette. Binding sites for 
primers used to test for double crossover recombination are shown. The table shows bands produced by PCR 
reactions used to discriminate the different recombinants.
An MC58 strain was transformed w ith the plasmid to test the production of double crossover mutants 
using the transformation protocol. Successful recombinants were selected by growth on 
erythromycin containing media. The transformation of the MC58 strain produced many colonies and 
four colonies were tested using PCR. Double crossover recombination was a common event in MC58 
transformation and all the colonies tested showed the correct band pattern (fig. 2).
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)3054
2036
1636
1018
1 = Clone 1—
2= Clone 2 PCR 1
3= Clone 3
4= Clone 4 ~
5= Clone 1 —
6= Clone 2 PCR 3
7= Clone 3
8= Clone 4 —
9= Clone 1 —
10= Clone 2 PCR 2
11= Clone 3
12= Clone 4
Figure 2. Colony PCR of clones from pBSUDGNA33 transformation into N. meningitidis MC58. Clones 1-4 were 
tested using PCR1 (Lanes 1-4) where no product is expected, PCR3 (Lanes 5-8) with an expected band of 1762bp 
and PCR2 (Lanes 9-12) with an expected band size of 1384bp.
Transformation of H44/76 strain also produced many colonies. Of three clones screened by PCR 
(fig.3), two clones (Clone 1 and 3) showed the correct band pattern for a double crossover in PCR 1 
(no band) but in PCR 2 and PCR 4 these clones produced bands not expected in a double crossover, a 
band of 1.8kilo base (kb) instead of 1.4kb in PCR 2 and a band of 2kb in PCR 4 where no band was 
expected. PCR 3 did not produce a clear result for these clones and so was not used.
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1= H44/76 clone 1 
2= H44/76 clone 2 
3= H44/76 clone 3 
4= H44/76
PCR 4
3054
2036
1636
1018
1 & 2= pBSUDGNA33Erm 
3 & 4= H44/76 clone 1 
5 & 6= H44/76clone 3
1 = H44/76 clone 1 
2= H44/76 clone 3 
3= H44/76
Figure 3. PCR for clones produced by 
transformation of pBSUDGNA33ERM into N. 
meningitidis H44/76. PCR1: PCR for three clones 
(lane 1-3) and wildtype H44/76 as a positive 
control (Lane 4) using the PCR1 primers. PCR2: PCR 
for clones 1 and 3 (lanes 1 and 2) and a wildtype 
negative control (lane 3) with PCR2 primers. PCR 4: 
PCR for clone 1 (lanes 3 and 4), clone 3 (lanes 5 
and 6) and pBSUDGNA33ERM as a positive control 
(lanes 1 and 2) with the PCR 4 primers.
The results of the PCR confirmed that the H44/76 clones were not double crossover mutants but the 
presence of erythromycin resistance in the clones indicated that the plasmid had integrated into the 
genomic DNA. Maps and PCR results from the predicted single crossover options were calculated (fig. 
4).
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A. Single crossover from the upstream fragment
GNA33 test rev (TR>
GNA33 test for (TF) GNA33(flank rev (FHJNA33SF1 (SF1)J3 GNA333R (3R1GNA33 2F (2FJ3NA33 flank rev (FR)GNA33SF1 (SF1)
Dow n- gna33 
stream
U p stream  Plasm id
I_______
D ow n­
stream
ermC U pstream
From plasmid
PCR reaction Length (bp)
PCR 1 (TF-TR) 1824bp
PCR 2 (TF-2F) 7501bp
PCR 3 (3R-SF1) 2191bp
PCR 4 (T3-TR) N/A
B. Single crossover from the downstream fragment
GNA33 test for (TF)
GNA333R (3R)
GNA33 2F (2F)
Down- ermC
stream
GNA33 flank rev (FR) GNA33 flank rev (FR)
GNA33SF1 (SF1) T3 GNA33 test rev (TR) GNA33SF1 (SF1)
U pstream Plasm id D ow n- gna33 
s t re a m .
U pstream
From plasmid
PCR reaction Length (bp)
PCR 1 (TF-TR) 7372bp
PCR 2 (TF-2F) 1563bp
PCR 3 (3R-SF1) 2191bp
PCR 4 (T3-TR) 1979bp
Figure 4. Single crossovers of pBSUDGNA33ERM into the N. m en ing itid is  genome. Single crossovers could 
occur at the upstream or downstream regions of homology in the gno33 recombination cassette. (A) Single 
crossover recombination at the upstream region of homology. (B) Single crossover recombination at the 
downstream region of homology. PCR results for the PCR reactions used to discriminate the crossover types are 
shown in the tables.
The bands produced by PCR of clones 1 and 3 corresponded to  the predicted sizes of bands in a 
downstream single crossover. The 2kb band in PCR4 showed the presence of a binding site fo r the T3 
primer indicating tha t these clones contained linearised plasmid. The lack of a band in PCR 1 was due 
to  the size of the band that would be amplified from a downstream single crossover (7.3kb), w ith an 
extension tim e of three minutes this is unlikely to be produced. However, the 1.8kb band in PCR2 was 
larger than the expected 1.5kb band for this crossover.
To confirm the downstream single crossover a southern blot fo r gno33 was performed. Genomic DNA
from a H44/76 gno33 clone (clone 1), the Agna33 MC58 strain and the w ildtype for both strains were
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digested w ith Pstl and subjected to  Southern blotting. Blotted membranes were probed with a 
digoxigenin labelled probe for gna33, produced using PCR with genomic DNA from  wildtype H44/76 
as the template. Measurement of probe luminescence showed that gna33 clone 1 contained a band 
matching the predicted size for a single downstream crossover. There was no band in the MC58 
Agno33 m utant showing that as expected it did not contain a gno33 gene. In the w ildtype strains 
there were no Pstl sites in the region of the gna33 gene so large fragments were produced.
M 1 2 3 4
2313G m m
9416—  mm
4361----- m m
2322—  m m  
2027—  m m
1= W ild type H44/76 
2=  H44/76 gna33  clone 1 
3=  W ild type MC58 
4 =  MC58 gna33  m utant
Figure 5. Southern blot for gna33 gene. Genomic DNA digested with Pstl from the strains wildtype H44/76 
(lane 1), H44/76 gno33 clone 1 (lane 2), Wildtype MC58 (lane 3) and MC58 Agna33 (Lane 4). Blots were probed 
w ith a DNA probe for the gno33 gene using a hybridisation temperature of 57°C.
Repeated transformations o f H44/76 w ith the plasmid produced only single crossovers (data not 
shown). To increase the likelihood of a double crossover event the plasmid was linearised before 
transform ation but this also only produced a mixture of upstream and downstream single crossovers.
Genomic DNA Expected GNA33 fragment 
(Pstl digestion)
W ildtype (MC58/ 
H44/76)
31711bp
MC58 Agno33 (gna33 
mutant)
No fragment
gno33 upstream 
single crossover
35816bp
gna33 downstream 
single crossover
5505bp
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Despite the ease of producing double crossover mutants in MC58 by this method, H44/76 did not 
produce double crossover mutants.
To generate a double crossover mutant an alternative approach was used, transforming the H44/76 
wildtype strain with genomic DNA from the MC58 Agna33 strain. Homologous recombination 
between the genomic DNA of the two strains should result in the insertion of the erythromycin 
resistance gene into gna33 in the H44/76 genome. Transformation produced erythromycin resistant 
colonies and PCR of the transformants showed that the band sizes were correct for a double 
crossover mutant (data not shown). Three of the clones were selected for southern blotting using the 
probe for the gna33 gene. No band corresponding to gna33 was seen, demonstrating that the gna33 
gene had been successfully knocked out (fig.6a). The clones were then backcrossed twice against 
wildtype H44/76 to ensure that the knockout of gna33 was the only genetic change introduced from 
the MC58 genomic DNA. Finally the region across the insertion was amplified by PCR and sequenced 
(fig.6b); this confirmed the region was correct.
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A
M 1 2 3 4 M
23130
9416
6557
4361
1= Wildtype 
2= Clone 1 
3= Clone 2 
4= Clone 3
2322
2027
B. GNA33TF
Genome
Down­
stream
GNA333R GNA332F 
lermC
GNA33SF1
Upstream] Genome
Contig 1 Contig 2
Figure 6. Backcross of genomic DNA from MC58 Agna33 strain into H44/76. (A) Southern blot of genomic 
DNA. Lane 1 Positive control Wildtype H44/76 genomic DNA digested with Pstl/Acll. Lanes 2-4 clones 1-3 from 
backcross of H44/76 with MC58 Agna33 genomic DNA digested with Pstl. (B) Diagram of sequencing of the 
Agna33 clone. Primers used in sequencing are marked with arrows showing direction of extension from the 
primers. Regions of sequencing contigs are shown by bars.
3.4 RNA production in the gna33  mutants
To confirm that the disruption of gno33 resulted in the loss of transcription, the Agno33 H44/76 
strain was tested by RT-PCR fo r expression of gna33 mRNA. Glucose-6-phosphate dehydrogenase 
{gdh) and porA mRNAs were used as controls to ensure even loading of total RNA. The Gdh protein 
has an important metabolic function in glucose metabolism and this should have ensured that it was 
consistently expressed. The porA gene is highly expressed and therefore easily detected, but as the 
PorA protein is known to have variable expression levels (152) the tw o control reactions were 
compared to each other (fig.7). Both mRNA species were expressed consistently across all the strains 
tested. The porA mRNA produced a clear band with fewer non-specific bands than the gdh RT-PCR 
and was used for the m ajority of fu rther RT-PCR experiments.
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1 = H44/76 Wildtype 
2= H44/76 gna33 single cross clone 1 
3= H44/76 gna33 single cross clone 3 
4= H44/76 gna33 mutant 
5 = H44/76 Wildtype 
6= H44/76 gna33 single cross clone 1 
7= H44/76 gna33 single cross clone 3 
8= H44/76 gna33 mutant
Lanes 1-4 gdh  RNA
Lanes 5-8 porA  RNA
Figure 7. RT-PCR comparison of gdh and porA  for use as controls. RT-PCR was performed on the gdh and porA 
RNA in the wildtype, gna33 single crossover and Agna33 (gna33 mutant) H44/76 strains. Lanes 1-4 show gdh 
RNA. Lanes 5-8 show porA  RNA.
The RT-PCR for gna33 RNA showed that the wildtype and gna33 downstream single crossover 
mutants were producing gna33 RNA as expected. The Agna33 mutant was not producing gna33 
mRNA, confirming that the gna33 gene was not being expressed (fig. 8).
7 8 M
1 =  W ildtype
2 =  gna33 single cross clone 1 
3 =  gna33 single cross clone 3 
4 =  gna33 m utant 
5 =  W ildtype
6 =  gna33 single cross clone 1 
7 =  gna33 single cross clone 3 
8 =  gna33 m utant
gdh RNA
gna33 RNA
Figure 8. RT-PCR for gna33 RNA in gna33 mutants of H44/76. Production of control RNA from gdh gene is 
shown in lanes 1-4. Production of gna33 RNA from wildtype and single crossover mutants is shown in lanes 5-7. 
Production of gno33 RNA from the Agna33 mutant (gna33 mutant) is shown in lane 8.
Previous RT-PCR experiments were performed on RNA extracted from bacteria grown in liquid 
culture. To test if the culture conditions changed the expression of gna33 RNA, RT-PCR was also 
performed on bacteria grown on solid media (blood agar plates). Both downstream single crossover
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gna33 mutants showed low or undetectable levels of RNA when grown on solid media (fig.9), despite 
showing normal RNA expression in liquid culture. Wildtype strain showed gna33 expression 
regardless of the growth media.
M 1
1= Wildtype H44/76  
2=  Wildtype H44/76  
3=  H44/76 gna33  single cross 
4=  Wildtype H44/76  
5=  Wildtype H44/76  
6=  H44/76 gna33  single cross
\gna33
|r n a
I porA 
RNA
Figure 9. RT-PCR for gna33 RNA in gna33 single crossover 1 grown on solid media. Expression of 
gna33 in wildtype bacteria grown on solid media is shown in lanes 1 and 2. Production from gna33 
single crossover mutant is shown in lane 3. Control for RNA levels [porA) is shown in lanes 4-6.
The result of a downstream single crossover was the introduction of the plasmid (including the ermC 
gene) into the genome and duplication of the upstream and downstream flanking regions of the 
gna33 gene. Sequence beyond the downstream flanking region of gna33 has been altered, with 
plasmid sequence inserted into the region. In the upstream single crossover the same sequences have 
been inserted and duplicated, but the plasmid sequence was inserted upstream rather than 
downstream of gna33. RNA analysis of this strain showed that it produced normal levels of gna33 
mRNA both on solid media and in liquid culture (data not shown), suggesting that it must be factors 
downstream of gna33 that are affecting expression. Varying gna33 expression levels in different
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media indicates that the GNA33 protein is beneficial to the organism in liquid culture. This would be 
consistent with the poor growth in liquid culture observed in the MC58 Agna33 strain (2).
3.5 Growth of N. meningitidis gna33 mutants
The Agna33 mutant has been reported to grow slower than.the wildtype due to an increased 
doubling time when measured by optical density and colony forming units per ml (CFU/ml) (2).
Growth curves were produced using the H44/76 Agna33 strain and the gna33 downstream single 
crossover mutant (referred to as the single crossover mutant). Growth of H44/76 Agna33 was slow 
and the mutant strain reached a much lower OD600 after 8 hours than the wildtype (fig.10).
Increased osmotic pressure is a stress factor for organisms grown in liquid culture. A number of 
factors, including the increase of gna33 expression when the single crossover was grown in liquid 
media, the function of GNA33 in maintaining the peptidoglycan and the slow growth of the Agna33 
strain suggested that osmotic pressure may affect the Agna33 mutant more than the wildtype.
Sodium chloride has been used previously to change the osmotic potential of bacterial growth media 
(32) and was chosen as an additive to test if changing osmotic potential could rescue the phenotype 
of Agna33 and restore growth to wildtype levels. The level of sodium chloride used was determined 
empirically with 0.5% v/v being found to be optimal for growth.
Addition of sodium chloride to the medium improved the growth of both the wildtype and Agna33 
mutant strains but did not restore the growth of the Agna33 strain to wildtype levels (fig. 10). The 
mean growth rate constant in the exponential phase (p) of both strains showed improvement; from 
0.33 to 0.38 in the wildtype strain and 0.23 to 0.32 in the Agna33 mutant. This change was not 
significant in the wildtype when compared by T-test (P=>0.05) but was significant for the Agna33 
mutant (P=<0.001). When the control and sodium chloride supplemented cultures were compared at 
the eight hour time point the wildtype values were not significantly different (P=>0.05), but the 
Agna33 strain did show a significant difference (P=<0.05). The improvement of the Agna33 mutant
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was greater than that of the wildtype; indicating that the strain did suffer increased osmotic 
instability. However if the H44/76 Agna33 strain, like the MC58 Agna33 strain, showed a clustering 
phenotype then comparisons by optical density would be affected by the change in particle size. This 
could be the primary cause of the difference in optical density, reflecting a change in morphology 
rather than a difference in growth of the organisms.
Growth o f w ild type  and gna33  m u ta n t in liquid cu ltu re  and w ith  add ition  o f 0.5% NaCI
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Figure 10. Growth of wildtype and Agna33 (gna33 mutant) strain with and without 0.5% sodium chloride in 
the growth media. Bacteria were grown in liquid culture for an eight hour period in media that contained 0.5% 
sodium chloride or control media that did not. Measurements of OD600 were used as a surrogate of growth. 
Curves represent the mean of three experiments.
Growth of the wildtype and single crossover gno33 mutants were similar and the OD600 values after 
eight hours growth were not significantly d ifferent (P=>0.05). The single crossover mutant produced 
w ildtype levels of gno33 RNA in liquid culture so was expected to  grow normally (fig. 11).
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Figure 11. Growth curve of wildtype and gna33 single crossover mutant. Growth curves taken over eight hours 
of growth in liquid culture. Measurements of OD600 were used as a surrogate of growth. Curves represent the 
mean of three experiments.
3.6 Cryo-Electron microscopy of whole organism wildtype and gna33 mutants
To examine the morphology of the H44/76 gna33 mutant strains VTF cryo-electron microscopy was 
used. This rapid freezing technique does not allow the water in the sample to crystallize, so structures 
are embedded in vitreous 'water like' ice. This preserves the bacteria in their hydrated state and 
reduces artifacts associated w ith other traditional electron microscopy techniques (3).
W ildtype bacteria were observed either as diplococcal or coccal forms (fig. 12). Some distended forms 
(G) were observed but these were likely artefactual and caused by the position of the bacteria 
between the carbon film  and the ice hole. The number of coccal forms observed indicated some 
natural variation in the shape of the bacteria. Misshapen bacteria were also observed (I and J), these 
were likely to be dead and degraded bacteria. The misshapen forms increased when the bacteria 
were le ft at room temperature in PBS for longer periods before freezing.
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Figure 12. Cryo-electron microscopy of N. m eningitid is H44/76. The wildtype strain was examined by 
VTF-Cryo-Electron microscopy for comparison to the mutant strains. (A) (C) (B) (D) Bacteria were observed 
in the expected diplococcal shape. Lighter circles on grid surfaces were holes in the surface carbon film to 
allow sample to be observed in vitreous ice w ithout the underlying support film. (A) and (B) 25,000X 
200kV (C) 12,000X 200kV (D)20,000X 200kV. (A), (B), (D) Scale bar 200nm. (C) Scale bar 500nm.
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Figure 12. Cryo-electron microscopy of N. m eningitid is  H44/76 (continued). (E), (F), (H) Cocci shapes 
were frequently observed in the wildtype sample. (G) Oval shapes were also observed although the 
distension in this picture is most likely artefactual from the bacterium lying over the edge of the 
quantifoil hole. (E) 30,000X 200kV (F), (G) and (H) 25,000X 200kV. Scale bar 200nm.
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I.
Figure 12. Cryo-electron microscopy of N. m eningitid is  H44/76 (continued). (I) and (J). Bacteria that 
appeared misshapen, with less electron dense cytoplasm and producing vesicles within the outer 
membrane envelope were observed. (I) 25,000X 200kV (J) 15,000X 200kV. Scale bar 200nm.
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The gna33 single crossover mutant was not morphologically different compared to  the w ildtype
(fig-13).
Figure 13. Cryo-Electron microscopy of gna33 single crossover strain. The gna33 single crossover 
appeared similar to the wildtype and showed no distinct phenotypic features. (A) (B) (C) (D) 20,000X 200kV. 
Scale bar 200nm.
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The clustering described in the MC58 Agna33 strain was also observed in the H44/76 Agna33 strain
(fig.14). Bacterial clusters made the formation of thin vitreous ice difficult, but this was overcome by
f
increased blotting times for the grids before plunge freezing. Observation was only possible at the 
edges of clusters or in smaller clusters, as the large clusters were still too dense for the electron beam 
to pass through. Examination of the clusters demonstrated that the bacteria were not surrounded by 
a continuous outer membrane as had been previously reported (2); each bacterium had a discrete 
outer membrane but the cells were in contact with each other (fig.14 E,G,H). Individual bacteria were 
observed in the sample, but these bacteria appeared dead and degraded.
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Figure 14. Cryo-Electron microscopy of the Agna33 strain. The clustering phenotype previously described by 
Abu-Bobie et al (2) was also present in the H44/76 Agno33 strain. Clusters were large and caused thick ice to 
form, making examination of the grids difficult. (A), (B), (C), (D) due to the thick ice only the edges of the 
clusters were easily observed. (A) (B) (C) (D) 20,000X 200kV. Scale bar 200nm.
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Figure 14. Cryo-Electron microscopy of the Agna33 strain (continued). (E) and (F) small clusters. (G) and (H)
the same clusters under higher magnification. (E), (G), (H) Close examination of the clusters showed that 
separate outer membranes can be seen between the bacteria within the clusters (red arrows). (E) (F) 20,000X 
200kV (G) (H) 30,000X 200kV. Scale bar 200nm.
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3.7 Effect of osmotic stabilizers on clustering phenotype of Agna33 strain
As clustering of Agna33 was not caused by a failure of outer membrane separation, it was 
hypothesized that the phenotype is caused by the osmotic instability of the Agna33 strain. Clustering 
would lim it the access of water to  the bacterial outer membrane and therefore reduce the osmotic 
pressure on the organism. Bacterial clusters could be observed under light microscopy follow ing 
Gram-staining. Bacteria were grown in media containing sodium chloride, Gram stained and 
examined by light microscopy (fig. 15).
Wildtype g n a33  m utant
Control
Figure 15. Light microscopy of N. meningitidis Agna33 (gna33 mutant) strain grown with and 
without the presence of 0.5% sodium chloride in the growth media. Bacteria were Gram strained 
prior to imaging. Images taken at 1000X under oil immersion.
Changing in the osmotic potential o f the media did not produce any observable changes in the 
phenotype, demonstrating that osmotic pressure was unlikely to be a factor in clustering. The results
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also confirmed that the increase in growth rate caused by the addition of sodium chloride was not 
related to a change in clustering of the bacteria.
3.8 Antibiotic resistance of gna33 mutants
GNA33 is an enzyme involved in the digestion and repair of peptidoglycan. The effect of GNA33 
deletion on the peptidoglycan turnover and outer membrane was tested by assessing the sensitivity 
of the strains to antibiotics that target peptidoglycan synthesis pathways and the outer membrane. 
The selected antibiotics were: ampicillin which affects peptidoglycan cross-linking by the penicillin
"V
binding proteins; vancomycin which interferes with the.transport of peptidoglycan across the inner 
membrane; D-cycloserine which blocks the formation of peptidoglycan precursors in the cytoplasm 
and polymyxin B which disrupts the outer membrane but does not interfere with peptidoglycan 
synthesis (for details see Chapter 1.3.1 pg. 4). N. meningitidis is naturally resistant to vancomycin, 
polymyxin B and D-cycloserine at clinical concentrations but high concentrations of these antibiotics 
killed meningococci in disc diffusion tests.
The wildtype and gna33 single crossover mutants showed similar antibiotic susceptibility profiles. The 
gna33 single crossover had a significant decrease in susceptibility (P=0.05) to ampicillin, almost 
certainly due to the presence of an ampicillin resistance gene in the plasmid that was incorporated 
into the genome. The Agna33 strain was significantly more susceptible to all the antibiotics (P=<0.05) 
(fig. 16). The most significant increases in susceptibility occurred with antibiotics that disrupt 
peptidoglycan synthesis by interfering with the penicillin binding proteins (vancomycin and 
ampicillin). This suggested that the later stages of peptidoglycan synthesis were acutely sensitive to 
GNA33 deletion. Susceptibility to Polymyxin B indicated that Agna33 had an unstable outer 
membrane. Outer membrane instability could have potentiated the effects of the other antibiotics 
tested, by increasing permeability to large compounds.
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■ Wildtype
■ gna33 single crossover
■ gna33 mutant
Antibiotic
P values from T-tests
Antibiotic Wildtype:gncr33 single crossover Wildtype:Zigno33
Ampicillin P=0.05 P=<0.01
Vancomycin P=>0.05 P=<0.01
Polymyxin B P=>0.05 P=<0.05
D-cycloserine P=>0.05 P=<0.05
Figure 16. Antibiotic susceptibility in gna33 mutants. Susceptibilities to Polymyxin B, Ampicillin, Vancomycin 
and D-cycloserine were tested by disc diffusion assay. Results represent mean of three replicates, error bars 
represent standard error of the mean (SEM). P values are given in the table. Blue cells indicate significant 
results. P values calculated by T-test.
3.9 Native vesicle production in wildtype and gna33 mutants
Increased vesicle production is a known phenotype of Agna33 mutants. Vesicles naturally produced 
by the w ildtype and gno33 mutants (for method see section 2.2.10 pg. 39) were compared for the 
amount o f the vesicles produced, the size and shape of the vesicles and the antigen content. OMV 
preparations from the strains were tested fo r the quantity of PorA and PorB by slot blotting, as
A n tib io tic  re s is ta n ce  in gna33 m u ta n ts
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surrogate markers for the amount of vesicles. Monoclonal antibodies fo r the H44/76 PorA variable 
antigen P I.7 (NIBSC no. 01/514) and P I.16 (01/538) and for the H44/76 PorB subtype (02/310) were 
used and a standard curve for estimation of protein content was produced using purified PorA and 
PorB proteins (Fig.17).
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Figure 17. Standard curves for calculation of protein amounts from slot blots. Curves were prepared by using 
known concentrations of purified protein, the slot blot for PorA detected with monoclonal antibody 01/514 
(P I.7) is shown.
The Agno33 strain produced more native vesicles than the equivalent w ildtype strain, indicated by
the increased amounts of PorA and PorB in the sample (fig.18), Agno33 showed a 35-fold increase in
PorA compared to the wildtype. However w ildtype levels of PorB were below the assay threshold of
detection, so a comparison could not be made. The gna33 single crossover also showed a mild
increase in vesicle production, raising the PorB level above the threshold of detection. Compared to
the gna33 single crossover Agno33 showed a 16-fold increase in PorB and a 24-fold increase in PorA.
The PorA (P I.7 monoclonal antibody) and PorB levels measured were similar to each other in both
the Agno33 and gno33 single crossover vesicles, showing that although the ratios of the tw o proteins
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were not identical in both mutants, there was no great change in the ratio of PorA to PorB. The 
results of two PorA antibodies 01/514 (P.1.7) and 01/538 (P1.16) were not in agreement. This 
indicated differences in the avidity of the two antibodies, with the P I.16 antibody displaying lower 
avidity than the P1.7 antibody in all cases. The results with other mutants (see chapter 6 fig. 13 pg. 
175) demonstrated that at higher concentrations of PorA the antibodies showed better accordance, 
which inferred a loss of accuracy of the standard curve at lower concentrations.
W ildtype gna33 single cross gna33 m utan t 
PorA P I.7 
(01/514)
1:200 1:200 1:1000
1:2000 1:2000 1:10000
PorA P I.16 
(01/538)
1:10000
PorB P3.15 
(02/310)1:2000 1:10000
Strain PorA P1.7 (01/514) 
(ng/pl)
PorA P1.16 (01/538) 
(ng/pl)
PorB P3.15 (02/310) 
(ng/pl)
Wildtype 1.0 climit of detection climit of detection
gna33 single cross 1.4 <limit of detection 1.9
Agna33 (gna33 mutant) 33.5 4.9 29.6
Figure 18. Slot blot immunoassay of PorA and PorB in native vesicles from the wildtype and gna33 mutants.
Dilutions of native vesicle preparations were blotted with the PorA (01/514 and 01/538) and PorB (02/310) 
monoclonal antibodies. Dilutions of 1:200 and 1:2000 were used for the wildtype and gna33 single crossover 
mutant. 1:1000 and 1:10000 was used for the Agna33 (gna33 mutant) strain. Calculated protein amounts are 
shown in the table per pi of vesicle sample. Limit o f detection was the level at which a signal above background 
level could not be detected by the software.
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3.10 Cryo electron microscopy of OMVs of wildtype and gna33 mutants
Morphology of vesicles from the wildtype and gha33 mutants was examined by VTF Cryo-Electron 
microscopy (fig. 19, 20, 21). Wildtype vesicles (fig. 19) were scarce even when samples were 
concentrated, as seen by low magnification views of the grid (fig. 19 D). OMVs were observed both in 
the ice holes and present on the carbon film. Too few vesicles were present to determine if the OMVs 
showed a preference for either surface and vesicles were most commonly observed at the edges of 
ice holes.
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Figure 19. Cryo-Electron microscopy of wildtype vesicle samples. Wildtype vesicles were difficult to observe 
even in concentrated samples. (A) and (B) Vesicles were observed both in the ice and on the carbon. (C) Vesicles 
in ice were more commonly observed at the edges of ice holes. (D) Lower magnification view of the quantifoil 
showing the scarcity of vesicles in the sample. (A) 25,000X 200kV. (B) and (C) 30,000X 200kV (D) 10,000X 200kV. 
(A) scale bar 200nm. (B) and (C) scale bar lOOnm. (D) scale bar 0.5pm.
OMVs from  the gna33 single crossover (fig.20) were also scarce, but were observed more commonly 
than in the wildtype sample. Vesicles were observed mainly in ice holes and were found both at the 
centre and edges of the ice. Anomalous vesicle morphologies were observed in the sample, such as a 
vesicle containing several membrane layers (fig.20 B) but these were rare.
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Figure 20. Cryo-Electron microscopy of OMVs from gna33 single crossover mutant. Vesicles of the single 
crossover mutant were still scarce in concentrated samples but more were observed in this sample than the 
wildtype sample. (A) and (C) Vesicles were observed mainly in ice holes, and were found both at the edges and 
in the centre of ice holes. (B) Anomalous vesicles were observed such as the double membrane vesicle shown 
here (arrowed) but these were not common in the sample. (D) Lower magnification view shows the distribution 
of vesicles in the ice holes of the grid. (A) (B) (C) 30,000X 200kV. Scale bar lOOnm. (D) 12,000X 200kV. Scale bar 
200nm.
91
The Agna33 OMVs (fig.21) were much more abundant than the OMVs of the other strains. Vesicles 
were concentrated on the carbon and the edges of ice holes, although a few vesicles were observed 
in the centre of the ice holes (fig. 21 F and H). OMVs from Agna33 appeared larger than those of the 
other strains and anomalous vesicles that were large, oddly shaped or were double vesicles were 
commonly observed (fig.21 A,B and D). Vesicles on the carbon film appeared misshapen (fig.21 E), but 
this distortion could have been the result of interaction with the carbon film.
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Figure 21. Cryo-Electron microscopy of OMVs from H44/76 Agna33 strain. A greater number of vesicles were 
observed in the Agno33 strain sample. (A) and (C) Vesicles were observed in ice holes but tended to be 
concentrated at the edge of the hole and on the surrounding carbon. (A) Large vesicles were observed much 
more commonly in the sample compared to the wildtype, both on the carbon film and in the ice (arrowed.) (B) 
and (D) Anomalous vesicles were also observed in several pictures, including vesicles contained within another 
layer of membrane (arrowed.). The amount of vesicle on the carbon compared to the ice holes is also shown. 
(A),(B),(C),(D) 30,000X 200kV. Scale bar lOOnm.
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Figure 21. Cryo-Electron microscopy of OMVs from H44/76 Agna33 strain (continued) (E) and (G) Vesicle 
concentration on the carbon is shown. Many vesicles appear to be misshapen, but this may be artefactual due 
to the carbon film. (F) Although the majority o f vesicles were observed at the edges of ice holes or on the 
carbon film, some were observed in the ice (arrowed). (H) Lower magnification view shows the concentration 
of vesicles on the carbon film and the edges of the ice holes and the variance of vesicle size and shape in the 
sample. (E),(F),(G) 30,000X 200kV. Scale bar lOOnm. (H) 12,000X 200kV. Scale bar 200nm.
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3.11 Comparison of size of OMVs from wildtype and gna33 mutants
In order to compare the size and shape of vesicles produced by the strains, the perimeters and areas 
of the vesicles were measured. Only vesicles that were found in ice holes could be measured and 
therefore forty-five vesicle measurements were obtained in the w ildtype sample. Forty-five vesicles 
were selected at random from the m utant samples (Table 1).
Table 1. Comparisons of vesicles from wildtype, gna33 single crossover and Agna33 strains. Values are a mean 
of 45 vesicles chosen at random from the gno33 single crossover and Agno33 strains. Significance values <0.01 
are marked in blue. P values were calculated by T-test.
Wildtype gna33 single crossover Agna33
Mean perimeter (nm) 130.14 123.14 178.00
SD 41.02 51.88 59.38
Mean area (nm) 1457.42 1411.48 2707.65
SD 1064.32 1353.89 1788.41
P values from T-test
Wildtype:gno33 single 
crossover
Wildtype:21gna33 gna33 single 
crossover\Agna33
Perimeter >0.1 <0.01 <0.01
Area >0.1 <0.01 <0.01
Vesicles of the w ildtype and the gno33 single crossover were not significantly different in area or 
perimeter (P=>0.05). By contrast the Agno33 mutant were significantly larger (P=<0.01) in both area 
and perimeter measurements compared to the wildtype and gno33 single crossover vesicles. Agna33 
OMVs were more variable (by comparison of the SD values) than the vesicles of the other tw o strains.
The apparent increased variability of the Agna33 vesicles was tested using an F-test on the perimeter 
and area values (Table 2).
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Table 2. F-test comparison of variability in the wildtype and Agna33  mutant. Values were calculated using a 45 
vesicle sample. F-statistic was calculated using F-test; significance level was set at 0.05.
Comparison Wildtype:dgncr33
Area <0.05
Perimeter <0.05
The Agno33 vesicles were also significantly more variable in area and perimeter measurements 
compared to the w ildtype sample. The strong disparity between the strains shows that the deletion 
of gno33 has disrupted vesicle release, making vesicles both larger and more variable in size than 
those of the w ildtype and gno33 single crossover strains.
3.12 Discussion
The aim of this study was to construct an H44/76 Agna33 mutant, assess the production of OMVs and 
compare its phenotype to  a previously described MC58 Agna33 mutant. Comparison showed the 
phenotypes of the two m utant strains to  be broadly similar. However, examination of the clustering 
showed that the hypothesis of a failure in cell separation as the cause of the phenotype was not 
correct. Examination of the Agna33 mutant phenotype also indicated links between the observed 
features and the lytic transglycosylase function of the GNA33 protein. Assessment of the OMVs 
produced by the m utant showed increased vesiculation but also a change in the vesicle 
characteristics, indicating d iffe rent processes controlling the release of vesicles in the Agno33 mutant.
Although they were not examined in detail, tw o interesting features were demonstrated by the 
strains used and produced during construction of an H44/76 Agna33 mutant. The first was an 
apparent difference in recombination between the MC58 and H44/76 strains. The MC58 strain was 
more amenable to double crossover recombination than the H44/76 strain, despite the sequences 
flanking the gna33 gene being identical in both. No differences in recombination frequency between 
the two strains have been reported. Therefore it was likely that the difference was specific to the 
gno33 gene, possibly indicating tha t double crossover recombination was more strongly selected
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against in the H44/76 Agna33 mutant. Secondly, variation of gna33 mRNA expression in the 
downstream single crossover mutant, which was low on solid media and increased in liquid media, 
demonstrated that gna33 transcription was affected by the insertion of the plasmid. The only factor 
currently known to control transcription and translation of gna33 was the formation of mRNA 
secondary structure in the signal sequence (126). Sequencing showed that there was no change in 
this sequence in the downstream single crossover mutant. Therefore, it was likely that other 
unknown mechanisms regulating gna33 transcription were being affected. ;
The close contact of the Agna33 mutant bacteria to each other in microscopy samples was referred to 
as clustering and this phenotype was strikingly different in the H44/76 Agna33 bacteria compared to 
the previously reported characteristics of the MC58 strain. Clustering was thought to be caused by a 
failure of the outer membrane to separate in cell division; however electron microscopy showed that 
the outer membranes of H44/76 Agna33 mutants were separated. This difference most likely 
resulted from the methods used for electron microscopy. Unlike the room temperature sectioning 
and staining technique, in VTF bacteria are examined in a hydrated state without requiring fixation 
and staining steps. Samples were also examined in an instrument operating at a higher voltage, 
increasing the resolution of the image. The separated outer membranes indicated that the clusters 
are being held together by an interaction occurring at or outside the outer membrane. Changes in the 
charge of the outer membrane would be a potential cause of clustering and electron microscopy of 
the membrane vesicles of the Agna33 mutant suggested that the vesicles showed a preference for 
the carbon film which holds a hydrophilic charge. However, the scarcity of vesicles in the wildtype 
sample makes it difficult to determine if this trait was unique to the Agna33 mutation. The core 
oligosaccharide of the LOS molecule usually provides the overall charge of the outer membrane and 
LOS must be passed through the cell wall to reach the outer membrane. Disruption of peptidoglycan 
structure caused by gna33 mutation was likely to affect the ability of the bacteria to transport 
molecules to the outer membrane, resulting in disruption of LOS transport and charge of the outer.
membrane. Other factors such as the capsule also warrant investigation as capsule transport through 
the outer membrane could also be affected by changes to the peptidoglycan structure. The effect of 
capsule expression on clustering could be examined by mutation of gna33 in an acapsulate mutant; if 
capsule is a cause of clustering such a strain would show a reduction or abolition of the clustering 
phenotype. A hydrated sectioning technique, for example Cryo-electron microscopy of vitreous 
sections (CEMOVIS), could also be used to visualise clusters too thick to be examined by VTF.
The involvement of GNA33 in the response to osmotic stress was shown by the slow growth of the 
Agna33 strain, which was improved when osmotic pressure was reduced, and the upregulation of 
gna33 mRNA in the single crossover mutant grown in liquid culture. When the enzymatic function of 
GNA33 is considered, there is a clear potential role for the protein in responding to osmotic pressure. 
Lytic transglycosylases like GNA33 are part of the enzymatic machinery responsible for the 
maintenance of the peptidoglycan. The enzymes break down peptidoglycan in a very specific manner 
that allows for repair and expansion. Loss of lytic transglycosylase enzymes leads to disruption of 
peptidoglycan structure, as seen following deletion of multiple functionally redundant lytic 
transglycosylases in E. coli (81). Unlike E. coli, N. meningitidis appears to rely on GNA33 as its main 
lytic transglycosylase for peptidoglycan remodeling. Disordering of the peptidoglycan scaffold has a 
detrimental effect on the bacteria's ability to cope with increased osmotic pressure by weakening the 
cell wall and making cells more prone to lysis. The most significant increases in antibiotic susceptibility 
in the strain were to both ampicillin and vancomycin, which target PBP proteins involved in the 
insertion and crosslinking of new peptidoglycan strands. This could indicate simply that disruption of 
the peptidoglycan is more acute when both insertion of new glycan strands and remodeling are 
directly affected. Also it has been hypothesized that proteins controlling synthesis, remodeling and 
degradation of the peptidoglycan (including lytic transglycosylases and penicillin binding proteins) act 
together as part of a multi-enzyme complex (62). GNA33 has been shown to interact with the 
meningococcal penicillin binding protein PBP2, which shares sequence homology with the E. coli PBP3
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(65), a known target for ampicillin (168). Co-ordination between GNA33 and the PBPs affected by the 
antibiotics could explain the acute effects of these antibiotics on the mutant strain. The links 
between changes in growth and antibiotic sensitivity and the enzymatic function of the protein 
highlight the importance of GNA33 in maintenance of peptidoglycan.
As explained above, the VTF technique allowed the examination of vesicle samples in a hydrated 
state, in vitreous 'water-like' ice, without the dehydration artefacts that are often associated with 
traditional staining techniques such as negative staining (3). In addition, the measurement of vesicles 
embedded is the holes of quantifoil grids meant that there was no potential distortion of vesicles by 
the carbon support film. Vesicle measuring methods used in other studies included dynamic light 
scattering (DLS) (150). DLS measures the size and size distribution of vesicles by measuring the 
scattering of monochromatic light passed through the vesicle sample. By contrast, VTF allowed 
vesicles to be measured directly and could give more information about vesicle shape~in terms of 
perimeter and area.
The wildtype vesicles examined in this study had a mean perimeter of 130.1 nm, which equated to a 
mean vesicle diameter of 41.4 nm. This was smaller than the diameter of native vesicles reported by a 
previous study by van de Waterbeemd et. al. which measured vesicles by DLS and calculated a vesicle 
diameter of 80.2 ±2.2 nm (150). This discrepancy could be due to either differences in the 
methodologies used to produce vesicles or to calculate vesicle size, or differences in the vesicles 
themselves. Both this study and the previous work used H44/76 strains and a similar methodology of 
filtration and ultracentrifugation to purify vesicles from the supernatant. An extra centrifugation step 
was used to remove bacteria from the supernatant prior to filtration in this study. However since this 
step has also been used in the purification of detergent derived vesicles (which are much larger than 
native vesicles) in the laboratory without the loss of large vesicles, it seemed unlikely that this could 
be the cause of the size discrepancy. It is also unlikely that freezing the samples has changed the size 
of the vesicles by contraction of the solvent, as vitrified liquids maintain the same volume as the
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liquid state (170). Previous work has shown that differences in the composition of growth media can ' 
affect both the protein and LPS constituents of vesicles (145) and the amount of vesicles released by 
strains (122). In this study bacteria were grown in MH broth, in the previous work bacteria were 
grown in chemically defined medium. It is possible that the composition of the media used also 
affected the size of released vesicles in this study. To test this hypothesis, vesicles grown in both 
media under identical conditions would have to be measured by both VTF Cryo-TEM and DLS. Such a 
comparison would also show if the differences in measurements were due to the different 
methodologies used for measuring the vesicles.
The increased production of OMVs by theAgna33 strain had been previously,reported (37), but 
results of this study showed that these vesicles were dissimilar to OMVs produced by the wildtype 
strain. Increased size and variability of the Agna33 vesicles indicated that vesicle size in the Agna33 
mutant was not controlled by the same mechanisms as in the wildtype. GNA33 is an outer membrane 
bound protein which is also linked to the peptidoglycan. Deletion of the protein may lead to 
destabilisation of the outer membrane through the loss of this structural bond. But the presence of 
other proteins in the cell wall such as RmpM, which form a similar link and are much more ubiquitous, 
make this an unlikely cause of vesiculation. The disruption of the cell wall caused by GNA33 deletion 
is therefore the more probable cause of the increase in vesiculation. Sensitivity of Agna33 to 
polymyxin B showed that the outer membrane of the bacteria is disrupted. Action of the antibiotic
requires it to pass through the outer membrane and entry into N. meningitidis is prevented in normal
s
cells by modifications to Lipid A and the action of porins and efflux pumps. Bending or thinning of the 
peptidoglycan will lead to changes in the turgor pressure in the cell wall. Such pressure changes could 
disrupt the outer membrane and cause vesicle release by forcing the outer membrane to bulge and 
eventually bleb. Vesiculation caused by increased stresses on the outer membrane and cell wall has 
been reported in other Gram negative bacteria (93) and this could be the cause of vesicle release in 
Agna33. However the strikingly different morphology of Agna33 vesicles would suggest that vesicle
release in the wildtype is not governed solely by outer membrane stress. Structural studies on the 
peptidoglycan of Agna33 mutants would provide more information on the precise nature of 
peptidoglycan disruption when gna33 is deleted.
The phenotype of the Agna33 mutant can be linked to the role of the protein as the primary lytic 
transglycosylase in N. meningitidis. Disorganised peptidoglycan and loss of structural strength of the 
cell wall is likely to cause the phenotype of slow growth and sensitivity to peptidoglycan disrupting 
antibiotics. Disruption of molecule transport through the peptidoglycan could also contribute to this 
phenotype and be a cause of the clustering, which is likely to involve the interactions of factors at or 
beyond the outer membrane. Finally high level production of atypical vesicles is likely to be linked to 
the changes in turgor pressure in the cell wall due to disruption of the peptidoglycan. Differences in 
vesiculation between the wildtype and Agna33 also indicates that different processes are controlling 
vesiculation in the two strains and that GNA33 is unlikely to be involved in wildtype vesiculation.
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Chapter 4- Construction of an N. meningitidis strain carrying the tol-pal genes
4.1 Introduction
The Tol-Pal complex is a group of proteins tha t spans the cell wall and is required for outer 
membrane stability in E. co li (156). Homologues of Tol-Pal have been identified in many other Gram 
negative species. Some bacteria lack the Tol-Pal complex. There is no phylogenetic relationship 
between these species but Tol-Pal is absent in several high vesiculating species including N. 
m ening itid is  (139). The complex consists of five core proteins, ToIR, TolQ, TolA, TolB and Pal, and 
spans the cell wall from the inner membrane to  the outer membrane. ToIR and TolQ are bound to  the 
inner membrane; TolA interacts w ith both ToIR and TolQ and bridges the inner membrane and 
peptidoglycan. Pal interacts w ith TolA in the periplasm and spans the peptidoglycan and outer 
membrane. The interaction of TolA and Pal is dependent on a proton motive force that is produced by 
the inner membrane TolQ and ToIR proteins. TolB interacts w ith TolA and Pal in the periplasmic space 
(see chapter 1.6.2 fig .3 pg.26) (164).
The to l-pa l complex is located at 17 minutes on the E. co li K12 genome linkage map (166). The 
complex is arranged into tw o operons, which contain seven genes. The operons are transcribed from 
the promoters and PB (fig. 1) (156). Promoter Px transcribes the genes ybgC-tolQ-tolR-tolA  and the 
PB promoter the genes tolB-pal-ybgF. The Px prom oter can also produce a transcript of the region 
from  ybgC-ybgF. The YbgC protein is a thioesterase involved in phospholipid synthesis and not 
connected to  the function of the Tol-Pal complex. The YbgF protein has been shown to interact w ith 
TolA (164), but is not required fo r the function of the Tol-Pal complex (156).
PI PB
Figure 1. The tol-pal complex. The complex consists of seven genes expressed from two promoters P2 for the 
genes ybgC, tolQ, toIR and tolA  and PBfor the genes tolB, pal and ybgF. The genes tolQ, tolR, tolA, tolB and pal 
form the to l-pal complex.
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Deletion of any of the tol-pal genes except tolB will abolish the formation of the functional complex
f  j
(166). The Tol-Pal complex has been shown to have an important structural role in the cell wall; the 
deletion of the Pal protein produces a mutant that is prone to lysis by detergents and increased 
sensitivity to some antibiotics (7,21). Release of membrane vesicles is a phenotype of the A tol-pal 
strain (7) and the deletion mutants also show aberrant cell division leading to 'chaining' of the 
bacteria. The Tol-Pal complex has been shown to localise to the poles of the cell during cell 
constriction, implying the complex has a role in cell separation during division. In addition vesicles 
have been shown to be released from the poles of the cell during division (45).
The aim of this study is to test the hypothesis that production of the Tol-Pal complex in N. 
meningitidis would lead to an attenuation of the vesicle releasing phenotype of the bacteria. The lack 
of the Tol-Pal complex in N. meningitidis and other highly vesiculating species and the phenotype of 
Ato/-po/ mutants in E. coli suggested that the absence of the complex may be a cause of high levels of 
vesicle release. Expression of the tol-pal complex from the pMIDG201 expression vector was used to 
create a Tol-Pal producing mutant; the phenotype of this strain could then be tested to assess the 
effect of Tol-Pal on vesicle release.
4.2 Construction of the tol-pal expression vectors pMIDGTol-Pal and pMIDGTol-Palner
To express the Tol-Pal proteins in N. meningitidis the expression vector pMIDG201 was used. This 
vector was constructed by manipulation of the Neisseria flavescens cryptic plasmid pMIDG2830. A 
kanamycin resistance gene, constitutive meningococcal promoter ner and two copies of the NeisseriaI 
DNA uptake sequence to act as transcriptional terminators and facilitate the uptake of the plasmid 
into N. meningitidis were inserted (103,104). The plasmid replicates using the repA origin of 
replication, which is a low copy number origin of replication in E. coli (39,46,103).
It was not known if the E. coli native promoters of the tol-pal operon would be functional in N. 
meningitidis. Therefore two cloning strategies were pursued in tandem. The plasmid pMIDGTol-Pal
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contained the to l-p a l genes under the control of the native promoters Pi and PB and the plasmid 
pMIDGTol-Palner contained the genes under the control of the ner promoter.
To construct pMIDGTol-Pal the to l-pa l genes were firs t amplified in two sections from the E. coli 
genome; the complex was amplified in two sections to  reduce the size of the PCR product inserted 
into the plasmid. The first section contained the genes ybgC, fo/Q, toIR and part o f tolA. The second 
contained the rest of the tolA  gene and the genes to lB  and pal. The division point of to lA  was a 
natural Eagl site in the gene (fig. 2a). The ybgC  gene was not removed from  the complex due to  the 
position of the Pi prom oter but the ybgF gene was not amplified as this gene has no effect on Tol-Pal 
complex assembly (49).
A. Tol-PalF l 
Xhol ^
Tol-PalF2
 Xmal
Tol-PalR2Toi-P alR l
Figure 2. PCR for amplification of the tol-pal complex under its native promoters. (A) Two PCR amplifications 
were carried out from the labelled primers, overlapping at the natural Eagl site in tolA. (B) The two fragments 
were reassembled using the natural Eagl site.
After amplification the PCR products were ligated into Topo vectors to create plasmids TopoTFl and 
TopoTF2 (fig 3.). The Topo plasmids were sequenced and the fragment TolForwardl was digested 
from the plasmid using the enzymes Xhol and Eagl. Insertion of the fragment into pMIDG201 
removed the ner prom oter from the vector. The TolForward2 fragment was then digested from the 
TopoTF2 plasmid and ligated into the construct to form  the pMIDGTol-Pal plasmid. Because a 
naturally occurring restriction site was used to  ligate the tw o halves of the complex there was no 
sequence change in t olA.
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^ E a g l  
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Tol Forward 1
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TopoTFl
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kanR
Tol Forward 1
kanR
Eagl
pMIDGTolFl jUptake sequence
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Forward 2
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TopoTF2
kanR
kanR Eagl
pMIDGTol-Pal Tol Forward 2
— Xmal
Uptake sequence
Figure 3. Construction of the pMIDGTol-Pal plasmid. The PCR amplified fragments of the to l-pal complex were 
ligated into Topo vectors (TopoFl and TopoF2). The fragment TolForwardl was digested from the topoTFl 
vector with Xhol and Eagl and ligated into the pMIDG201 plasmid to form the plasmid pMIDGTolFl. The plasmid 
was then digested with Eagl and Xm al and the second fragment TolForward2 was digested from the topoTF2 
vector and ligated into the plasmid to form the construct pMIDGTol-Pal.
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Construction of the plasmid containing tol-pal under the control of the ner prom oter required the 
removal o f the native promoters and ybgC gene. Also all the genes had to  be present in the same 
reading frame, to be transcribed as a single polycistronic transcript. The genes were amplified in two 
sections, TolForward3 contained the genes tolQ, toIR and tolA and TolForward4 contained tolB and 
pal. The region containing the PB prom oter was not amplified in either fragment (fig 4.a).
Tol-PalnerF2 
Kpnl X
Tol-P alnerF l 
Bam HI ^
X
Tol-PalnerR l
Kpnl-Xm al
B.
Figure 4. PCR amplification of the tol-pal complex for expression under the ner promoter. (A) PCR
amplification of the to l-pal complex with the primers Tol-PalnerFl, Tol-PalnerRl, Tol-PalnerF2 and Tol-PalR2 
removed the Pi promoter and the ybgC gene. The primer Tol-PalnerRl contains a Kpnl site that is in frame with 
the tolA  gene as well as the Xmal site used for cloning into pMIDG201. The primer Tol-PalnerF2 also carries a 
Kpnl site. (B) When the fragments are ligated together using the Kpnl sites inserted during PCR the PB promoter 
is deleted and the tolA  and tolB genes are brought into a single reading frame, allowing the complex to be 
transcribed from a single promoter.
A Kpnl site was added to the 3' end of the first fragment, in the same reading frame as the tolA gene. 
The second fragment also contained a Kpnl site at its 5' end, in frame w ith the start codon of the tolB 
gene. When the tw o fragments were ligated all the genes were in frame could be transcribed as a 
single transcript (fig.4b). A fter amplification the two fragments were inserted into Topo vectors 
(fig.5) resulting in the plasmids TopoTF3 and TopoTF4. After sequencing, TolForward3 was digested 
from  the plasmid and ligated into the pMIDG201 vector downstream of the ner prom oter to  produce 
the plasmid pMIDGTolF3. Ligation of the Tolforward4 fragment w ith this plasmid resulted in the 
plasmid pMIDGTol-Palner (fig.5).
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Figure 5. Construction of the pMIDGTol-Palner plasmid. The PCR amplified fragments were cloned into Topo 
vectors and the fragment Tol Forward 3 was digested from TopoTF3 with BamHI and Xmal for insertion into 
pMIDG201, creating the plasmid pMIDGTolF3. The plasmid pMIDGTolF3 was then digested with Kpnl and Xmal 
to allow the fragment Tol Forward 4 to be inserted with the tolA  and tolB  genes in a single reading frame.
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After construction the plasmids were sequenced to ensure the sequence of the tol-pal complex was
correct in both plasmids. Both plasmids had some mismatches compared to the reference sequence, 
most of these were synonymous mutations but three mutations in the pMIDGTol-Pal sequence and 
two mutations in the pMIDGTol-Palner sequence caused changes to the amino acid sequence (table 
1).
Table 1. Sequence mismatches in pMIDGTol-Pal and pMIDGTol-Palner. Sequencing of the tol-pal genes 
contained in the plasmids pMIDGTol-Pal and pMIDGTol-Palner showing non-synonymous changes. Sequencing 
was compared to the E. coli K12 genomic sequence. Mismatches were confirmed by sequencing on both strands 
of the plasmid sequence.
Plasmid Mutation and position Effect Gene
pMIDGTol-Pal A10359G Gly/Asp toIR
C9504T Ser/Pro tolQ
C10814T Ala/Val tolA
pMIDGTol-Palner T6703C Leu/Ser tolQ
C8363T Ala/Val tolA
Mismatch errors are not the same between the two plasmids, showing that the mismatches were not 
changes in the template sequence used to amplify the tol-pal genes. These errors were not seen in 
the sequencing of the Topo plasmids, indicating that the errors occurred during replication of the 
plasmids in E. coli. As these mutations could have affected the function of theTol-Pal proteins, a tol- 
pal knockout E. coli strain was used to test the ability of the plasmids to complement the Atol-pal 
phenotype.
4.3 Phenotype complementation of the E. coli Atol-pal strain by pMIDGTol-Pal and pMIDGTol- 
Palner
The Atol-pal strain has reduced growth on detergent containing media (45). Competent E. coli Atol- 
pal bacteria were prepared and transformed with pMIDGTol-Pal and pMIDGTol-Palner and the 
presence of the plasmids was confirmed by plasmid preparation and restriction digests. Successfully 
transformed strains were tested for detergent sensitivity by growth on LB agar containing 0.5% DOC
i
(% 6).
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OD6oo value of culture
\E. co li A to l-pa l 
(TB28TolQ-Pal)
E. co li A to l-pa l
containing
pMIDGTol-Pal
E. co li A to l-pa l 
containing 
pMIDGTol- 
PalpmB
E. co li A to l-pa l 
containing 
pMIDGTol- 
Palner
W ildtype 
E. co li
Figure 6. Phenotype complementation of Atol-pal mutant E. coli strain with pMIDGTol-Pal and pMIDGTol- 
Palner plasmids. Phenotype complementation of the Atol-pal strain was tested by growth on media containing 
0.5% Deoxycholate. 5pl drops of Serial dilutions o f a starting culture OD600 value of 0.02 are shown left to right. 
Size marker is shown below image. Clearance of opaque plate (panels 3 ,4  and 5) indicated that bacteria were 
metabolizing deoxycholate. pMIDGTol-PalPmB was a pMIDGTol-Pal plasmid that also contained the high copy 
number origin of replication PmB (see section 5.3 pg. 125).
109
The wildtype strain grew at all the dilutions and also produced zones of clearance of the opaque 
plate, indicating that the bacteria were metabolizing the deoxycholate. By contrast the Atol-pal 
mutant did not grow at any of the dilutions. The pMIDGTol-Palner plasmid, with the constitutive ner 
promoter, complemented the Atol-pal strain demonstrating that the plasmid encoded a functional 
Tol-Pal complex and that transcription of functional single polycistronic mRNA occurred from the 
Neisserial ner promoter in E. coli. When the pMIDGTol-Palner plasmid was transformed into wildtype 
E. coli bacteria, it increased the detergent sensitivity of the strain (data not shown). The strain that 
contained pMIDGTol-Pal (tol-pal under the native E. coli promoters) only grew at the strongest 
concentration of bacterial suspension and produced only a mild change in the phenotype of the Atol- 
pal strain. The proteins encoded by this plasmid could have either not been functional or had reduced 
functionality, possibly due to the point mutations acquired during cloning. A high copy number 
variant of the pMIDGTol-Pal plasmid (pMIDGTol-PalPmB) that contained the same tol-pal genes 
restored growth at all dilutions in the Atol-pal strain and the bacteria cleared some deoxycholate 
from the plate. However, the phenotype was not completely returned to that of the wildtype. 
Therefore the pMIDGTol-Pal plasmid was producing Tol-Pal proteins capable of complementing the 
Atol-pal phenotype, but not in sufficient quantities. Either the native promoters did not act as 
efficiently when present on a plasmid as they do when in the E. coli genome or the mutations in the 
tol-pal genes have reduced the efficiency of the complex, so more proteins must be produced to 
complement the phenotype.
4.4 Transformation of N. meningitidis with pMIDGTol-Pal and pMIDGTol-Palner
Following transformation of the tol-pal expression plasmids into N. meningitidis strain H44/76, 
kanamycin was used to select for successful transformants. The tol-pal insert reduced transformation 
frequency for both expression vectors compared to the empty vector. There would have been 
approximately half the number of the large tol-pal expression vectors (llk b ) than the empty vector 
(6.6kb) in the lpg of DNA used and this may have accounted for the reduced transformation
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frequency. Primers for PCR were designed to  amplify the tol-pol genes at the two ends of the operon
(fig-7).
A. SF1-T1R1
1967bp
T2F2-pMIDG SeqR 
1558bp
B.
£
SF1-T1R1
2225bp
T2F2-pMIDG SeqR 
1558bp
ybgC * tolQ toIR tolA tolB pa l
Figure 7. PCR products used to identify successful N. m en ing itid is  to l-p a l transformants. Bacteria carrying the 
plasmids were identified from transformation plates by PCR. (A) pMIDGTol-Palner PCR products. (B) pMIDGTol- 
Pal PCR products.
The reaction T2F2-pMIDG SeqR which amplifies tolB and pal was used to  confirm the presence of the 
plasmid after transform ation (fig. 8).
I l l
Figure 8. Transformation of pMIDGTol-Pal and pMIDGTol-Palner into wildtype H44/76 N. m ening itid is. Colony 
PCR from a transformation of pMIDGTol-Pal and pMIDGTol-Palner using the primers T2F2-pMIDG SeqR. Clones 
from pMIDGTol-Pal transformation are in lanes 1 and 2, clones from pMIDGTol-Palner transformation are in 
lanes 3 and 4. Expected band size was 1558bp.
Following transformation with pMIDGTol-Palner or pMIDGTol-Pal all the colonies tested were positive 
for the tol-pal region. Colonies were sub-cultured for 24 hours after transformation and the presence 
of the tol-pal genes was tested using the PCRs at the 5' and 3' ends end of the region (SF1-T1R1 and 
T2F2-pMIDG SeqR) (fig.9).
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1= pMIDGTol-Palner clone 1 n qF1 T1R1 5= pMIDGTol-Palner clone 2 n T1R1
2= pMIDGTol-Palclone 1 6= pMIDGTol-Palclone 2
3= pMIDGTol-Palner clone 1 n _ _ 7= pMIDGTol-Palner clone 2 -i D
4= pMlDGTol-Pal clone 1 ]  T2F2-pMIDG SeqR 8= pMIDGTol-Pal clone 2 J T2F2-pMIDG SeqR
Figure 9. Colony PCR from pMIDGTol-Palner and pMIDGTol-Pal clones after twenty-four hour incubation.
Colony PCR with the primers SF1-T1R1 and T2F2-pMIDG SeqR. Lanes 1 and 3 and 5 and 7 show pMIDGTol-Palner 
clones 1 and 2. Lanes 2 and 4 and 6 and 8 show pMIDGTol-Pal clones 1 and 2.
After 24 hours the tol-pal DNA could not be detected in the colonies, but the clones had maintained 
kanamycin resistance. Therefore it was likely that the plasmid had undergone recombination to excise 
the tol-pal genes but had not been eliminated from the bacteria. Multiple transformations of both 
tol-pal containing plasmids produced the same result; initially positive clones lost the tol-pal region 
after 24 hours further growth.
4.5 Recombination of the tol-pal containing plasmids by N. meningitidis
Potential recombination of the tol-pal containing plasmids was examined by isolating plasmids from 
transformants that maintained antibiotic resistance but became PCR negative for the tol-pal region.
To amplify the plasmids for sequencing E. coli ToplO cells were transformed with plasmid recovered 
from two pMIDGTol-Pal and two pMIDGTol-Palner N. meningitidis transformants. The E. coli were 
RecA' and therefore recombination deficient, preventing alteration of the plasmids. Plasmid prepared 
in this way was sequenced to identify the regions of DNA that were lost and to locate the sites of
recombination. Because the clones remained kanamycin resistant, sequencing was performed from 
within the kanR gene in both upstream and downstream directions (fig. 10).
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Figure 10. Recombination of the pMIDGTol-Pal and pMIDGTol-Palner plasmids by N. meningitidis. Plasmid 
recovered from the N. meningitidis to l-pa l clones was sequenced to find the sites of recombination. (A) The 
pMIDGTol-Pal plasmid was shown to have lost the region between 8431bp-3957bp. (B) pMIDGTol-Palner had 
lost the region between 6305bp-2888bp. The two plasmids did not show common recombination sites, both 
maintained the Kanamycin resistance gene, the repA gene and the repA origin of replication.
pMIDGTol-Palner
11039bp6305bp
2888bp
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Recombination had occurred to remove the tol-pal complex from both plasmids whilst maintaining 
the antibiotic resistance and origin of replication. The pMIDGTol-Pal plasmid had recombined to lose 
6917bp, deleting the entire tol-pal region. The pMIDGTol-Palner plasmid lost 7621bp, removing the 
tol-pal region and the ner promoter. The sites of recombination in the two plasmids were not
i
common and recombination was.not the result of homologous sequences at the ends of the deleted 
regions, also no known sequences prone to recombination were identified. Loss of the tol-pal genes 
occurred in all N. meningitidis transformants tested; the lack of obvious motifs prompting 
recombination in the plasmid implied that there was a strong selection pressure on the bacterium to 
remove the tol-pal complex.
4.6 Transformation of N. meningitidis with pMIDGTolFl
The selection pressure against tol-pal could be due to either the functional Tol-Pal complex or its 
individual proteins. To test if the assembled complex was responsible, N. meningitidis was 
transformed with a plasmid (pMIDGTolFl) containing the first genes of the tol-pal operon ybgC, tolQ, 
toIR and a large portion of tolA under the control of the native Pj. promoter. The pMIDGTolFl plasmid 
produced colonies and the presence of the partial tol-pal region was tested by a PCR that amplified 
the region between tolQ and tolA. The presence of the plasmid in the transformants was assayed 
following transformation and after a further twenty four hours growth (Fig.ll).
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After transformation
Wildtype pMIDGTolFl 
clones 1-9
2056 -
24 hours post 
transformation
Wildtype pMIDGTolFl 
clones 1-8
9= control pMIDGTolFl plasmid
Figure 11. Transformation of the pMIDGTolFl plasmid into wildtype N. m eningitid is. The transformation was 
tested with PCR using primers SF1-SR6 to produce a product 2618bp in length. The top gel shows nine clones 
tested after transformation. The bottom gel shows eight of the clones tested after 24 hours further incubation.
Following transformation all of the clones were PCR positive and showed a fa in t band at 2.5kb. After 
24 hours however, most of the clones had become negative for the tolQ-tolA region but maintained 
the antib iotic resistance. One clone (clone 9) did not grow when subcultured, probably the result of 
losing the kanamycin resistance gene. A single colony (lane 2) maintained the plasmid after repeated 
subcultures of the strain and the presence of the partial tol-pal region could be confirmed by PCR 
(data not shown). The plasmid could have contained a point mutation or small loss of sequence, but it 
did not show the deletion of the tol-pal genes that was seen in all of the other plasmids.
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4.7 Discussion
The original hypothesis underlying this work was that the expression of the Tol-Pal complex in N. 
meningitidis would reduce the production of membrane vesicles. However expression of the complex 
in wildtype N. meningitidis could not be achieved, because the plasmids containing the genes were 
lethal to the meningococcus. Cloning of the tol-pal genes into the expression vector presented no 
problems and expression of the Tol-Pal proteins from the plasmids was tolerated in E. coli, 
complementing the detergent sensitivity of theAtol-pal strain. However, when the plasmids were
introduced into N. meningitidis the bacteria were under a strong selection pressure against the tol-pal
0
genes and the plasmids underwent recombination that deleted the five tol-pal genes in every 
surviving clone. Deletion of any of the genes tolQ, toIR, tolA, tolB or pal will prevent the function of 
the Tol-Pal complex. In the case of the pMIDGTol-Palner plasmid, removal of the ner promoter would 
also prevent transcription and therefore function. The consistent deletion of all the genes indicated 
that the selection pressure operating against tol-pal in N. meningitidis was against the expression of 
the individual Tol-Pal proteins and not the formation of a functional multi-protein complex. Later 
work (Chapter 5 fig. 5 pg. 127) confirmed that mRNA was transcribed from the tol-pal genes in N. 
meningitidis demonstrating that the proteins were likely to be expressed in the bacteria.
The genes tolQ, toIR and the portion of tolA were not tolerated even without the rest of the tol-pal 
region present. However if the intolerance of the complex was due simply to these proteins, 
constructs containing the other tol-pal genes (the complete tolA, tolB and pal) would have been 
expected to be recovered from the bacteria. As there were no obvious motifs in tol-pal or the vector 
backbone sequence to indicate another reason why the complete complex was removed in every 
clone, it is likely that at least one of the genes tolA, tolB and pal is also partially responsible for the 
selection pressure against meningococcal strains expressing tol-pal. To establish the toxicity of the 
tol-pal genes individually, plasmids could be constructed containing each gene under a constitutive or 
inducible promoter but this was beyond the scope of this project.
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The structure and biology of the Tol-Pal proteins indicates that they could potentially interfere with 
the normal cellular functions of N. meningitidis, leading to the selection pressure against the 
expression of these genes. TolQ and ToIR show sequence homology to the E. coli inner membrane 
proteins ExbB and ExbD of the TonB system and can partially complement an ExbB ExbD null 
phenotype (111). Both TolQ and ToIR and ExbB and ExbD are thought to produce a proton motive 
force to drive the interactions of their respective complexes. The TonB system is also present in N. 
meningitidis; it is involved with the translocation of iron and other molecules across the cell wall and 
provides a link between the inner and outer membranes. The N. meningitidis ExbB and ExbD proteins 
share 30% sequence similarity with the E. coli TolQ and ToIR proteins (138) so it is possible that the 
TolQ and ToIR proteins may disrupt the normal functioning of the TonB system. It has been 
demonstrated that disruption of TonB affects nutrient uptake, but at least some of these uptake 
processes can be complemented by other proteins (111,138). Disruption of TonB in N. meningitidis is 
not lethal. Therefore, although disruption of the TonB system could be part of the cause, it is not on 
its own sufficient to lead to such a strong negative selection pressure against the Tol-Pal proteins.
In E. coli Tol-Pal is important in cell division and a chaining phenotype is present in Atol-pal strains 
(45). In order to function in cell division the Tol-Pal complex must be assembled, however it is still 
possible that individual proteins may interfere with cell division if they were properly folded and 
transported to the correct locations in the cell wall. The only targeting mechanism identified for the 
Tol-Pal complex is the targeting of the Pal protein by the LolABCDE system (21). A putative 
homologue of the LolA protein has been identified in the N. meningitidis MC58 genome (NMB0622) 
and some outer membrane proteins in N. meningitidis contain signal sequences consistent with 
transport by the Lol system (14). Therefore it is possible that Pal may interfere in cell division.
Although the individual Tol-Pal proteins could potentially interfere with the cellular functions of N. 
meningitidis, it is difficult to identify a mechanism of disruption that would produce such a strong 
negative selection pressure. Accumulation of misfolded or misdirected Tol-Pal proteins could itself
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become a severe stress to the bacteria. Protein accumulation could lead to disruption of the outer 
membrane due to increased pressure in the periplasmic space, in turn increasing the likelihood of cell 
lysis. The overproduction of Tol-Pal in a wildtype E. coli clone produced a phenotype of increased 
detergent sensitivity, indicating that an increase in Tol-Pal proteins in the cell wall causes outer 
membrane disruption. If accumulation of Tol-Pal proteins in the cell wall were lethal in N. 
meningitidis, it would explain the deletion of all the tol-pal genes in the clones and the presence of 
the selection pressure against the Tol-Pal proteins regardless of whether all or some of the tol-pal 
genes are expressed: Although the interference with N. meningitidis cellular processes by functional 
proteins such as TolQ, ToIR and Pal could be contributing to the selection pressure against the genes, 
it seems likely that a mechanism based on misfolded or misdirected protein is the most likely 
explanation for the selection against the expression of tol-pal.
Both disruption by accumulation of protein and the potential interference of Tol-Pal proteins in 
cellular processes, such as the functioning of the TonB system and cell division, would affect the cell 
wall and particularly the outer membrane. Increased vesiculation could allow for greater tolerance of 
the Tol-Pal proteins, it has been indicated in E. coli that vesicles are used to remove misfolded protein 
from the cell (93). Mutants of N. meningitidis outer membrane proteins that show high vesiculation 
could therefore show tolerance of the tol-pal genes. In addition to their increased vesicle release, 
changes in the structure of the outer membrane and cell wall could lessen the interference of the Tol- 
Pal proteins or allow the Tol-Pal proteins to compensate for the outer membrane protein mutations.
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Chapters- Investigation of the phenotype of an N. meningitidis strain containing the tol-pal genes
5.1 Introduction
The tol-pal complex is commonly found in the genomes of Gram negative bacteria, but is absent in N._ 
meningitidis (139). As described in the previous chapter, attempts to express tol-pal in the wildtype 
H44/76 N. meningitidis strain demonstrated that the tol-pal genes were not tolerated. It was 
subsequently hypothesized that the intolerance of the tol-pal genes was due to the Tol-Pal proteins 
disrupting the structure of the cell wall, either because of interference by functional proteins or 
accumulation of misfolded protein.
In E. coliAtol-pal mutants have been shown to have phenotypes of vesicle release, membrane 
instability and aberrant cell division (7,21,45). A similar phenotype of high vesicle release, membrane 
instability and a failure of cells to separate has been shown for the Agna33 mutant of N. meningitidis 
(Chapter 3 pg. 82 and (2,37). The ArmpM mutant also released a high level of outer membrane 
vesicles compared to the wildtype (Chapter 6 pg. 175 and (150)). Selection pressure against the Tol- 
Pal complex may be less stringent in these mutants, the Tol-Pal proteins may be able to compensate 
for the mutated meningococcal proteins by stabilizing the outer membrane or, if accumulation of 
misfolded protein is the cause of the intolerance, increased vesiculation in both strains could allow 
this to be removed. Although such mutants would not be expressing the Tol-Pal proteins in a 
wildtype background, strains would provide evidence of the effects of theTol-Pal proteins on N. 
meningitidis and information on the reasons why the Tol-Pal proteins are not tolerated in the 
wildtype.
The aim of this study was to assess the stability of the tol-pal genes in the mutant strains Agna33 and 
ArmpM by transforming these strains with the tol-pal expression vector pMIDGTol-Pal. If stable Tol- 
Pal expressing strains could be produced, the phenotypes of these stains would provide evidence of 
the effects of the Tol-Pal proteins on N. meningitidis.
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5.2 Transformation of N. meningitidis outer membrane protein mutants with pMIDGTol-Pal
The plasmid pMIDGTol-Pal which contained the gene operon under the transcription control of the 
native E. coli promoters was transformed into N. meningitidis ArmpM and Agna33 strains (fig.l).
A . I
B ‘l
-3054
-2036 3054-
-1636 2036-
1636-1
1= T2F2-pMIDG SeqR
1= SF1-T1R1 
2» SF5-T2R2  
3= T2F2-pMIDG SeqR
Figure 1. Transformation of an H44/76 ArmpM mutant with pMIDGTol-Pal. (A) Colony PCR with the primers 
T2F2-pMIDG SeqR for a colony produced by transformation of ArmpM with pMIDGTol-Pal (B) Colony PCR with 
primers SF1-T1R1, SF5-T2R2 and T2F2 -  pMIDG SeqR (lanes 1-3) for the same colony after 24 hours incubation.
Transformation of the ArmpM strain produced a single colony containing the pMIDGTol-Pal plasmid, 
confirmed by colony PCR. After a further twenty four hours of growth the Tol-Pal complex had been 
lost from the plasmid, indicating that expression of the Tol-Pal proteins was lethal for this mutant as it 
was in the wildtype.
Transformation of the Agna33 strain did not produce any colonies with the pMIDGTol-Pal plasmid
despite repeated transformations. As the Agna33 strain would not produce transformants, the gna33
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single crossover strain was also transformed. This strain contained a linearised gno33 knockout 
plasmid integrated downstream of the gna33 gene and showed slightly increased vesiculation and 
variable levels o f gno33 mRNA expression; low on solid media and higher in liquid culture (chapter 3 
fig. 9 pg.73). Transformation w ith pMIDGTol-Pal produced eight colonies that were positive fo r the 
Tol-Pal complex by PCR. After 24 hours fu rther incubation tw o colonies were still positive fo r both the 
5' and 3' ends of the Tol-Pal complex (fig.2).
M 1 2 3 4
3054-
2036-
636 1= Clone 1 SF1-T1R1 
2= Clone 1 T2F2-pMIDG SeqR 
3= Clone 2 SF1-T1R1 
4= Clone 2 T2F2-pMIDG SeqR
Figure 2. Transformation of the gna33 single crossover strain with pMIDGTol-Pal. Colony PCR for two clones 
produced by transformation of gno33 single crossover strain with pMIDGTol-Pal. Lanes 1 and 3, colony PCR with 
the primers SF1-T1R1. Lanes 2 and 4, colony PCR with the primers T2F2-pMIDG SeqR.
The pMIDGTol-Pal plasmid was stable in these colonies after repeated subcultures, but to  ensure that 
no point mutations or small recombinations had occurred, plasmid recovered from  the strains was 
analysed by restriction digestion and sequencing (fig.3).
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1= Clone 1 C l — 7 - Clone 2 C l—
2= Clone 1 C2 8 = Clone 2 C2
3= Clone 1 C3 EcoRV Clone 2 C3
4= Clone 1 C4 10 = Clone 2 C4
5= Clone 1 C5 11 = Clone 2 C5
6= Clone 1 C6 — 12 = Clone 2 C6—
EcoRV
Expected fragments 
5312
3099_____________
1831_____________
1025
Figure 3. Restriction digest of plasmid recovered from N. meningitidis gna33 single crossover::tol-pal strains.
Recovered plasmid from the N. meningitidis strains was transformed into E. coli. 6 transformants (Cl-6) from 
each strain were tested. Lanes 1-6: gno33 single crossover;:to/-po/clone 1. Lanes 7-12: gna33 single 
crossover::to l-pal clone 2.
Restriction digestion w ith EcoRV demonstrated that the plasmid from the first gna33 single 
crossover:.to/-po/ clone had the expected band pattern for the pMIDGTol-Pal plasmid. The plasmid 
from clone 2 however showed a loss o f approximately lkb  from the 5312bp band. The plasmid was 
also overloaded compared to the plasmid from clone 1, despite the tw o plasmids being prepared 
from the same volume of E. coli culture and the same amount being added to the restriction digests. 
This suggested that the copy number of the plasmid had changed. A BamHI digest performed on the 
plasmid (not shown) also exhibited overloading and a band lkb  smaller than the expected size. The 
tol-pal regions of both plasmids were sequenced and shown to  be identical to the sequence of the 
pMIDGTol-Pal plasmid, confirm ing that no recombination or point mutation had occurred. The gno33 
single crossover mutant was therefore capable of maintaining the pMIDGTol-Pal plasmid. Because the 
strain maintained the tol-pal genes under the native promoters, the plasmid containing the tol-pal
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genes under.the constitutive ner promoter was also transformed into the gna33 single crossover 
mutant. However, the strain would not maintain this plasmid (data not shown).
5.3 Recombination of the pMIDGTol-Pal plasmid by gna33 single crossover mutant
The apparent increase in plasmid copy number in clone 2 suggested that the plasmid had undergone 
recombination outside the tol-pal sequence. A high copy number plasmid could have been produced 
by the insertion of a different origin of replication, most likely from the plasmid introduced into the 
genome of the gna33 single crossover (see chapter 3 fig.4 pg. 68). The linearised gna33 knockout 
plasmid contained the PmB origin of replication, which has a high copy number in E. coli (75) and a 
361bp region of sequence homologous with the pMIDGTol-Pal plasmid. Sequencing of the tol-pal 
plasmid recovered from clone 2 found 1394bp of inserted sequence from the linearised plasmid, 
including the PmB origin of replication. This plasmid had a high copy number in E. coli, but not in N. 
meningitidis where the PmB origin is not functional. The plasmid was named pMIDGToi-PalPmB and 
was used to test the ability of the pMIDGTol-Pal plasmid to complement the Atol-pal E. coli strain 
(Chapter 4 fig. 6 pg. 109).
5.4 Transformation of gna33 single crossover with pMIDGTolFl
Unlike the wildtype, the gna33 single crossover mutant was capable of maintaining the pMIDGTol-Pal
>
plasmid in two out of eight clones. However, the mutant could not maintain a plasmid where the tol- 
pal complex under the control of the constitutive ner promoter (data not shown). These results 
indicated that the selection pressure against the Tol-Pal complex was ameliorated, but not abolished, 
in the gna33 single crossover. In the wildtype, transformation with a plasmid containing only the 
genes tolQ, toIR and part of tolA under their native promoter (pMIDGTolFl) was not tolerated. To test 
if the amelioration of the selection pressure in the gna33 single crossover was due to tolerance of 
these genes and if the selection pressure against the complex was increased by the number of tol-pal 
genes present, the strain was transformed with the pMIDGTolFl plasmid. Colonies positive for the
(
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tolQ, toIR and partial tolA genes by PCR after transformation were tested for the presence of the 
genes after a fu rther 24 hours growth (fig.4).
After transformation
gna33 single crossover 
pMIDGTolFl clones 1-9
M 1 2 3 4 5 6 7 8 9 M
24 hours post transformation
gna33 single crossover 
pMIDGTolFl clones 1-9
Figure 4. Transformation of the pMIDGTolFl plasmid into gna33  single crossover strain. The transformants 
were tested with colony PCR using primers SF1-SR6 producing a 2618bp product. Nine colonies were tested 
immediately after selection from the transformation plate and twenty four hours after subculture from the 
transformation plate.
The gna33 single crossover strain tolerated the genes tolQ, toIR and partial tolA in all the clones. 
Although bands in the PCR after transformation were faint, eight of the nine clones were strongly 
positive fo r the tol-pal genes after 24 hours fu rther growth. The clone in lane 2 was weakly positive 
for the construct. It is possible that the strains may contain smaller recombinations or point 
mutations that are not shown by the PCR, but the large loss of DNA shown in all the other strains 
transformed w ith tol-pal constructs was not seen. Unlike the wildtype, the gna33 single crossover
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tolerated the partial plasmid. Therefore amelioration of the selection pressure against the complete 
operon in the mutant was likely to result from the tolerance of the genes tolQ, toIR and partial tolA, 
but there remained a selection pressure against the expression of other tol-pal genes.
5.5 Transcription of tol-pal in the gna33 single crossover::tol-pal strain
The Tol-Pal proteins were not visible on SDS-PAGE gels and monoclonal antibodies against the 
proteins were not available. Therefore RNA was used as an indicator of expression of the Tol-Pal 
proteins. To establish if the gna33 single crossover::tol-pal mutant was producing mRNA from the tol- 
pal genes, total RNA from the strains was examined using RT-PCR (fig.5).
1636  —
1 0 1 3 -
5 0 6 -
m i
1= Wildtype porA 6 =  Tot-Pal clone 1 tol-pal 2
2 =  Wildtype tol-pal 1 7 =  Tol-Pal clone 2 porA
3 =  Wildtype tol-pal 2 8 =  Tol-Pal clone 2 tol-pal 1
4 =  Tol-Pal clone 1 porA 9 =  Tol-Pat clone 2 tol-pal 2
5s= Tol-Pal done 1 tol-pal 1
Figure 5. RNA production from gna33 single crossover;:to/-po/ mutants. RT-PCR products of the background 
strain (gna33 single crossover) and the two to l-pa l containing mutants. porA mRNA production is used as a 
control (582bp). Lanes 1-3 contain cDNA from porA  mRNA and the two to l-pal mRNA transcripts (760bp and 
652bp) in the gna33 single crossover mutant. Lanes 4-6 cDNA from the gna33 single crossover::to l-pal clone 1. 
Lanes 7-9 cDNA from the gna33 single crossover::to l-pa l clone 2.
The mRNA products were detected by using two primer pairs, to test for transcripts from both
promoters Px (lanes 5 and 8) and PB (lanes 6 and 9). As in previous experiments, porA RNA was used
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as a control. The background strain (gna33 single crossover) showed no expression of either of the 
tol-pal mRNA species. The gna33 single crossover::tol-pal clone 1 showed bright single bands for both 
transcripts, clone 2 showed a bright band for the tolQ-tolA transcript (from the Pi promoter) but the 
band for the tolB-pal transcript (PB promoter) was relatively weaker. A similar amount of total RNA 
was present in both reactions; therefore'clone 2 was not transcribing the product from PB as 
efficiently as clone 1. It is possible that the PB promoter is non-functional in this strain; read-through 
expression of tolB-pal is known to occur from Pi. However, sequencing of this region showed no 
change in the PB promoter in the plasmid. Because of this difference in expression levels, clone 1 was 
used for further phenotypic studies.
5.6 Production of gna33 RNA in gna33 single crossover::tol-pal
!
The gna33 single crossover mutant produced low levels of gna33 RNA when grown on solid media, 
but wildtype levels when the bacteria were grown in broth (chapter 3 fig. 17). To see if this . 
characteristic was also present in the gna33 single crossover::tol-pal mutants the expression of gna33 . 
RNA from cultures grown on solid media was assayed using RT-PCR (fig.6).
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Figure 6. Changes in the transcription of gna33 RNA in gna33 single crossover;;to/-po/ mutants. cDNA 
products produced by RT-PCR from the gna33 single crossover and gna33 single crossover::fo/-po/ strain (clone 
1) using the GNA33RNAF and GNA33RNAR primer pair. cDNA from porA  was used as a control. gna33 cDNA 
produced by RT-PCR from the two strains grown on solid media was loaded in lanes 1 and 2. porA cDNA was 
loaded in lanes 3 and 4.
As expected, the transcription of gna33 in the gna33 single crossover was low on solid media.<v
However when the tol-pal genes are expressed the production of gr\a33 mRNA was upregulated. The 
control of gna33 production is influenced at both a transcriptional and post-transcriptional level by an 
upstream signal sequence, which has been suggested to form a GC-rich stem loop (126). This signal 
sequence was present twice in the gna33 single crossover genome, due to inclusion of the linearised 
plasmid. Both regions were sequenced in the gna33 single crossover and gna33 single crossover::to/- 
pal strains (data not shown). Signal sequences were identical to the reference sequence in both the 
gna33 single crossover and the gna33 single crossover "tol-pal mutants. Therefore changes in 
transcription in the mutant strains were not the result of sequence changes to this region.
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5.7 Growth of gna33 single crossover::tol-pal
Growth of the gno33 single crossover::tol-pal strain was compared to the background strain and the 
wildtype. Antibiotics were included in the growth media to  maintain the gna33 single crossover 
(erythromycin) and the pMIDGTol-Pal plasmid (kanamycin) (fig. 7).
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Figure 7. Growth curve of gna33 single crossover::tol-pal mutant. Growth of the wildtype, gna33 single 
crossover and gno33 single crosso\/er::tol-pal strains in liquid culture over an eight hour period. Measurements 
o f OD600 were used as a surrogate of growth. Curves represent the mean of three experiments.
There was no significant difference between the growth of the gno33 single crosso\/er::tol-pol mutant 
and the background strain or wildtype when the OD600 values were compared at 8 hours (P=>0.05). 
The m utant did show a slight lag in growth compared to the background and w ildtype strains. In a 
control experiment the gna33 single crossover transformed w ith vector w ithou t Tol-Pal insert did not 
show any difference in growth (data not shown), so any lag was likely to be due to the expression Tol- 
Pal complex.
5.8 Antibiotic sensitivity phenotype of gna33 single crossover::tol-pal
To examine the stability of the cell wall, bacteria were assayed for their sensitivity to  a selection of 
antibiotics that disrupted either peptidoglycan synthesis or the outer membrane (fig.8).
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Figure 8. Antibiotic sensitivity on solid media. Sensitivity to the antibiotics polymyxin B, ampicillin, vancomycin 
and D-cycloserine was tested using disc diffusion assay. Bars represent mean diameter of inhibition zone of 
three experiments. Error bars represent SEM.
The gno33  single crossove r::to l-pa l strain showed no significant change in susceptibility to  any of the 
antibiotics tested compared to the background strain (P=>0.05). The gna33  single crossover:.to/-po/ 
strain was not significantly different to  the w ildtype in susceptibility to vancomycin, D-cycloserine or 
polymyxin B (P=>0.05). Both the gna33  single crossover and gna33  single crossover:.to/-po/were 
significantly less susceptible to ampicillin compared to  the wildtype (P=<0.05). This was due to  the 
ampicillin resistance gene introduced into the genome in the production of the gno33  single 
crossover strain. Expression of the Tol-Pal proteins in the gno33 single crosso\zer::to l-pal strain did not 
cause an increase in the susceptibility o f the strain to  the antibiotics tested, therefore it was unlikely 
tha t expression of the proteins significantly disrupted the cell wall when the bacteria were grown on 
solid media.
The growth of N. m eningitid is  in liquid culture was shown to  be improved by the addition of sodium 
chloride (chapter 3 Fig. 11) and it was hypothesized tha t the bacteria were under osmotic stress. 
Additional osmotic stress could change the response of the gno33  single crossover:\to l-pa l mutant to
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antibiotics, so the strains were assayed for their susceptibility to the antibiotics ampicillin and 
polymyxin B in liquid culture. Ampicillin was used to disrupt peptidoglycan synthesis and polymyxin B 
because its mode of action was directly affected by disruption of the outer membrane. The survival of 
the bacteria was calculated by the CFU present in the treated samples compared to untreated 
controls and expressed as percentage survival (fig.9).
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Figure 9. Antibiotic sensitivity in liquid media. Antibiotic sensitivities of the gno33 single crossover and gna33 
single crossover::to l-pal in liquid media were assayed. Sensitivity was assayed by changes in the number of 
colony forming units in samples after exposure to antibiotics. (A) Exposure to 3pg/ml ampicillin. (B) Exposure to 
lOpg/ml polymyxin B. Results are the mean of three experiments. Error bars represent SEM. Significance values 
were calculated by T-test.
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The gna33 single crossover::tol-pal mutant exhibited significant differences in the susceptibility to the 
tested antibiotics compared to the background strain. Both ampicillin and polymyxin B produced a 
decrease in survival in the gna33 single crossover::tol-pal strain (P=0.04). To ensure the plasmid was 
not being lost from the gna33 single crossover::tol-pal strain, cultures were also tested on plates 
containing kanamycin; these results were not significantly different from the cultures grown without 
kanamycin (P=>0.05, data not shown). The increased sensitivity to antibiotics indicated that the 
gna33 single crossover::tol-pal mutant had a disrupted outer membrane and disrupted ' 
peptidoglycan.
5.9 Cryo-Electron microscopy of gna33 single crossover;;to/-po/
The effects of the Tol-Pal proteins on the outer membrane, peptidoglycan and inner membrane of the 
bacteria were of particular interest, due to the potential of the proteins to interact with the cell wall. 
Cryo-electron microscopy was used to examine the morphology of the gna33 single crossover::tol-pal 
mutant (fig.10).
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Figure 10. Cryo-electron microscopy of gna33  single crossover ::to l-pa l strain. Bacteria were compared to the 
background strain (Chapter 3 fig. 13 pg.80). (A) and (B) Some bacteria were observed as single organisms or in 
pairs, however the majority o f bacteria were observed in clusters of several organisms (C) and (D). (A) 25,000X 
200kV, (B) 20,000X 200kV. Scale bar 200nm. (C) and (D) 12,000X 200kV. Scale bar 0.5pm.
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Figure 10. Cryo-electron microscopy of gna33 single crossover::to l-pa l strain (continued) (E) and (F) Bacteria 
were observed in small clusters with dead bacteria (E). Separate outer membranes were clearly visible between 
clustered bacteria (F). Vesicles were commonly observed (arrowed in (F)). (FI) Large clusters were commonly 
observed. (E) 25,000X 200kV, (F) and (G) 20,000X 200kV. Scale bar 200nm. (H) 12,000X 200kV. Scale bar 0.5pm.
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Figure 10. Cryo-electron microscopy of gna33 single crossover:;to/-po/ strain (continued) (I) and (J) Large 
clusters observed seemed to show loose association between the bacteria, however bacteria were only rarely 
observed outside of these clusters. (J) Closer examination of the bacteria showed them to have separate outer 
membranes (arrowed), other than some that appear to be in the process of dividing. A normal phenotype 
bacterium was also observed separate from the cluster. (I) 10,000X 200kV. Scale bar 0.5pm. (J) 20,000X 200kV. 
Scale bar 200nm.
Morphology of the gna33 single crossover background strain was similar to that of the w ildtype 
(chapter 3 fig. 12 and fig .13 pg.77-80). However, electron microscopy of the gna33 single 
crossover::tol-pol mutant revealed that organisms were mainly in large clusters. Although some 
bacteria were observed individually (Fig. 10, panels A and J), the majority of bacteria in the sample 
were found in clusters o f at least three cells. Large clusters o f five or more bacteria were commonly 
observed (H), (I) and (J). Bacteria were observed in contact w ith both live and degraded bacteria (C), 
(D) and (E). Examination of these clusters showed tha t the bacteria had individual outer membranes 
and did not appear to  be connected together by any visible part of the cell wall architecture, a similar 
clustering phenotype to the Agna33 mutant. Bacteria also showed no visible changes to  the interior 
of the cells, the dark spots that appear w ithin some of the bacteria are artefactual. The cell walls of 
individual bacteria also appeared morphologically normal. Other than the clustering, the morphology 
of the bacteria appeared similar to  the background strain.
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5.10 Transformation of AsiaD mutant with pMIDGTol-Pal
The clustering phenotype of the gna33 single crossover;:to/-po/ does not occur due to an obvious 
defect in the separation of the outer membrane. Therefore the attraction between the bacteria must 
occur due to an agent on the surface of the cells or outside the outer membrane; the capsule is a 
candidate for such an interaction. An acapsular mutant AsiaD (147) was transformed with the plasmid 
containing the tol-pal region to test if the mutant was more tolerant than the wildtype of tol-pal 
expression (Fig.ll) and if the clustering phenotype persisted in the double mutant.
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Figure 11. Transformation of a H44/76 ASiaD mutant with pMIDGTol-Pal. PCR of colonies produced by 
transformation of AsiaD strain with pMIDGTol-Pal. (A) Colony PCR with T2F2-pMIDG SeqR on 9 clones after 
selection from transformation plate. (B) Colony PCR with T2F2-pMIDG SeqR of the same 9 clones 24 hours after 
selection from the transformation plate.
The plasmid was unstable when transformed into the AsiaD strain. Nine of the ten colonies selected 
lost the plasmid within twenty four hours (Fig. l ib );  the remaining the remaining colony (lane 9) lost 
its plasmid after forty-eight hours growth (data not shown). Therefore, although it was not possible 
to test whether capsule production caused the clustering of bacteria, it was not a factor affecting 
plasmid stability.
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5.11 Native OMV production from gna33 single crossover::tol-pal
In E. coli, absence of theTol-Pal complex leads to increased vesicle production. To establish the effect 
of the presence of the Tol-Pal complex in the mutant strain preparations of vesicles produced by the 
bacteria were examined. First, an immunoassay was used to quantify the level of PorA and PorB in 
the vesicle preparations as a surrogate of vesicle quantity (fig.12).
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Figure 12. Slot blot immunoassay of PorA and PorB in native vesicles from the wildtype, gna33 single 
crossover, and gna33 single cross;:to/-po/ strain. Dilutions of the native OMV samples immunoblotted with 
monoclonal PorA and PorB antibodies. Dilutions of 1:200 and 1:2000 were used for the wildtype and gna33 
single crossover strains. 1:1000 and 1:10000 was used for the gna33 single crossover::tol-pal strain. Calculated 
protein amounts per \i\ of vesicle sample are shown in the table. Protein amounts were calculated using the 
Kodak Ml software by comparison to standard curves (see chapter 3 fig. 17). In samples below the limit of 
detection no signal above the background level could be detected by the software.
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Immunoblotting showed that the gna33 single crossover::tol-pal strain native OMV sample contained 
more PorA and PorB than the wildtype or background strain samples. The level of PorA assayed by 
the 01/514 and 01/538 antibodies did not correlate as was observed for the gna33 mutants (Chapter 
3 fig.18 pg.88) confirming that the PorA antibodies do not show agreement at low concentrations of 
antigen. The amount of PorB and PorA (from the 01/514 antibody) were approximately seven and 
eight times higher than in the background strain. The ratios between PorB: PorA was 1:1.1 in the
gna33 single crossover::tol-pal strain and 1:1.3 in the gna33 single crossover. As both the increase in
\.
PorA and PorB and the ratio of the two proteins in both strains were consistent, this indicated an 
increase in vesicle size or number, but not in the protein content of the vesicles. Repeated 
experiments showed similar levels of increase,in the samples.
5.12 Cryo-electron microscopy of native vesicles from gna33 single crossover::tol-pal
The quantity and morphology of OMVs produced by the gna33 single crossover::tol-pal strain was 
examined by Cryo-electron microscopy (fig.13) and compared to the wildtype and background strains 
(Chapter 3 fig. 19 and fig.20 pg. 90-91)
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Figure 13. Cryo-Electron microscopy of native OMV produced by the gna33 single crossover::tol-pal mutant.
Vesicles were observed much more often in the gno33 single crossover::to l-pa l mutant than in the background 
strains (see Chapter 3 fig.20 pg.91) (A), (B), (C), (D) Vesicles were most commonly observed on the carbon film, 
although some vesicles were seen at the edges of ice holes. Vesicles also showed variation in size and shape. 
(A),(B),(C),(D) 30,000X 200kV. Scale bar lOOnm.
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Figure 13. Cryo-Electron microscopy of native OMV produced by the gna33 single crossover::tol-pal mutant 
(continued). (E) and (G) Vesicles were plentiful on the carbon film but were only found at the edges of the 
holes. (F) and (H). 30,000X 200kV. Scale bar lOOnm.
Electron microscopy confirmed the results of the immunoassay; the gno33 single crossover::tol-pal 
mutant sample contained more vesicles in the field examined than were observed in the w ildtype or 
gno33 single crossover strains. The vesicles in the sample were found mostly on the carbon film  but 
were also observed at the edges of the ice holes. Vesicles appeared to  vary in size and shape, those 
on the carbon film  may have been distorted but vesicles in the ice also showed variation. Unlike
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E. coli, where presence o f the Tol-Pal complex decreases vesiculation, Tol-Pal increased vesiculation in 
N. m eningitid is.
5.13 Morphology of native vesicles from gna33 single crossover::tol-pal
Morphology of the vesicles in the electron micrographs was compared in terms of size and shape to 
the background strain (table 1 and 2).
Table 1. Comparison of vesicles from gna33 single crossover and gna33 single crossover::tol-pal strains.
Values are a mean of 45 vesicles from gno33 single crossover and gna33 single crossover::to l-pal mutants. 
Vesicles were randomly selected from the samples. Significance values <P=0.01 are marked in blue. P values 
calculated by student's T-test.
gna33 single crossover gna33  single 
crossover ::tol-pal
Mean perimeter (nm) 121.46 166.71
SD 49.13 59.22
Mean area (nm) 1359.04 2461.9
SD 1234.51 2057.49
P values from T-test
gna33 single crossover: 
gna33 single crossover::tol-pal
Perimeter <0.01
Area <0.01
Vesicles produced by the gno33  single crossover::to l-pa l strain had significantly larger perimeter and 
area measurements compared to  gno33 single crossover OMVs. Presence of the Tol-Pal complex 
increased both the amount and size of vesicles produced.
The change in size of the gno33  single crossover::to l-pa l vesicles was similar to the changes observed 
in the Agna33  mutant (Chapter 3 table 1 pg.95). Therefore Agna33  and gno33 single crossover-to l- 
pal mutant vesicles were also compared and showed there was no significant difference in the 
perimeter and area values (P=>0.05). Standard deviations of the gna33  single crossover::to l-pa l 
vesicles suggested tha t the vesicles may also be more variable than those of the background strain.
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The variance of the gna33  single crossove r::to l-pa l strain was compared to both the gna33  single 
crossover and the Agna33  strain using an F-test (Table 2).
Table 2. F-statistic values for the vesicle samples. F-statistic calculated using F-test. Significance value set at 
0.05.
F-statistic values
Comparison gna33  single crossover\gna33 
single crossover::tol-pal
Agna33:gna33 single 
crossover ::tol-pal
Area <0.05 >0.05
Perimeter >0.05 >0.05
The gna33  single crossove r::to l-pa l strain vesicles were significantly more variable than those of the 
background strain in the area measurement and although it is not significantly different in the 
perimeter measurement, the F-test value was close to  significance (F=0.06). Variability of the Agna33  
and gna33  single crossover;.To/-po/ strain vesicles was similar w ith no significant differences between 
the strains.
5.14 Discussion
In the previous chapter it was demonstrated tha t a plasmid containing the to l-pa l genes could not be 
stably maintained in wildtype N. m eningitid is. This was not due to  the formation of the complete Tol- 
Pal complex, but was caused by some or all o f the gene products of the to l-pa l operon. It was 
hypothesized that this was due to  either interference of the Tol-Pal proteins w ith the normal 
functioning of N. m en ing itid is  proteins or accumulation of misfolded or mislocalised protein. This was 
sufficiently detrim ental to the cell that only strains lacking the to l-pa l genes survived. Mutants fo r N. 
m ening itid is  outer membrane proteins may have been able to  maintain the to l-pa l plasmids, due to 
the changes in the cell wall caused by the m utant genotype or because increased vesiculation allowed 
the removal o f misfolded protein. The high vesiculating A rm pM  strain did not stably maintain the 
plasmid, indicating that removal of potentially misfolded Tol-Pal protein by vesiculation did not
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enhance bacterial survival. The Agna33 strain did not produce colonies when transformed with the 
tol-pal plasmid. As transformation into the Agna33 mutant could not be achieved with other plasmids 
or with genomic DNA, it was likely that vthe strain itself was not competent. However, the gna33 
single crossover strain stably maintained the plasmid in two clones. It was therefore possible to 
stabilize the tol-pal region in a mutant strain; although even this was only possible with the relatively 
low level of tol-pal expression from the native promoters.
A plasmid containing the genes tolQ, toIR and part of tolA was stable in the gna33 single crossover 
strain, but only maintained by a single clone in the wildtype. The difference in the stability of the 
complete complex in the two strains was therefore most likely to be caused by a reduction in the 
detrimental effects of the tolQ, toIR and partial tolA genes on the gna33 single crossover strain. 
Consequently, the recombination of the plasmid containing the complete tol-pal region in some 
gna33 single crossover clones was due to the additional presence of the tolA, tolB and pal genes. This 
supports the hypothesis that instability of the tol-pal region in the wildtype was due to multiple genes 
and that both clusters tolQ-tolR-partial tolA and tolA-tolB-pal contained genes that caused the 
instability.
The effects of expressing the tol-pal genes included the upregulation of gna33 transcription when the
bacteria were grown on solid media. Previously the gna33 single crossover strain had been shown to
have a low level of gna33 mRNA when grown on solid media but upregulated transcription of the
gene when grown in liquid culture. It was hypothesized that this change was in some way related to
an increase in membrane stress associated with growth in liquid culture. If production of the Tol-Pal
proteins was also leading to membrane stress in the bacteria, this could account for the upregulation
of gna33 in the gna33 single crossover::tol-pal strain on solid media. However, if the presence of
GNA33 is required to maintain the tol-pal region stably, why was it not maintained in the wildtype
where GNA33 was produced consistently at higher levels? The answer could lie in the level of gna33
expression; it was possible that although gna33 transcription was increased in the single crossover ■
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mutant, expression may not have been at wildtype levels. This partial increase could have been 
sufficient to allow the bacteria to adapt to the increased membrane stress caused by the presence of 
the tol-pal genes, by improving peptidoglycan organization, but not enough to have caused a strong 
negative selection pressure due to the presence of GNA33. Further, the ability to change the 
expression level of gna33 to a 'compromise' level that allowed the tol-pal region to be maintained 
could have been what differentiated clones capable of stably maintaining the tol-pal containing 
plasmid and those that did not. The maintenance of the plasmid containing the partial complex in all 
the clones tested would indicate that the factor requiring low GNA33 levels was most likely in the 
tolQ-toIR-partial tolA region. The factor requiring a higher GNA33 levels would lie in the tolA-tolB-pal 
gene cluster. Pal would seem the most likely candidate, as the protein directly interacts with the 
peptidoglycan. Disruption of the peptidoglycan structure was strongly indicated in the Agna33 
mutant and has been previously recorded in lytic transglycosylase mutants in E. coli (81).
Alternatively, GNA33 may simply allow the cell wall to adapt better to increased disruption caused by 
the presence of the Tol-Pal proteins, particularly disruption of the outer membrane by Pal protein in 
the periplasmic space. Antibiotic sensitivity results indicated that the outer membrane of the gna33
i
single crossover::tol-pal has some slight disruption to the outer membrane. The 'compromise' level of 
gna33 expression could therefore be one that allowed sufficient GNA33 to be expressed to prevent 
disruption of the peptidoglycan or to compensate for the outer membrane disruption caused by 
misfolded proteins in the periplasm. However GNA33 production would not be sufficient to enhance 
interference by other Tol-Pal proteins {toIR, tolQ or partial tolA) enough to cause negative selection. 
Examination of the gna33 mRNA produced by the gna33 single crossover mutant transformed With 
the partial plasmid could provide evidence for this hypothesis.
The hypothesis of a 'compromise' level of gna33 expression suggests that regulation of gna33 is 
complex and is likely to be affected by stress in the cell wall. Other than the effect of the signal 
sequence of gna33, little is known about the control of membrane bound lytic transglycosylases in N.
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meningitidis or E. coli. However, the soluble lytic transglycosylase Slt70 has been shown to be 
controlled by the stringent response, a stress response pathway in E. coli (9). The overexpression of 
lytic transglycosylases has the potential to cause cell lysis; therefore it is logical that such enzymes 
and other murein hydrolases would be tightly controlled. Testing the levels of gna33 mRNA after 
transformation with individual tol-pal genes and using a more accurate RNA quantitation technique 
such as real time PCR, would test the hypothesis of 'compromise' expression more rigorously and 
may provide more information on the factors affecting gna33 mRNA expression.
The gna33 single crossover::tol-pal provided a model for studying the effects of the Tol-Pal complex, 
even though the proteins were not expressed in a wildtype background. The phenotype of the gna33 
single crossover::tol-pal strain was similar but less severe than that.of the Agna33 strain. The strain 
showed evidence of a mildly disrupted outer membrane and had a clustering phenotype similar to 
that of the Agna33 mutant (although clusters were smaller). It produced OMVs similar to those of the 
Agna33 mutant but significantly different from the OMVs produced by the wildtype and single 
crossover background strain. The OMVs were also more often observed on the hydrophilic carbon 
film than in the ice holes in both strains. However gna33 single crossover::tol-pal did not have a 
significantly decreased growth rate. The similarity of the phenotypes of the two strains could be 
caused by reduced expression of GNA33, due to a 'compromise' expression level being reached in the 
gna33 single crossover::tol-pal strain, leading to a milder phenotype than the complete Agna33 
knockout. However, the strong selection pressure against the tol-pal region in the wildtype indicates 
that expression of the Tol-Pal proteins would produce phenotypic effects of their own. The 
phenotype of the gna33 single crossover::tol-pal mutant was therefore likely to be caused by a 
combination of changes in GNA33 expression and the expression of Tol-Pal proteins. The similarity of 
the gna33 single crossover::tol-pal phenotype to that of the Agna33 mutant indicated that the two 
phenotypes were caused by the same underlying processes. Cell wall disruption would be the most 
likely common factor between the two strains, in Agna33 disruption occurred due to changes in the
normal structure of peptidoglycan, in the gna33 single crossover::to/-po/ strain it was caused.by the 
accumulation of Tol-Pal proteins in the cell wall and by changes to gna33 expression. This stress led to 
disruption of the outer membrane and the increase in vesiculation in both strains. Stress in the cell 
wall and outer membrane directly related to the accumulation of misfolded protein has been shown 
to lead to increased vesiculation in E. coli (92,93). The increased detergent sensitivity observed in an 
E. coli strain that overexpressed the Tol-Pal proteins also supports the hypothesis that accumulation 
of Tol-Pal proteins can lead to disruption of the outer membrane. Disruption of the peptidoglycan 
could exacerbate the problems of misfolded proteins, by preventing correct insertion of 
peptidoglycan spanning proteins into the cell wall.
The gna33 single crossover::tol-pal mutant does not display any defect in growth or membrane 
stability severe enough to indicate why the complex is so unstable in wildtype N. meningitidis. The 
genetic changes in the background strain may be ameliorating these effects, most likely by 
modulation of the expression of the GNA33 protein. The original aim of the Tol-Pal study was to test 
the hypothesis that the expression of the Tol-Pal complex in N. meningitidis would reduce the vesicle 
releasing phenotype of the bacteria. The instability of the tol-pal genes in the wildtype made it 
impossible to test this and when the genes were expressed in the gna33 single crossover mutant they 
showed the opposite effect, increasing vesiculation. High vesiculation in N. meningitidis (and most 
likely in other high vesiculating Gram negative species that lack the tol-pal genes) is therefore not due 
directly to the absence of the complex. Absence of the tol-pal genes in so many high vesiculating 
species may still indicate a more complicated link with the vesiculation phenotype. For example the 
loss of the Tol-Pal complex may be required to develop high vesiculation, but this is likely to be the 
result of further evolution of the cell wall structure without Tol-Pal present rather than directly due to 
the gene loss.
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Chapter 6- Investigation into phenotype and vesicle production of an H44/76 brmoM  strain and a
strain containing a truncated rmoM  gene
6.1 Introduction
The major outer membrane proteins of N. meningitidis were originally classified by size and structural 
analysis into five classes by Tsai et al. in 1981 (144). Of these five classes, classes 1, 2 and 3 contained 
the porin proteins PorA and PorB and the, class 5 opacity protein Opa. The class 4 protein was found 
to cross-react with immune sera raised against the N. gonorrhoeae reduction modifiable class 3 
protein RmpG (85). Sequence analysis and SDS-PAGE showed the class 4 protein to be a reduction 
modifiable protein that shared significant sequence similarity with the gonococcal RmpG (70,85) and 
the protein was named RmpM.
The rmpM gene (NMB0382) is 729bp long, found at position 385529-386257 in the N. meningitidis 
MC58 genome and is not known to be part of any operon. RmpM is a protein of 242 amino acids with 
a molecular weight (Mw) of 26.2kDa. The protein Can be divided into 4 domains (Fig.l) consisting of, 
an N and C-terminal region separated by a proline rich hinge and a 22 amino acid signal peptide which 
is cleaved from the mature protein (54).
A functional domain with homology to the peptidoglycan binding domain of the E.coli protein OmpA 
has been identified at the C-terminal end of RmpM (70). Although classified as an outer membrane 
protein and purified with outer membrane proteins, no recognised motif for incorporation into the 
outer membrane has been identified in the N-terminal portion (54). It has been hypothesised that 
outer membrane binding occurs through interactions between the N-terminal domain of RmpM and 
outer membrane proteins such as PorA, PorB (64) Omp85 (162) and iron acquisition proteins 
including FetA (114). Complexes of these proteins and RmpM have been shown to occur (64,119) 
supporting this hypothesis. It has also been suggested that RmpM has a role in stabilisation of outer 
membrane protein complexes (64).
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The structure of the C-terminal OmpA like domain of the RmpM protein was determined by Grizot et 
al. using X-ray crystallography (54). Sequence alignments also showed conserved residues at the 
positions D120, Y127, R135 and R197 (fig.l). Computer docking experiments indicated that the 
residues Y127, R135 and R197 could form hydrogen bonds with the disaccharide moiety of the 
peptidoglycan, although only one conformation of protein-peptidoglycan binding was tested. This 
structural study also identified a disulphide bond linking two alpha helices (a-4 and a-5) to form an 
extended loop beneath the putative peptidoglycan binding domain. However, homology to other 
OmpA domains suggested that this loop was not involved in peptidoglycan binding (54).
The construction of an ArmpM  strain was undertaken by Klugman et al. and the mutant was shown to 
have a similar morphology and growth to the wildtype strain (70). It has been observed that the 
ArmpM strain produces more vesicles more than the wildtype strain (150) but this increase has not 
been quantified. It has been hypothesised that RmpM forms a structural link between the 
peptidoglycan and outer membrane (54,71) and that the loss of this link results in separation of the 
outer membrane from the peptidoglycan. This allows more blebs to be formed and therefore 
increases the amount of vesicles released. Alternatively the increased vesiculation may be due to 
changes in the arrangement or stability of proteins in the outer membrane that interact with RmpM, 
which in turn destabilises the outer membrane. The aim of this study was to characterise the function 
of the RmpM protein by examining the phenotype of the ArmpM  mutant strain. A mutant which is 
lacking the peptidoglycan binding domain of the RmpM protein, but maintains the binding to outer 
membrane proteins, was used to test the hypothesis that it is the loss of the linkage between the 
peptidoglycan and outer membrane provided by RmpM that causes the high vesiculation phenotype 
in the ArmpM  strain.
\
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6.2 Construction of an rmpM  m utant lacking the C-terminal peptidoglycan binding function
The construction of a m utant lacking a peptidoglycan binding function required the deletion of part of 
the C-terminal domain. This domain constitutes over half of RmpM, therefore complete deletion of 
the region had the potential to  destabilise the rest of the protein. A strategy was devised to delete 
the last 69 amino acids of the C-terminal domain, using a natural Xbal restriction site that occurred at 
517bp in the C term inal region. The putative peptidoglycan binding residue R197 and the residues 
that form the disulphide bond between the helices a4-a5 were distal of the Xbal site (fig 1). The 
removal of these residues should have been sufficient to  destroy or greatly reduce peptidoglycan 
binding in the mutant protein.
Xbal
Signal , i* ? i/i ]Hinge
peptide N-terminal region region j^yC-terminal regionj |
rmpM gene
Figure 1. Structure of the rmpM  gene The rm pM  gene is divided into four domains. The 22 amino acid signal 
peptide is cleaved from the mature protein. The N-terminal region contains 40 amino acids followed by a 
proline rich hinge region of 20 amino acids; this is followed by the 150 amino acid C-terminal region. A 
disulphide bond is formed between the residues C169 and C192. Amino acids involved in peptidoglycan binding 
are shown in purple and blue. The Xbal site used in truncation is shown and the key residues removed by the 
truncation are shown in blue.
The cloning strategy fo r replacement of the RmpM protein w ith the truncated form is shown in figure 
2 .
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Figure 2. Cloning strategy for construction of RmpM C-term mutant. The rm pM  gene was amplified by PCR and
cloned into a topo vector to produce TopoRmpM. TopoRmpM was digested with Xmal and Hindlll and the 
rm pM  fragment was cloned into the pUC19 vector to  produce the plasmid pUCRmpM. A KanR cassette was 
amplified by PCR using a primer that contains a stop codon TAA after the Xbal site on the 5' end. The PCR 
product was cloned into a topo vector to produce TopoKan2. The fragment was then digested from TopoKan2 
using Xbal and Nsil and ligated into pUCRmpM to form the plasmid pUCRmpMC-term. The ligation inserted a 
stop codon just after the Xbal site in rm pM . The complete cassette was then amplified from pUCRmpMC-term 
with a 5' primer containing the neisserial DNA uptake sequence. The PCR product was then transformed into 
N. m eningitid is H44/76. Homologous regions of sequence on both ends of the cassette allowed recombination 
with the Neisserial genome and clones were successfully selected on kanamycin containing medium.
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The cloning strategy is described in the figure legend, although an alteration of the primer 5' of the 
rm pM  gene was required to  move it closer to  the start codon. Transformation into N. meningitidis 
was carried out and the transformants were grown on kanamycin containing media to select colonies 
that had the replacement cassette inserted into the genome. A sample of colonies was tested by 
colony PCR for the rmpM  truncation using the primers which amplified from  sequence upstream of 
the rm pM  gene to  the end of the konR gene (fig 3a).
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Figure 3. Transformation of RmpMC-term cassette into N. m ening itid is  (A) Colony PCR of clones produced 
from transformation of H44/76 with PCR product produced from pUCRmpMC-term. (B) Sequencing of four of 
the clones (3, 7,12 and 17). Amino acid sequence is shown beneath the sequence alignment. Comparison was 
made against the theoretical sequence of the correct insertion.
All 24 transformants produced a band at the expected size of 1.7kb, although some were faint. The
genomic DNA of four clones (3, 7, 12 and 17) was sequenced; all the clones contained the correct
truncation (fig.3b).
6.3 rmpM  transcription in ArmpM  and RmpM C-term mutants
An RT-PCR was used to  confirm both tha t mRNA from the truncated rm pM  gene was being
transcribed and that full length rm pM  mRNA was no longer being expressed (fig.4).
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1= Wildtype — 8= Wildtype “ 15= Wildtype
2= rmpM mutant 9= rmpM mutant 16= rmpM mutant
3= Clone 3 10= Clone 3 rmpM RNA 17= Clone 3 rmpM RNA
4= Clone 7 rnn 11== C'°ne 7 truncated 18= Clone 7 full length5= Clone 12 (control) 2  c|o  12 19= Clone 12
6= Clone 17 13= Clone 17 20= Clone 17
7= Clone 23 - 1 14= Clone 23 — 21= Clone 23 J
Figure 4. RT-PCR of rmpM  RNA from wildtype, ArmpM and RmpM C-term mutants. Gel electrophoresis of RT- 
PCR products for full length and truncated rm pM  RNA. Arm pM  strain is labelled as rm pM  mutant. Lanes 1-7 
show control RT-PCR for PorA mRNA. Lanes 8-14 show PCR product from truncated rm pM  gene. Lanes 15-21 
show PCR product from full length rm pM  gene.
The RmpM C-term m utant clones all showed clear bands fo r the truncated rm pM  mRNA (469bp lanes 
10-14) and no band for the full length rm pM  mRNA (lanes 17-21). This showed that the full length 
rm pM  gene had been successfully replaced by the truncated version and that the truncated rm pM  
gene was being transcribed (fig.4). The wildtype produced the full length rmpM  mRNA (622bp, lane
15) and also a band for the truncated product (469bp, lane 8) amplified from the full length mRNA. 
The ArmpM  mutant contains, as expected, no rm pM  RNA either full length or truncated (lanes 9 and
16) although there is some non-specific amplification of the incorrect size occurring (lane 9).
155
6.4 RmpM protein expression in ArmpM  and RmpM C-term mutants
The molecular weight (Mw) of the complete RmpM protein is 26.18kDa, however RmpM shows 
unusual electrophoretic m obility when reduced and the apparent molecular weight of the protein 
increases to  32kDa (70,85). Outer membrane of the wildtype, ArmpM  and RmpM C-term mutant 
were prepared and subjected to  SDS-PAGE under reducing conditions (fig. 5).
Figure 5. SDS-PAGE for RmpM Protein
Outer membrane preparations for the 
wildtype, Arm pM  (rm pM  mutant) and 
RmpM C-term mutant strains were 
examined on a 12% SDS-PAGE gel. Bands for 
PorA, PorB and RmpM proteins are marked.
The RmpM protein could be clearly seen in the wildtype preparation, a strong band was present at 
32kDa. However, it was not visible in either mutant strain. The truncation of the RmpM protein 
removed 69 amino acids from  the C-terminal portion of the protein and the Mw of the truncated 
protein was calculated to be 16.5kDa using the ExPASy p l/M w  tool. There was no band in the RmpM 
C-term preparation to correspond to  the truncated protein, although as the band would run at the 
very bottom of this gel it may not have been visible. Gels focusing on the lower molecular weight
PorB
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proteins also did not show a clear band fo r the protein (data not shown). If the protein was being
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translated it was not running at a larger size than the predicted Mw as is the case with the reduction'
v modified complete protein. The removal of the terminal disulphide bond in the RmpM C-term mutant
\
was likely to change the way the protein is affected by reducing conditions, as disulphide bonds 
would be an obvious target for reduction modification. This could have lead to the protein running at 
an unexpected molecular weight.
6.5 Protein complex formation in rmpM  mutants
Complexes of RmpM and other proteins including FetA and the porins PorA and PorB have been . 
identified in the wildtype strain (64,114,119). The presence of a functional RmpM N-terminal domain 
in the RmpM C-term mutant should allow the formation of complexes with other outer membrane 
proteins whereas the deletion of RmpM should disrupt complex formation. To investigate the outer 
membrane complexes, preparations of outer membrane were crosslinked with formaldehyde.
y
Crosslinking by formaldehyde occurs by the condensation of amino groups with nearby nitrogen 
containing groups’such as primary amides and guanidines (40). Crosslinked proteins were run against 
un treated controls on an 8% SDS-PAGE gel following the method of Sanchez et al. (119) (fig. 6).
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Figure 6. Protein complexes in the outer membrane examined by Formaldehyde crosslinking. (A)
Formaldehyde cross-linked protein complex profiles for the wildtype, Arm pM  (rm pM  mutant) and RmpM C- 
term mutant strains. The first three lanes show non-formaldehyde treated control samples, the next three lanes 
contain formaldehyde treated samples. (B) Enlargement of the region above lOOkDa in (A). The control lanes 
are not shown. Bands identified in the PorB western blot are indicated by (*) (C) Cross-linked gels Western 
blotted with PorB monoclonal antibody. Bands are marked with (*). (D) Estimation of band sizes for the bands 
marked in (B and C), bands are numbered in ascending size order.
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The non-formaldehyde treated controls show very few high molecular weight bands because of the . 
disassociation of the non crosslinked protein complexes into protein monomers. The formaldehyde 
treated wildtype strain shows several high molecular weight bands (greater than lOOkDa) that do not 
appear in the non-formaldehyde control and represent protein complexes. The formaldehyde 
treated ArmpM strain produced few bands above or close to lOOkDa with only four visible bands at 
170kDa, 127kDa 105kDa and 94kDa (fig.6a + b). The wildtype strain contained bands corresponding to 
these sizes, suggesting that these complexes do not contain RmpM. Western blotting with PorB 
monoclonal antibody (02/310) showed one additional band at 150kDa that was also represented in 
the wildtype strain (fig.6c). The RmpM C-term also showed several bands above lOOkDa and most of 
the bands in the wildtype sample were also present in the RmpM C-term mutant. However the two 
strains do not show identical band profiles; the RmpM C-term mutant showed two high molecular 
weight bands (above 206.3kDa) that were not present in the wildtype sample. These bands may have 
been caused by aggregation of protein complexes in the outer membrane. Western blotting with anti- 
PorB (fig.9 C and D) showed PorB containing bands in the wildtype and RmpM C-term mutants. Of the 
six bands shown, four (at 89kDa, 94kDa, 114kDa and 150kDa) were present at the same position in 
both samples. Bands at 109kDa (band 3) and 179kDa (band 6) in the wildtype strain were shifted to 
119kDa (band 4) and 202kDa (band 6) in the RmpM C-term mutant. RmpM C-term containing 
complexes were expected to have a lower molecular weight due to the protein truncation. The shifts 
in molecular weight were lOkDa (band 4) and 23kDa (band 6). Neither shift was large enough to 
indicate the addition of PorA or PorB subunits (42kDa and 36kDa respectively) or the correct size to 
indicate the addition of either one or several truncated RmpM proteins (16.5kDa). This shift must. 
have been related to the RmpM truncation, but without further analysis such as mass spectrometry 
to identify the constituents of the complexes this shift was difficult to explain.
Examination of the level of monomeric PorA (42kDa) and PorB (36kDa) proteins in the cross-linked 
samples (fig.6a) showed that the ArmpM  strain contained a much higher concentration of the
monomeric forms of these proteins than the wildtype. The RmpM C-term mutant contained less 
monomeric PorA and PorB than both the ArmpM and the wildtype strain. Other bands in the region 
of the monomeric proteins showed that loading was even. Therefore the increase in monomeric PorA 
and PorB and the lack of high molecular weight bands in the ArmpM  strain indicated that the porins 
were not being sequestered into high molecular weight complexes. By contrast the low levels of 
monomeric porins in the RmpM C-term mutant demonstrated that the porins were being efficiently 
sequestered into complexes.
6.6 Growth of rmpM  mutants
To analyse the effect of the changes made to the RmpM protein, growth of the wildtype, ArmpM  and 
RmpM C-term mutant strains was measured in liquid culture over an eight hour period (fig.7).
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Figure 7. Growth curves for wildtype, ArmpM and RmpM C-term mutant (A) Eight hour growth curves of the 
wildtype and Arm pM  (rm pM  mutant) and RmpM C-term mutant grown from an OD600 value of 0.05 in liquid 
culture. Curves are the mean of three experiments. Error bars represent SEM. (B) Four hour growth curve of 
the Arm pM  (rmpM  mutant) strain grown from an OD600 value of 0.1. Error bars represent SEM. Curve is the 
mean of three experiments.
W ildtype growth was consistent w ith the rate measured in previous experiments and the RmpM C-
term  m utant did not show any difference in growth rate compared to the w ildtype. The ArmpM  strain 
grew poorly, despite growth curves in earlier studies reporting that the mutant grew at a similar rate 
to  the w ildtype (70). The growth curve o f the ArmpM  mutant only began to  climb after 7 hours (Fig 
7a) and the OD600 value after 8 hours showed tha t the ArmpM  mutant reached 0.16 compared to the 
w ildtype value of 0.71. However, after overnight growth little  difference was seen in the OD600 values 
of w ildtype and ArmpM  cultures (data not shown). From a higher starting OD600 of 0.1 growth of 
Arm pM  was similar to that of the w ildtype (fig. 7b). These results indicated that the slow growth from
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0 D 6 0 o =  0.05 was the result of a lengthened lag phase, as bacteria started from a higher concentration 
of cells (with more cells able to divide) or given a longer incubation period showed normal growth. 
Increased lag phase in the bacteria could have been a symptom of a nutrient deficiency, in lag phase 
bacteria synthesise components needed for the division process and a lack of nutrients will increase 
the time it takes for the cell to be ready to divide.
An N. meningitidis group B ArmpM strain (M1080) had grown normally from an OD600 of 0.04 in the 
work of Klugman et al. The experiment used Neisserial typing media (140), as opposed to the Mueller 
Hinton media used in this study. Both media contained comparable levels of starch and animal tissue 
derived components. However, the typing media also contained inorganic salts and Isovitalex, an 
additive containing amino acids, co-factors, nucleic acids, inorganic ions (ferric nitrate) and dextrose. 
To test if the nutritional content of the two media were responsible for the differences observed in 
the growth, nutritional supplements including an inorganic ion mixture identical to that of the 
gonococcal typing media were added to the Mueller Hinton media. None of these supplements 
(either singly or in combination) altered the growth characteristics of ArmpM. Nutritional 
requirements did not account for the difference in growth between the ArmpM mutants in an H44/76 
background in this experiment, and the previously reported growth in the M1080 strain background 
(70).
6.7 Temperature sensitivity of the rmpM  mutant strains
Although the ArmpM  mutant showed severe growth' retardation, the RmpM C-term mutant showed 
wildtype like growth. The poor growth phenotype was therefore linked to the presence of the N- 
terminal portion of the RmpM protein, making it likely that stabilisation of outer membrane protein 
complexes by RmpM was a factor in the poor growth rate. If the stability of complexes was affected 
by the absence of RmpM, growth at a lower temperature may have ameliorated this effect. The 
membrane would become less fluid at lower temperatures and more fluid when the temperature is
raised and these changes in flu id ity would affect the movement of proteins in the outer membrane. 
Interactions between proteins may also be affected directly by changes in temperature. To test this, 
bacteria were grown at a range of temperatures for seven hours from a starting OD600 of 0.05. The 
OD600 measurement at the seven hour point was taken (fig.8).
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Figure 8. Growth of wildtype, ArmpM (rmpM mutant) and RmpM C-term mutant at different growth 
temperatures. Cultures were grown from OD600=0.05 for seven hours at different temperatures. OD600 values 
were taken after the seventh hour of growth. (A) 7 hour OD600 values with strains shown on the x axis. 
Significant differences within strains at different temperatures are shown. (B) 7 hour OD600 values with 
temperatures shown on the x axis. Significant differences between strains at each growth temperature are 
shown. Results are a mean of three experiments. P values calculated by T-test. Error bars represent SEM.
The w ildtype strain did not show any significant differences (P=>0.05) in growth at the three 
temperatures, but optim um  growth occurred at 37°C. The RmpM C-term strain showed a similar
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temperature sensitivity profile to the wildtype, but growth in this strain was significantly lower at 
39°C compared to 35°C (P=0.001). Unlike the other two strains, the ArmpM  mutant was highly 
temperature sensitive and grew significantly better at the lower temperature of 35°C compared to 
37°C and 39°C (P=<0.001 for both) (fig .lla).
A comparison of the strains at different growth temperatures was made using the same data 
(fig .llb). The RmpM C-term mutant grew significantly better than both the wildtype and ArmpM
\
strains at 35°C (P=0.02 and P=0.001 respectively). ArmpM also showed significantly improved growth 
compared to the wildtype at 35°C (P=0.02). Increased growth of both ArmpM  and RmpM C-term at 
35°C indicated that loss of the peptidoglycan binding function of the protein was beneficial for growth 
at lower temperatures. However the growth of ArmpM decreased sharply at both 37°C and 39°C and 
significantly poorer than the growth of both the wildtype (P=0.03 at 37°C and P=<0.001 at 39°C) and 
RmpM C-term mutant (P=0.02 at 37°C and P=0.001 at 39°C). Compared to ArmpM, the other two 
strains showed both a higher optimum temperature and lower sensitivity to temperature increase. 
This suggested that the N-terminal of RmpM was important in the growth of the organism at higher 
temperatures.
6.8 Antibiotic sensitivity of the rmp/W mutant strains
Changes in protein complexes may have also affected antibiotic sensitivity in the strains, by altering 
the permeability of the outer membrane to antibiotic compounds. Reduction in the minimum 
inhibitory concentration (MIC) of some (3-lactam antibiotics have been reported in porin deficient 
mutants of E. coli and it has been hypothesized that the porin channels are involved in the uptake of 
(3-lactam antibiotics (56). The putative structural role of RmpM could also lead to defects in cell wall 
structure in the mutants. The rmpM  mutants were therefore tested with the panel of antibiotics to 
test the integrity of peptidoglycan and the outer membrane (fig. 9).
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Antibiotic sensitivity in rmpM  m utants
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Figure 9. Antibiotic sensitivity of wildtype, A rm pM  (rm pM  mutant) and RmpM C-term mutant. Sensitivity to 
the antibiotics polymyxin B, ampiciHin, vancomycin and D-cycloserine was tested using disc diffusion assay. Bars 
represent mean of three experiments. Error bars represent SEM. Significance values calculated by T-test.
The mutants and wildtype showed no significant difference in susceptibility to  all the antibiotics 
tested (P = >0.05). Polymyxin B interacts directly w ith the outer membrane and equal susceptibility 
between the w ildtype and mutant strains indicated that there was no significant disruption of the 
outer membrane in the rmpM  mutant strains. The ampicillin, vancomycin and D-cycloserine 
antibiotics all interfere w ith peptidoglycan synthesis, the sim ilarity of the rm pM  mutants and wildtype 
indicated tha t peptidoglycan structure was also not severely affected by the deletion of rmpM.
6.9 Electron microscopy of rmpM  mutant strains
The rm pM  mutants were examined under VTF Cryo-electron microscopy (Fig. 10 and 11) and 
compared to  the w ildtype (see chapter 3 fig .12 pg.77). The ArmpM  strain showed no major 
morphological changes, but the preparation of the bacteria for electron microscopy did highlight 
differences between the strains. All other strains in the study were resuspended in PBS before 
application to  the grid by pipetting, but the Arm pM  strain could not be prepared by this method.
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When resuspended in PBS the suspension was too viscous to allow the formation of thin vitreous ice, 
even when the preparation was diluted. To overcome this problem grids were floated on a 
suspension of the bacteria in Mueller Hinton broth and RmpM C-term bacteria were also prepared in 
this way, to ensure consistency (see fig. 11 M and N). Although there were no conspicuous 
morphological differences between the wildtype and ArmpM strains there appeared to be a higher 
quantity of dead material in the ArmpM sample and some unique features were observed in the 
ArmpM mutant. In fig.10 A, B, E sections of the outer membrane were missing on some bacteria 
(indicated by arrows). This phenotype was not seen in the wildtype or the RmpM C-term mutant 
sample. It could have been the beginning of cell degradation, but the bacteria appeared otherwise 
healthy. There were also some features visible on the surface of the bacteria (fig. 10 A, B, C, E, F, H), 
these were common in the rmpM  mutants but were not present in the wildtype. The features appear 
as thread like particles in the otherwise electron dense bacteria and may have represented alteration 
in either the surface membrane or cytoplasm that changed the electron density of that region. Again 
this could reflect cell breakdown, in the wildtype sample, dead bacteria were often observed with 
membranous material inside the cell (Chapter 3 fig.13 I, J). Although the ArmpM  strain was observed 
to cluster at several sites on the grid this phenotype was not consistent, indicating that it was not a 
requirement for the ArmpM  mutant to cluster unlike the Agna33 strain. In images C and H the 
bacteria were frozen whilst dividing. The peptidoglycan in both cases has divided to enclose both 
daughter cells separately; however the outer membrane has not yet separated. This order of division, 
with peptidoglycan separation before outer membrane invagination begins would be consistent with 
septal division as described in rod shaped Gram negative bacteria (47) but no sign of increased 
vesiculation was seen at the poles of division unlike the observations made in dividing E. coli (45). In 
image (H) vesiculation did appear to be occurring at one pole of the dividing organism but the 
position of these vesicles and their apparent superimposition onto each other suggested that their 
presence may have been co-incidental. Potential vesiculation sites were common on the surface of 
the bacteria and vesicles more common in the surrounding ice than in the wildtype sample. This was
not unexpected in a high vesiculating m utant but vesiculation did not appear to  be confined to 
particular regions of the membrane and was occurring around much of the surface of the bacteria.
Figure 10. Cryo-electron microscopy of N. m en ing itid is A rm pM  strain (A) Arrows indicate an area of 
vesiculation on the surface of the bacteria (1), features on the surface of the bacteria (2), the separation 
between two bacteria (3) and an area at one end of a bacterium where the outer membrane was not visible (4). 
(B) Further areas of missing outer membrane (5) are shown and budding vesicles (6) and surface features (7) 
are also marked. (C) Arrows indicate peptidoglycan separation in dividing bacteria (8). The area of light 
colouration in the other cell in the image is artefactual. An area of membranous material not associated with a 
bacteria or vesicle is also indicated (10). (D) A dead bacterium is marked on the right side of the image (11). 
Close contact between the bacteria is also indicated (12). (C) and (D) Bacteria were often observed in clusters 
although arrows indicate that the separation between the membranes of adjacent bacteria could be seen (9 & 
12). All images taken at 30000X 200kV. Scale bar lOOnm.
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Figure 10. Cryo-electron microscopy of N. m en ing itid is A rm pM  strain (continued) (E) Positions where outer 
membrane was absent are indicated (1). Also indicated is another multilayered membranous structure (2) 
similar to that previously observed in (C). (F) Vesiculation sites on the sides of the bacteria are marked (3). (G) 
Potential sites o f Vesiculation are marked (4). The blue arrow indicates a large membrane bound structure 
which was possibly a large membrane vesicle (5). (H) Dividing cell that also showed peptidoglycan separation (6) 
and concentration of vesicles around one pole of the division site (7). Surface features (green arrow) can also be 
observed in the dividing cell (8). A similar feature was also present in the other daughter cell. All images taken 
at 30000X 200kV. Scale bar lOOnm.
Electron microscopy of the RmpM C-term m utant showed bacteria that were morphologically similar
to  the w ildtype strain, although like the Arm pM  strain there were some m inor differences. The most
obvious of these was the difference in the behaviour of the outer membrane. Fig. 1 1 A-D showed
bacteria w ith normal morphology, but a large number of potential vesiculation sites were visible on
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the bacteria's surface in image D. Images E-M all show bacteria exhibiting a phenotype of outer 
membrane 'bulging', the outer membrane was expanded out from the side of the bacteria, although 
the peptidoglycan (indicated by purple arrows) remained continuous with the inner membrane. This 
phenotype indicated a disconnection between the outer membrane and peptidoglycan; as would be 
expected in a mutant lacking the peptidoglycan binding function of RmpM. However, the same 
phenotype was not observed in the ArmpM  mutant. The RmpM C-term bacteria also had many 
vesiculation sites on the cell surface, particularly on bacteria that also exhibited bulging. Potential 
vesiculation sites appeared to be more common in this mutant than in the ArmpM sample. In image H 
and image I a large bleb can be seen separated from the bacteria, the bacteria found very near the 
bleb (and from which it is most likely to have been shed) has no defects in its outer membrane 
suggesting that release of large membrane vesicles was not detrimental to the bacteria. Large 
membrane bulges also did not seem to occur at any particular point of the bacterial surface, they 
could be observed in a range of positions and on bacteria of differing morphologies. At some 
vesiculation sites indicated with an arrow in images J (on a large bulge) E, I and D (on normal vesicles) 
the forming vesicles appeared to show a continuation of the membrane past the beginning of the 
vesicle bulge on one side. This raised the intriguing possibility of the re-growth of the outer 
membrane as the vesicle developed, the outer membrane growing from one edge of the vesicle to 
cover the area from where the vesicle has been released. Bacteria I and H showed some surface 
features similar to that observed in the ArmpM  strain, suggesting that these features could be related 
to the loss of the C-terminal end of RmpM. Comparison of the two preparation methods for the 
bacteria (fig. 1 1 A-L are resuspended in PBS, M-N are resuspended in Mueller Hinton) showed that 
the same features were observable in both, including the increased vesiculation sites on the RmpM C- 
term (fig .ll N). However, although the membrane bulging was still present in the Mueller Hinton 
preparation (Fig. 11 M) it was less pronounced. Greater amounts of dead material were also seen in 
the Mueller Hinton preparation compared to the PBS. This indicated that the greater amount of dead 
material observed in the ArmpM  preparation may have been due to the preparation method. Floating
the grid on the surface of the suspension would allow the least dense material to  attach preferentially 
to  the grid, which may have lead to the increase in dead material in the sample. Clustering of the 
bacteria was also more commonly observed in the floatation sample (data not shown) indicating that 
this may also be artefactual in the ArmpM  preparation.
Figure 11. Cryo-electron microscopy of N. m en ing itid is  RmpM C-term mutant. (A) and (B) Bacteria appeared 
similar to wildtype (see chapter 3 fig. 12 pg.77). A membrane vesicle is marked (blue arrow 1 & 2). (C) and (D). 
Some degradation products from dead bacteria were observed as arrowed in (C) (3). (D) Bacteria showed many 
sites of vesiculation (4). In the most developed of the vesiculation sites the outer membrane can be observed to 
be overlapping the edge of the vesiculation site on the right hand side. All images taken at 25000X 200kV. Scale 
bar 200nm.
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Figure 11. Cryo-electron microscopy of N. m en ing itid is  RmpM C-term mutant (continued). (E) Bacteria were 
often found with large portions of membrane apparently detached from the peptidoglycan (1) which remains in 
close proximity to the inner membrane (purple arrow 2). There is also a vesiculation site present on the other 
side of the bacteria (4) and a large quantity of vesicles in close proximity to the bacteria (blue arrow 3). (F) 
Dividing bacteria, also showing detached outer membrane (5). The outer membrane has separated in this 
division and the division between the daughter cells can be seen (6). (G) and (H). Further bacteria showing 
separation of the outer membrane from the peptidoglycan. (G) The separation appears to encompass over half 
the membrane surface of the bacteria (7 & 8). Areas of possible separation into smaller vesicles can also be 
seen at the bottom edge of the separated membrane (8). (H) A very large membrane bleb as well as some 
smaller blebs (blue arrows) can be seen (10). An area of surface structure can also be seen (9). All images taken 
at 25000X 200kV. Scale bar 200nm.
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Figure 11. Cryo-electron microscopy of N. m en ing itid is  RmpM C-term mutant (continued) (I) Bacterium shows 
areas of developing vesicles on the membrane surface (1) as well as large areas of membrane loss (2) with 
continuous peptidoglycan around the bacterium (purple arrow 3). A large membrane bleb can also be seen 
(blue arrow 4) and some areas of internal structure (5). (J) Bacteria also showing large membrane detachment. 
An area of overlapping membrane can be seen on the left side of the bleb (6) and continuous peptidoglycan can 
also be seen (purple arrow 7). (K) and (L). (K) Separating bacteria shows outer membrane being released from 
one pole but not the other (9). Large membrane bleb (8) and membrane vesicles are both visible (9), as well as 
potential sites of vesicle release (10). (L) Bacteria showing two areas of membrane detachments (11 & 12). The 
right side of the bug appears to have a membrane bleb that is more developed, the top edge of the bleb 
appears to be folding inwards (11), on the bottom edge there is an area of membrane overlapping the edge of 
the bleb as has been seen previously. The left hand side bleb is not as well developed (12), but the 
peptidoglycan layer can be seen (13). Another potential site is also indicated (14). All images taken at 25000X 
200kV. Scale bar 200nm.
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Figure 11. Cryo-Electron microscopy of N. m en ing itid is  RmpM C-term mutant (continued). Bacteria were also 
prepared by floatation onto the grid, by the same method as the ArmpM  strain for comparison. (M) The images 
were similar to the RmpM C-term mutant prepared by the direct application method however the membrane 
bulging phenotype was less pronounced in this sample (purple arrow 1), membrane vesicles were frequently 
observed (blue arrow 2). (N) Bacteria were still observed to have many vesiculation sites on the surface (3) a 
greater amount of debris was observed in this sample than was seen in the direct application grid (green arrow 
4). All images taken at 25000X 200kV. Scale bar 200nm.
6.10 Native vesicles produced by the rmpM  mutants
The disconnection of the outer membrane and the frequent sites of vesiculation displayed by the 
RmpM C-term m utant suggested that like the Arm pM  m utant the strain would also be a high 
vesiculating strain. To test this hypothesis native vesicles were prepared from ArmpM, RmpM C-term 
and the w ildtype bacteria and the preparations were run on an SDS-PAGE gel (fig.12).
173
37.7kD
29.4kD
54.8kD
17.5kD
PorB 36kD a
PorA 42kDa
Figure 12. SDS-PAGE of native OMV for wildtype, ArmpM and RmpM C-term mutant. SDS PAGE gel showing 
preparations of native vesicles. Equal volumes of native vesicle preparations from the wildtype, Arm pM  (rmpM  
mutant) and RmpM C-term mutants were loaded onto the gel.
PAGE fo r the standard (20pil of concentrated preparation) amounts loaded. However both the rmpM  
mutants produced bands for PorA and PorB, the most abundant outer membrane proteins, at the 
expected sizes of 42kDa and 36kDa. Therefore both ArmpM  and RmpM C-term were high vesiculating 
mutants. Although equal volumes of the three OMV preparations were loaded, band intensity was 
different between the two mutants w ith a greater amount of PorA and PorB in the RmpM C-term 
sample compared to  ArmpM.
Slot blotting and immunoassay w ith specific monoclonal antibodies was used to  produce a more 
accurate PorA and PorB quantification in the vesicles of the mutants (fig.13).
W ildtype preparations of native vesicles do not usually produce enough protein to  be seen by SDS-
W ildtype r m p M  m utan t RmpM C-term
1:200
1:2000
1:1000
1:10000
1:1000
1:10000
PorA P I.7 
(01/514)
PorA P I.16 
(01/538)
1:10000 1:10000
1:200 1:1000 1:1000
PorB P3.15
1:2000 1:10000 1:10000 (02/310)
Strain PorA P I.7 (01/514) 
(ng/pl)
PorA P I.16 (01/538) 
(ng/pl)
PorB P3.15 (02/310) 
(ng/pl)
W ildtype 1.0 clim it of detection <lim it o f detection
ArmpM 68.3 64.5 140.7
RmpM C-term 213.2 205.3 156.3
Figure 13. Slot blot immunoassay of PorA and PorB in native vesicles from wildtype, ArmpM and RmpM C- 
term mutants. Dilutions of native OMV from wildtype, Arm pM  (rmpM  mutant) and RmpM C-term mutants 
were immunoblotted with monoclonal PorA and PorB antibodies. Dilutions of 1:200 and 1:2000 were used for 
the wildtype sample and 1:1000 and 1:10000 were used for Arm pM  and RmpM C-term. Calculated protein 
amounts per pi of vesicle sample are shown in the table. Protein amounts were calculated using the Kodak Ml 
software by comparison to standard curves (see chapter 3 fig. 25). In samples below the lim it of detection no 
signal above the background level could be detected by the software.
Slot blotting w ith antibodies against PorA P I.7 (01/514) and P I.16 (01/538) and PorB P3.15 (02/310) 
showed that PorA and PorB levels were both increased in the RmpM C-term m utant compared with 
the w ildtype and ArmpM  strain. This result was also observed w ith other prelim inary slot blot assays 
of vesicle preparations produced by these mutants. Densitometry was used to  quantify the amount of
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protein in each sample using the standard protein curves (see chapter 3 fig. 17 pg.87). Both mutants 
contained more of the porin proteins than the wildtype, which was only detected by one antibody in 
the PorA assays and was below the limit of detection in the PorB assay. There was good agreement 
between the two PorA antibodies for the amount of PorA present, showing that although these 
antibodies did not show good agreement at lower levels of PorA consistency of the two was better at 
higher PorA levels. Both PorA and PorB proteins were present in greater amounts in the native 
vesicles from RmpM C-term mutant compared to the ArmpM  strain; in this assay the RmpM C-term 
mutant showed a 10% increase in the level of PorB protein and a ~3-fold increase in the PorA protein. 
An increase in vesicle number or size would have increased the levels of PorA and PorB by the same 
amount, so the ratios between the two proteins would have been the same in the OMVs of both 
strains. However, the RmpM C-term mutant vesicles contain 30% more PorA than PorB, whereas the 
ArmpM  strain vesicles contain 100% more PorB than PorA. Therefore the change in relative 
proportions of porin protein was unlikely to be caused simply by an increase in the number of 
vesicles. Instead it indicated a change in protein expression or in the incorporation of the porins in 
the OMVs.
6.11 Electron microscopy of membrane vesicles from rmpM  mutants
VTF-Cryo-electron microscopy was used to examine the vesicle preparations and ArmpM  and RmpM 
C-term vesicles were compared to the wildtype sample (chapter 3 fig. 19 pg.90). The ArmpM  strain 
(fig. 14) showed a large number of vesicles compared to the wildtype. Vesicles were frequently 
observed both in ice holes and on the carbon film, showing no preference in the vesicle sample for 
either surface. Some large and deformed vesicles were observed including a vesicle with a double 
membrane (fig. 14 F) and a broken vesicle (D), but most vesicles appeared to be intact and of similar 
size and shape.
176
i i i s i i
.Fit-
Figure 14. Cryo-electron microscopy of vesicles from the A rm pM  mutant. The preparation showed many more 
vesicles than the equivalent wildtype (chapter 3 fig .19 pg.90) preparation. (A) and (B) Vesicles were observed in 
both the holes and carbon surface of the quantifoil. Most vesicles appeared of a similar size; however some 
larger vesicles were observed (red arrows). (C) and (D) Vesicles were distributed across the ice holes, a broken 
vesicle can be seen at the top left of image D. All images were recorded at 30,000X, 200kV. Scale bar lOOnm.
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Figure 14. Cryo-electron microscopy of vesicles from the A rm pM  mutant (continued). (E) and (F) Red arrows 
indicate deformed and double membrane vesicles, although these were not commonly observed in the sample. 
(G) and (H) Lower magnification showing the distribution of vesicles on the grid surface. The vesicles are mostly 
of similar size and shape; some larger vesicles can be seen (arrowed). (E) and (F) 30,000X 200kV. Scale bar 
lOOnm. (G) and (H) 12,000X, 200kV. Scale bar 200nm.
The vesicles of the RmpM C-term mutant (fig. 15) appeared much more numerous than those of the 
ArmpM  strain and the wildtype. The vesicles appeared similar in size and shape to those of the 
ArmpM  strain. Large and double membrane vesicles were observed in (A) and (B) but these were few 
in number compared to  the total vesicles in the preparation. High magnifications of the vesicle 
preparations (E and F) showed some evidence of surface features on the vesicles; however the
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resolution of these images made further characterisation difficult. Low magnification images (G and
H) showed the consistency of vesicle size and shape in the sample and that vesicles were spread 
consistently across the grid both in ice holes and on the carbon film.
Figure 15. Cryo-electron microscopy of vesicles from RmpM C-term mutant. The mutant vesicles were much 
more numerous than the vesicles of the wildtype or Arm pM  strain. Most vesicles appear of similar shape and 
size, although some larger vesicles can be observed. Some double membrane vesicles could be observed in (A) 
and (B). Similar levels of vesicles were observed in all the ice holes examined on the grid. Images recorded at 
30,000X, 200kV. Scale bar lOOnm.
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Figure 15. Cryo-electron microscopy of vesicles from RmpM C-term mutant (continued). (E) and (F) vesicles 
observed at a higher magnification. Although there is some variation in vesicle shape vesicles are of similar size. 
(G) and (H) Lower magnification images of the grid surface shows vesicles coating the entire grid. The number of 
vesicles appears greatly increased compared to the other mutants. (E) Image recorded at 60,000X, 200kV. Scale 
bar 50nm. (F) 50,000X 200kV. Scale bar lOOnm. (G) and (H) 12,000X 200kV. Scale bar 200nm.
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6.12 Comparison of rmpM  m utant membrane vesicles
To test the consistency of the vesicle size and shape, vesicles were sampled from the electron 
micrographs and measured. As w ith previous strains, forty-five vesicles were randomly selected from 
the A rm pM  and RmpM C-term mutant images for comparison to the w ildtype (table 1).
Table 1. Comparison of wildtype, Arm pM  and RmpM C-term native vesicles. Measurements are a mean of 45 
vesicles. P values <0.05 are shown in blue. P values calculated by T-test.
Wildtype Arm pM RmpM C-term
Mean perimeter (nm) 130.14 141.08 144.56
SD 41.02 39.27 20.48
Mean area (nm) 1457.42 1682.86 1695.04
SD 1064.32 1152.33 482.54
P values from T-test
\N\\dtype:Arm pM Wildtype:RmpM C-term ArmpMiRrrvpM C-term
Perimeter >0.05 0.04 >0.05
Area >0.05 >0.05 >0.05
There were no significant differences between the w ildtype and A rm pM  vesicles in terms of 
perimeter or area (P=>0.05). The RmpM C-term mutant showed a significant increase compared to 
the wildtype in terms of perimeter (P=0.04) but did not have a significantly different area 
measurement. The vesicles of the three strains were therefore very similar in terms of size and shape.
The standard deviation values suggested that the RmpM C-term m utant vesicles were less variable 
than those of the w ildtype and Arm pM  strains. To test the significance of this the variability o f the 
samples were compared using an F-test (table 2.)
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Table 2. Comparison of the wildtype, ArmpM and RmpM C-term samples by F-test. Wildtype, Arm pM  and 
RmpM C-term variation was compared with a sample of 45 vesicles. F values <0.05 are indicated in blue. Values 
calculated by F-test. Significance level was set at 0.05
Comparison \N\\dtype:ArmpM Wildtype:RmpM C-term Arm pM :RmpM C-term
Area >0.05 <0.05 <0.05
Perimeter >0.05 <0.05 <0.05
W ildtype and ArmpM  vesicles were similarly variable (F=>0.05), but the RmpM C-term sample was 
significantly less variable than the wildtype or ArmpM  strains in both area and perimeter (F=<0.05) 
(table 2).
6.13 Discussion
The aim of this study was to  investigate the causes of increased vesiculation in ArmpM  strains, the 
function of the RmpM protein and the characteristics of the vesicles. A mutant was constructed 
expressing a truncated RmpM protein, to test if loss of only the peptidoglycan binding function of the 
protein would increase vesiculation. Although the truncated RmpM protein was not seen on SDS- 
PAGE gels, data showing that the gene was transcribed together w ith the phenotypic characteristics 
of the RmpM C-term mutants provided strong evidence tha t a functional truncated RmpM protein 
was expressed. Increased vesiculation was most likely caused by the loss of the C-terminal end of 
RmpM, severing the link between outer membrane and cell wall peptidoglycan. Function of the N- 
terminal end of RmpM, which it has been suggested is involved in the stabilization of OMP complexes 
(121), was shown to be im portant for the growth of the organism. Vesicle production was increased 
in both rm pM  m utant strains, but their OMVs were morphologically similar to those produced by the 
w ildtype organism. Vesicles produced by the mutant expressing the truncated form  of RmpM were 
enriched for the PorA protein, compared w ith those produced by the knockout mutant.
Cross-linked outer membranes of the ArmpM  mutants contained few protein complex bands and 
larger amounts of the monomeric forms of PorA and PorB. This indicated that either porin complexes 
were not formed, or were not as stable as those of the other strains. These results differed from  a
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previous study by Marzoa et al. which reported no differences in high molecular weight complexes 
between the wildtype and mutant strains (88). This indicated that porin complexes were formed in 
the ArmpM strain. However Marzoa et al. used the technique of Blue Native (BN) PAGE to visualize 
the protein complexes. BN-PAGE uses the anionic dye Coomassie G-250, rather than SDS, to confer 
charge on protein complexes. It has been previously shown that the ArmpM  outer membrane protein 
complexes have a higher sensitivity to SDS denaturation than wildtype complexes (88). Although the 
chemical cross-linking should prevent dissociation of complexes, this was the likely cause of the loss 
of some of the complexes from the ArmpM  sample. Therefore, the results of these two studies 
indicated that the lack of complex bands was most likely due to a change in complex stability and not 
due to a failure of complex formation. Presence of the truncated form of RmpM improves the 
stability of the complexes but also affects the molecular weight of some of the complex bands 
observed; unexpectedly increasing the apparent molecular weight of the bands compared to the 
wildtype sample. A previous study by Volokhina et al. with a similar truncated RmpM protein showed 
a reduction in the molecular weight of complexes (162). But this study did not use a crosslinking 
technique, instead using a semi-native SDS PAGE method. The lack of a tether to the peptidoglycan in 
the truncated RmpM protein could allow protein complexes to be in closer proximity in the outer 
membrane, which could in turn have lead to cross linking between complexes which otherwise would 
not have occurred. Mass spectrometry could be used for a more accurate comparison of bands in the 
wildtype and RmpM C-term mutants and would show if the increase in molecular weight is an effect 
of the technique used to examine the OMP complex profile of the strains or an increase in the 
amount of the protein involved in the complexes formed. BN-PAGE may provide a better 
methodology for the isolation of complexes, as it does not require a cross-linking step that may 
introduce artefactual associations into the samples.
The loss of the N-terminal functionality of RmpM in the ArmpM strain lowered the optimum 
temperature for growth and extended lag times when the strain is grown at higher temperatures.
Changes in temperature can alter the fluidity of the outer membrane (99) and although gross changes 
in fluidity occur over a wide temperature range, changes of 10°C are sufficient to alter the fluidity of 
, the cytoplasmic membrane in E. coli (157). Changes in membrane fluidity, combined with a decrease 
in stability of the protein complexes could explain the effects of temperature on the growth of the 
ArmpM  strain. Lower temperatures may reduce the requirement for RmpM to stabilize the protein 
complexes and leading to better growth of the ArmpM  strain. The unchanged antibiotic sensitivity of 
the ArmpM  strain suggested there was no gross change in the permeability of the outer membrane. 
The comparison of phenotypes in the ArmpM  and RmpM C-term mutants therefore showed that 
although the N-terminal end of the RmpM protein was important in the stability of outer membrane 
protein complexes, destabilization of protein complexes did not cause significant disruption to the 
outer membrane.
The C-terminal end of the RmpM protein contains the region hypothesized to be involved in the 
binding of peptidoglycan. Frequent sites of vesiculation were observed on both the ArmpM and the 
RmpM C-term mutant by election microscopy. This indicated that the truncation of the protein had 
affected the peptidoglycan binding function, leading to the outer membrane being disconnected from 
the peptidoglycan. It also showed that it was likely to be the loss of the C-terminal of RmpM that 
caused increased vesiculation in the strains. The increase in the number of vesicles produced by both 
strains indicated the importance of RmpM as a major structural protein. In samples prepared in PBS 
for cryo-EM, large areas of outer membrane disconnected from the peptidoglycan were seen in the 
RmpM C-term mutant. However, the lack of large areas of disconnected membrane in RmpM C-term 
mutants prepared in Mueller Hinton broth and the absence of unusually large vesicles in the native 
vesicle preparation suggested that this was an artefact of the preparation method rather than a 
consequence of the mutation.
Both the ArmpM and RmpM C-term mutants released large numbers of OMVs, but the differences
between the two mutants offered further insights into the production of vesicles by rmpM  mutants.
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Normal growth of the RmpM C-term mutants showed that the increased production of vesicles does 
not affect .the growth rate of the organism. In fact, the measurements of porin proteins and electron
microscopy indicated that the RmpM C-term mutant was producing more vesicles than the ArmpM
\
mutant. Although not significantly different in size and shape, the RmpM C-term vesicles appear more 
consistent than both the wildtype and ArmpM vesicles. However, regular packing of vesicles in the ice 
as can be observed in the RmpM C-term sample may cause the vesicles to appear more regular than if 
the sample was diluted. As well as indicating increased vesicle production, the immunoassay for the 
porin proteins showed a different ratio between PorA and PorB in the RmpM C-term sample 
compared to ArmpM. This indicated that PorA was enriched relative to the amount of PorB in the 
vesicles of the RmpM C-term mutant, although further experiments are required to confirm this 
result. Upregulation of PorA, which has variable expression levels (152), could also contribute to the 
increase, but no increase was seen in the levels of denatured PorA in the SDS-PAGE gels of the RmpM 
C-term strain or OMVs. The most.likely explanation for the observed change in the amount of PorA 
was a difference in between the ArmpM  and RmpM C-term mutants in the stability of OMP 
complexes. Stable OMP complexes containing RmpM C-term probably persist longer in the 
membrane, making the complexes more likely to be included in OMVs than monomeric forms of the 
proteins. RmpM has been shown to associate both with homotrimers and heteromeric complexes of 
the porin proteins (64,88), with the majority of complexes observed as heteromers (88,119-121). 
Therefore, the ratio of PorA to PorB in the heteromeric complexes may be affecting the ratio of the 
proteins in the vesicles. Better.evidence of the in vivo stoichiometry of porin complexes, or high 
enough levels of wildtype vesicles to measure the porin content of these vesicles accurately by 
immunoassay, would be required to test this hypothesis.
The RmpM protein examined in this study is multifunctional. The C-terminal domain provides an 
anchor for the outer membrane to the peptidoglycan, stabilizing the outer membrane and preventing 
the bacteria from releasing high levels of OMVs. The N-terminal domain maintains the stability of the
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porin complexes and other complexes such as those involving Omp85 (162). Better definition of the 
N-terminal domain of RmpM is needed to fully understand the effects of specific interactions on the 
stability of outer membrane protein complexes. The differences between the vesicles produced by 
the ArmpM and RmpM C-term mutants show the importance of fully understanding the role the N- 
terminus of RmpM plays in vesicle composition. Increased vesicle production and enrichment of the 
immunodominant PorA protein are both likely to be important for the production of native vesicle 
vaccines.
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Chapter 7 - Discussion
The aim of this study was to investigate the factors involved in vesicle release from N. meningitidis, by 
elucidating the roles of two N. meningitidis proteins (GNA33 and RmpM) that were thought to affect 
the release of OMVs and have a structural function in the cell wall. The £  coli protein complex Tol- 
Pal, which is common in Gram negative bacteria but absent in N. meningitidis and other species with 
high vesicle production, was inserted to test if expression of the complex would decrease vesicle 
production in the strain. Wildtype vesiculation in N. meningitidis is known to be higher than that of 
other Gram negative species such as E. coli. The four mutants created by the study all had a 
phenotype of increased vesiculation. This phenotype was expected in the Agna33 and ArmpM 
mutants, but was surprising in the strain with an inserted tol-pal complex. In £  coli Tol-Pal stabilises 
the outer membrane and mutation of the complex leads to increased vesicle production. The mutants 
also showed distinct phenotypes, differing in growth and membrane stability as well as in the size and 
variability of the vesicles they produced.
The Agna33 and gna33 single crossover::tol-pal mutants produced vesicles that were similar when 
compared to each other. However, the OMVs were significantly larger and more variable in size than 
those of their respective background strains. In contrast the two mutants of the RmpM protein 
(ArmpM and RmpM C-term) produced a much greater number of vesicles than all of the other strains 
and these vesicles were similar in size compared to the wildtype. The four mutants could therefore be 
divided into two groups; strains that produced increased levels of wildtype-like vesicles and strains 
that produced vesicles with an altered morphology.
7.1 Vesicles similar to the wildtype
The increase in vesiculation in the rmpM  mutants has been shown by this study to be related to the 
C-terminal peptidoglycan binding function of RmpM. The other function of RmpM as a stabiliser of 
outer membrane protein complexes does not appear to be involved directly with vesiculation in these
187
strains. The production of vesicles in these strains was most likely to be due to the disconnection of 
the outer membrane and the peptidoglycan allowing the outer membrane to bulge and bleb more 
easily. This form of OMV release would be a passive process: vesicles would occur when a local build­
up of turgor pressure caused the membrane to be forced outwards. The similarity of the vesicles to 
those produced by the wildtype suggests that a mechanism for controlling vesicle size was still 
present. Therefore, the control of vesicle size was not related to the RmpM protein.
7.2 Vesicles different to the wildtype
Both the Agna33 and gna33 single crossover::tol-pal strains demonstrated a phenotype consistent 
with outer membrane and peptidoglycan disruption. The Agna33 strain was much more severely 
affected than the tol-pal strain. In both strains disruption to the peptidoglycan was likely to be caused 
by absence or reduction of gna33 expression, as GNA33 is the primary lytic transglycosylase in N. 
meningitidis. Disruption of the outer membrane was probably caused by changes to peptidoglycan 
structure and in addition in the gna33 single crossover::tol-pal by the accumulation of misfolded or 
mislocalised protein in the cell wall. It has been previously hypothesised by Zhou et al. that changes 
to peptidoglycan structure may cause vesiculation by altering the local turgor pressure in regions of 
the outer membrane, causing it to bulge and eventually bleb (175). Membrane disruption is also a 
cause of membrane vesicle release in other Gram negative species and one function of OMV release 
may be to remove misfolded protein from the periplasm (93). Consequently, membrane stress caused 
by misfolded and mislocalised Tol Pal proteins in the cell wall could have lead to vesicle release. The
greater size and variability of these vesicles indicated mechanisms controlling vesicle size are
?
disturbed, due to the disruption of the outer membrane or linked to loss of a specific protein such as 
GNA33.
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7.3 A model of vesicle release in N. meningitidis
Native vesicle release in other Gram negative bacteria has been ascribed to the localised lowering of 
the concentration of proteins linking the peptidoglycan to the outer membrane (31). The results of 
this study suggest that a similar model could be applied to N. meningitidis and could be used to link 
the changes in vesicle release, size and variability in the different mutants studied.
The RmpM protein is ubiquitous in the outer membrane and is the only major outer membrane 
protein shown to have a peptidoglycan binding domain. The RmpM protein therefore is likely to 
represent the major structural linkage between the outer membrane and peptidoglycan in N. > 
meningitidis. Localised disconnection of RmpM from the peptidoglycan or outer membrane would be 
a potential mechanism for increasing the amount of vesicles released. The GNA33 protein also binds 
to both the peptidoglycan and outer membrane, although it is present in the outer membrane at 
much lower levels than RmpM.
In this model of vesicle release, disconnection of the linkage between the outer membrane and 
peptidoglycan provided by RmpM produces regions of membrane more prone to bulging and forming 
membrane blebs. GNA33 and other proteins linking the outer membrane and peptidoglycan provide 
anchors in regions of the membrane. These anchor proteins would most likely include the other 
putative membrane bound lytic transglycosylases identified in the N. meningitidis genome and the 
TonB system. Vesiculation must occur between these protein anchors, controlling the size of the 
vesicles produced. The size of vesicles in the RmpM mutants remains regular because although the 
RmpM protein is absent or disconnected from the peptidoglycan or outer membrane, the anchoring 
proteins prevent large regions of the membrane from disconnecting from the peptidoglycan. When 
the GNA33 protein is mutated vesiculation presumably becomes irregular due to a combination of the 
loss of GNA33 as a protein anchor and disorganisation of the peptidoglycan affecting the distribution 
of other anchoring proteins. Disruption of the distribution of anchor-proteins would result in the
189
formation of irregularly sized vesicles. Widening of the spaces between anchoring proteins will 
increase vesicle size. OMVs from the Agha33 strain showed both increased variability and an 
increased average size. The increased number of vesicles released by the Agna33 mutants is probably 
caused by disruption to the peptidoglycan structure, which could alter the turgor pressure between 
the peptidoglycan and outer membrane. Deletion of gna33 may also cause disconnection of RmpM, 
as the protein may not be able to bind to the disorganised peptidoglycan. Addition of the Tol-Pal 
proteins also disrupts this interaction, by affecting GNA33 expression and potentially interacting with 
other anchoring protein complexes such as TonB. The model of vesicle release is shown in figure 1.
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1. W ildtype
2. A bsence of G N A 33
3. A bsence o f Rm pM
O uter m em brane  
Peptidoglycan IGNA33 protein
T T t  Localised build up Anchor proteins (o ther than GNA33)
I
of turgor pressure 
RmpM protein Absent or disconnected RmpM
Figure 1. Model of veside release in N. m ening itid is. Model of vesicle release in (1) the wildtype, where 
changes to the amount of RmpM connecting the outer membrane to the peptidoglycan, localised build up of 
turgor pressure and presence of anchor proteins with even spacing lead to controlled vesicle release. (2) A 
Agno33 mutant, where loss of GNA33 leads to changes in the spacing of anchor proteins and release of vesicles 
that are larger and more variable in size. (3) A ArmpM  mutant, loss of the connection between the OM and 
peptidoglycan made by RmpM causes increased vesiculation between anchor protein sites, leading to increased 
vesicle number but not increased variability in vesicle size.
Presence of the N-terminal portion of RmpM increases the stability of protein complexes in the outer 
membrane, improving the robustness of bacteria to  changes in growth temperature and increasing 
the number of vesicles released. The increase in vesicle production could be due simply to  improved 
growth of the strain. However, the model of vesicle release described above also indicates another 
method by which protein complexes could affect vesicle release. If turgor pressure is responsible for
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the bulging of the outer membrane, then the number and position of channels that allow the passage 
of water and solutes through the outer membrane will be an important factor in OMV release. The N- 
terminal of the RmpM protein stabilises the Omp85 protein complex, which is the major machinery 
for insertion of (3-barrel proteins into the outer membrane. In the ArmpM mutant fewer (3-barrel 
proteins may be correctly inserted into the outer membrane, reducing the number of channels that 
would allow water and ionic solutes to pass through the outer membrane. This would make a build­
up of turgor pressure and therefore the bulging of the membrane slower to occur in these mutants. 
The RmpM C-term mutant, with its functional N-terminus of RmpM, would produces bulges in the 
outer membrane and vesicles more frequently.
This model makes several predictions about vesiculation and the proteins involved. The first is that 
GNA33 and other potential anchor proteins are not randomly arranged in the membrane. The 
requirement for tight control of GNA33 and its known role in protein complexes to penicillin binding 
protein 2 (37) make it unlikely that the protein is randomly distributed in the cell wall. A second 
prediction of the model is that a double mutant of both Agna33 and ArmpM  would produce large 
vesicles with less control over the size of the vesicles produced. It seems very likely that this mutant 
would not be viable if this model of vesicle release is true. As the GNA33 protein is so important to 
the maintenance of peptidoglycan structure, the loss of RmpM would exacerbate the effects of 
changes in the osmotic pressure between the peptidoglycan and outer membrane resulting in lysis. 
Finally, the model predicts that localised reduction of the number of RmpM protein molecules or 
disconnection of the protein from the outer membrane or peptidoglycan must occur for vesiculation 
to happen in wildtype strains. Testing of these predictions could include examining the vesicle 
releasing phenotypes of strains mutated for other proteins anchoring the outer membrane to the 
peptidoglycan, to confirm these mutants also show irregular vesicles. Monoclonal antibodies raised 
against the potential anchor proteins could also be used with immunogold labelling and electron
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microscopy to examine if the potential anchor proteins show regular arrangements in the outer 
membrane.
7.4 Control of vesicle release in N. meningitidis
Release of large amounts of membrane vesicles does not seem to have a detrimental effect on the 
fitness of meningococci in in vitro culture, as the RmpM C-term mutant demonstrates. However, the 
potential of vesicles to induce an immune response against the bacterium in the host means it would 
be beneficial to the organism to control vesicle release during colonisation. Control of vesicle release 
may also play a part in additional cellular functions. In other Gram negative bacteria, for example E.
• coli and Salmonella enterica (93), evidence has indicated.that elevated vesicle release may be a co­
ordinated response to increased outer membrane stress. In E. coli outer membrane stress can result 
from accumulation of misfolded protein in the periplasm. Consequently the oE pathway is activated 
and leads to protein degradation. However when oE pathway is disrupted misfolded protein is 
preferentially packaged into OMVs and vesicle release is increased. N. meningitidis lacks some of the 
key genes of the oE pathway (chapter 1 table 1 pg. 16). Higher levels of vesicle release in N. 
meningitidis may provide an alternative mechanism for reducing membrane stress. This process 
would have to be tightly controlled in order to maintain outer membrane integrity. Use of a 
microarray could identify changes in gene transcription in response to conditions designed to 
increase stress on the outer membrane. When candidate genes have been identified, the functions 
' of the proteins encoded by them and the effect on OMV release of the mutation of these proteins will 
help identify the pathways involved in response to membrane stress.
The RmpM protein would be a candidate as a method of controlling vesicle release. To increase the 
release of vesicles, the amount of RmpM linking the outer membrane to the peptidoglycan would 
have to be reduced. There are several ways in which this could be achieved. The first would be 
reduction of the expression of RmpM, which would increase vesicle release across the whole outer
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membrane. Reduction of expression would require control of RmpM at the transcriptional or 
translational level, which has not been previously reported. The promoter of rmpM  has not been 
identified, although a putative -10 sequence can be identified 63bp upstream of the rmpM  start 
codon and a -35 sequence 87bp upstream of the start codon. However, little is known about the 
regulation of the rmpM  expression. To quantify the amount of RmpM being expressed real-time PCR 
could be used to quantify changes to RNA expression and western blotting used to quantify the 
amount of protein present in the outer membrane. Alternatively, the arrangement of the RmpM 
protein in the outer membrane could be altered, by degradation of the protein in the outer 
membrane. This would lead to the reduction in the local density of RmpM molecules and the release 
of vesicles from specific areas of the membrane. Using a monoclonal antibody against RmpM, 
immunogold labelling and electron microscopy could be used to examine the positioning of RmpM in 
the cell wall and confirm if concentration is lower in regions of the bacteria which also show vesicle 
formation.
Thirdly, the link between the outer membrane and peptidoglycan formed by RmpM could also be 
severed by preventing the interaction of either the N-terminal domain with outer membrane proteins 
or the C-terminal domain with peptidoglycan. Controlling the formation or stability of either of these 
interactions would allow vesiculation to be initiated or prevented in specific areas of the membrane. 
RmpM does not bind directly to the outer membrane; instead the link is formed by the interaction of 
the N-terminal domain of RmpM with the inner face of outer membrane proteins including the 
porins. The N-terminal has not been fully characterised and the mechanism of interaction and 
complex formation with outer membrane proteins is unknown. Stability of the complexes could be 
affected either by changes to the conformation of the proteins involved in the complexes, or by 
addition of an accessory protein to stabilise the interaction. To date no accessory protein has been 
identified in mass spectrometry of complexes containing PorA, PorB and RmpM (89).The N-terminal 
portion of RmpM contains serine, tyrosine and threonine residues. Phosphorylation of these amino
acids is a common mechanism of controlling protein interactions and could also modulate the binding 
of RmpM protein. The C-terminal OmpA like domain is common amongst outer membrane proteins 
of Gram negative bacteria, but a mechanism to control the interaction of this domain has never been 
reported. RmpM has been shown to be present in outer membrane vesicles indicating that the 
disconnection of RmpM is more likely to occur at the C-terminal end of the protein, leaving RmpM 
attached to the protein complexes in the vesicles. Previous work has indicated that RmpM may bind 
peptidoglycan as a dimer (54), therefore control of the interaction could stem from either direct 
conformational changes in the peptidoglycan binding site, or by changes to the residues controlling 
dimerization of the protein. However, if conformational changes are responsible for control of the 
protein interactions at either end of the protein, then it may be possible to identify residues in the 
putative binding sites of the proteins by protein modelling. Site directed mutagenesis could then be
used to mutate these residues and identify changes in complexes formed with RmpM or interactions
/
of RmpM with the OMP or peptidoglycan.
Of these three potential methods of controlling RmpM linkage, the third would allow for the fastest 
and most sensitive response to changing conditions in the outer membrane, as it would not require 
changes to expression, degradation or protein transport.
7.5 Vesicle releasing mutants and vaccines
To date, the production of OMV vaccines has been based on a detergent extraction process to 
produce a sufficient amount of vesicles from bacterial cultures. Detergent extraction is an efficient 
means of vesicle production and has the additional benefit of reducing the amount of endotoxic 
components in the vesicles. However it has been shown that the proteomic profiles of detergent 
extracted vesicles differ from those of vesicles natively produced by a Agna33 mutant. The detergent 
extracted vesicles contained more cytoplasmic proteins while some lipoprotein antigens were .
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solubilised and therefore reduced or even lost from the vaccine preparation. Native vesicles also 
offered broader cross protection than detergent derived vesicles from the same strain (37).
Production of large amounts of native outer membrane vesicles is therefore an attractive method of 
OMV vaccine production. Deletion of the rmpM  gene has been shown to be an effective method of 
increasing native vesicle release (150). An ArmpM  mutant is already being used as a strain for 
production of the multivalent PorA vesicle vaccines known as HexaMen and NonaMen (151), 
although detergent is still used to extract vesicles (84). In addition to the problems of producing 
enough native vesicles for vaccine production, the attenuation of the endotoxic LOS component of 
the vesicles must also be considered. Reduction of LOS has been achieved by deletion of the IpxA 
gene (133), but if LOS is reduced, the adjuvant effect of the LOS component is also lost. By contrast, 
deletion of the IpxLl gene changes the structure of the LOS, reducing the endotoxic effect but 
maintaining the adjuvant activity (150,154). The ability to make these modifications to the LOS 
component is therefore an important consideration in any N. meningitidis vaccine candidate strain.
Other factors also have to be considered in the development of a potential native OMV vaccine 
candidate, including the content of the immunogenic proteins, such as the immunodominant PorA 
protein. Consistency is also key; subsequent lots of vaccine must be similar to the vaccine lots for 
which clinical efficacy has been established to ensure that safe, effective vaccine is always produced. 
Standardisation of the vaccine will be made easier if the vesicles produced by the strain are consistent 
in terms of size and quantities of the protein antigens. The four strains examined in this study all 
vesiculate at a level higher than the wildtype. However, the suitability of any of the strains for vaccine 
production will be affected by the tolerance of the strain to mutation to remove the endotoxic LOS 
component and to the culture conditions required for large scale vaccine production. The consistency 
of the vesicles and the level of immunogenic proteins in the vesicles produced would also be equally 
important.
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The Agna33 mutant strain was originally suggested as a possible candidate for the production of a 
native OMV vaccine (37) and both this strain and the gna33 single crossover::tol-pal strain produce 
increased amounts of vesicles. However, the vesicles produced are highly variable. The Agna33 strain 
exhibits poor growth, membrane instability and a clumping phenotype which are likely to make 
growth in large culture volumes and consistent vesicle production difficult. The gna33 single 
crossover::tol-pal mutant grows normally and both membrane instability and clumping are much 
milder in this strain. However, vesiculation is lower than found in the Agna33 mutant and the strain 
has other potential problems that may make growth in large culture difficult. The change in growth 
conditions when the bacteria are grown on a large scale is likely to lead to changes in the stability of 
the tol-pal genes and cause recombination and loss of the plasmid. Additionally, any vaccine made 
from this strain may contain Tol-Pal proteins. The Pal protein in particular is known to be 
immunogenic, producing antibodies and inducing pro-inflammatory cytokines in mice (149). The 
inclusion of Pal in vesicles may therefore cause additional problems for the safety and 
immunogenicity of the vaccine product.
Both rmpM  strains show good characteristics for a vaccine strain, and a ArmpM  strain is already in 
use in the production of HexaMen (151). However, there are differences between them. The RmpM 
C-term mutant releases more membrane vesicles than the ArmpM  strain and the size of vesicles 
produced appeared less variable in the RmpM C-term mutants. OMVs from the C-term mutant are 
also enriched for the immunodominant PorA protein. The change in the ratios of PorA and PorB in the 
sample suggests that the vesicles are incorporating more PorA when they are released, probably 
because of the inclusion of protein complexes in the vesicles. The effects of complexes in the outer 
membrane on immunogenicity have not been fully explored, but complexes consisting of PorA and 
PorB have been shown to elicit a modified immune response to the proteins, with new 
conformational epitopes present in the PorA/PorB complexes, when presented in liposomes (120). 
The incorporation of increased levels of PorA should increase the immunogenicity of the OMVs
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produced from the RmpM C-term strain. Increasing the level of PorA in the vesicles also means fewer 
OMVs will be required for each vaccine dose. This will decrease the amount of any endotoxic 
components of the OMVs present, which may be useful in improving the safety and cost of any 
vaccine produced. Enrichment of PorA in the vesicles is an important factor to consider if the strain is 
used to produce vesicles for a multivalent PorA vaccine.
Of the strains tested in this study, the combination of high vesicle production, robustness of the 
strain, consistency in the vesicles produced and enrichment for the immunodominant PorA antigen 
makes the RmpM C-term mutant the most attractive candidate for the production of an outer 
membrane vesicle vaccine. The eventual production of a vaccine from this strain would require other 
genetic changes to the strain to remove the endotoxic LOS component. The vaccine may also be 
tailored to deliver multiple subtypes of PorA or enriched for other immunogenic proteins such as 
FetA, fHbp, NHBA, and NadA. A AlpxA/ArmpM strain has been constructed (132), as well as a strain 
producing modified LOS with substantially reduced endotoxin activity (Alpxll) and with a deleted 
rmpM  gene (150). It is therefore likely that RmpM C-term strains could also be manipulated to 
remove the endotoxic LOS component.
A combination vaccine for group B N. meningitidis, which contains both recombinant proteins and
OMVs, has recently been developed and has performed well in clinical trials. The OMV component of
the vaccine has been shown to be very important for its immunogenicity (38,130). Evidence also
shows that broader protection is induced by natively released OMVs (37,150). Therefore the ability
to produce safe, immunogenic native OMVs in large quantities is a major part of N. meningitidis
vaccine development. On a wider scale, OMVs are a potentially vaccine delivery system not only for
N. meningitidis, but also other organisms through the expression of heterologous antigens in the
OMVs. This methodology has already been used to express the NspA protein in OMVs from the
commensal strain N. flavescens (104). Expression of green fluorescent protein in E. coli OMVs has also
been achieved (24). Their natural adjuvant properties, presentation of antigens in the context of the
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v outer membrane and the significant work already done in their production and manipulation could 
make neisserial OMVs an attractive vaccine delivery system for many different antigens.
7.6 Conclusions
I .
Native OMV provide an attractive option for the production of more broadly protective vesicle
vaccines. Understanding the reasons and mechanisms underlying vesicle release is important for the
production of native outer membrane vesicle vaccines, as sufficient levels of safe and consistent
vesicles must be produced without the use of detergent extraction. The current study has produced a
\
model for OMV production in N. meningitidis which may be useful in further developing strains and 
conditions to optimise vesicle production. The work has also shown that the mutation of the C- 
terminal peptidoglycan binding region of RmpM, whilst leaving the N-terminal protein binding region 
functional, creates an excellent candidate strain for vesicle production. This strain produces large 
quantities of membrane vesicles, which are consistent in size and enriched for the PorA protein. By 
expanding the understanding of the mechanisms of vesicle release and the effects of vesicle 
composition the best methods for production of a safe, consistent and effective OMV vaccine will be 
discovered.
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